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Atlanta, Georgia
AGING AND MULTIMORBIDITY
B4-1:
Anesthesia Exposure and Risk of Dementia and
Alzheimer’s Disease: A Prospective Study
Erin J. Aiello Bowles,1 Eric B. Larson,1,2 Ryan P. Pong,3
Rod L. Walker,1 Melissa L. Anderson,1 Onchee Yu,1
Shelly L. Gray,4 Paul K. Crane,2 Sascha Dublin1,5
Group Health Research Institute, Group Health
Cooperative, Seattle, WA; 2Division of General
Internal Medicine, Department of Medicine, University
of Washington, Seattle, WA; 3Department of
Anesthesiology, Virginia Mason Medical Center, Seattle,
WA; 4School of Pharmacy, University of Washington,
Seattle, WA; 5Department of Epidemiology, University
of Washington, Seattle, WA
1

Background/Aims: Studies have demonstrated conflicting
results about the association between anesthesia exposure
and subsequent dementia risk. However, prior studies were
retrospective, collecting data on anesthesia exposure after
determining dementia status. We used prospectively collected
data to evaluate the associations between anesthesia and risk
of dementia or Alzheimer’s disease (AD).
Methods: We conducted a cohort study among communitydwelling members of the Adult Changes in Thought cohort
(N=3,988) who were age 65 or older and free of dementia
at baseline. Participants self-reported all prior surgical
procedures with general or neuraxial (spinal or epidural)
anesthesia at baseline and reported new procedures every two
years. We compared people who had high-risk surgery with
general anesthesia, other surgery with general anesthesia,
and other surgery with neuraxial anesthesia exposures to
those who had no surgery and no anesthesia. We used Cox
proportional hazards models to estimate hazard ratios (HR)
and 95% confidence intervals (CI) for dementia and AD
associated with time-varying lifetime and recent (past 5 years)
anesthesia exposures.
Results: At baseline, 254 (6%) people reported never having
anesthesia; 248 (6%) had one or more high-risk surgeries
with general anesthesia, 3,363 (84%) had one or more
other surgeries with general anesthesia, and 123 (3%) had
one or more surgeries with neuraxial anesthesia. Lifetime
exposure of high-risk surgery with general anesthesia was not
associated with an increased risk of dementia (HR: 0.86, 95%
CI: 0.58–1.28) or AD (HR: 0.95, 95% CI: 0.61–1.49) relative
to no history of anesthesia. People with lifetime exposure
of other surgery with general anesthesia had a lower risk of
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dementia (HR: 0.63, 95% CI: 0.46–0.85) and AD (HR: 0.65,
95% CI: 0.46–0.93) than people with no history of anesthesia.
There was no association between recent anesthesia exposure
and dementia or AD. When comparing the results for highrisk surgery with general anesthesia directly to other surgery
with general anesthesia, HR was 1.37 (95% CI: 1.04–1.80) for
dementia and 1.46 (95% CI: 1.07–1.99) for AD.
Conclusion: Anesthesia exposure was not associated with an
increased risk of dementia or AD in older adults. Future studies
should continue to explore whether there is truly an increased
risk of dementia and AD following high-risk surgery.
Keywords: anesthesia, dementia
A4-2:
Advance Care Planning Practices in Caring for
Vulnerable Elders: An Analysis of Electronic Health
Record Data and Interviews With Physicians
Ellis C. Dillon,1 Judith Chuang,1 Atul Gupta,2 Ming
Tai-Seale1
Palo Alto Medical Foundation Research Institute,
Palo Alto, CA; 2Department of Economics, Stanford
University, Stanford, CA
1

Background/Aims: Because patients with serious illnesses
often reach a point when they cannot speak for themselves,
it is critical to discuss advance care planning (ACP) and
document patient preferences via advance health care
directives (AHCD) and physician orders for life-sustaining
treatment (POLST). We aim to characterize ACP discussion
and documentation practices and determine how a palliative
care program established in 2010 at the Palo Alto Medical
Foundation influenced ACP practices.
Methods: We analyzed Palo Alto Medical Foundation patients
≥ 65 years old who presented from 2013 to 2014 and had no
record of ACP prior to 2013 in the electronic health record
problem list. Logistic regression examined the relationship
between ACP documentation and 1) type of serious illness
(defined by the National Committee for Quality Assurance
Palliative Care measurement set), 2) travel distance to palliative
care specialists, and 3) patient and physician characteristics.
We also interviewed physicians (N=15) in primary care,
oncology, pulmonology and cardiology about ACP.
Results: Among 65,253 patients with no ACP prior to
2013, 11.6% had ACP documentation by the end of 2014
and 88.4% did not. Among those with serious illness, at the
end of 2 years 21.13% had ACP (12.09% AHCD, 5.42%
POLST, 3.62% both) and 78.87% had no ACP. Patients
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with chronic obstructive pulmonary disease were more likely
to have AHCD (odds ratio [OR]: 1.094, P<0.01) and POLST
(OR: 1.215, P<0.01). Greater travel distance to palliative care
lowered the likelihood of documented AHCD (OR: 0.904,
P<0.01) and POLST (OR: 0.866, P<0.01). Male, Asian and
black patients were less likely to have AHCD. Patients with
brain cancer (OR: 4.165, P<0.01), esophageal cancer (OR:
4.697, P<0.05) and debility (OR: 1.923, P<0.01) were more
likely to have POLST. Some interviewed physicians believed
ACP discussions were every physician’s responsibility; others
preferred appointing a “quarterback” (preferably a primary
care physician). Interviewees suggested three stages of ACP: 1)
initial patient-physician conversations, 2) patient investigates/
discusses with family, and 3) follow-up with physician.
Conclusion: The overwhelming majority of older patients
without preexisting ACP do not have ACP documented at the
end of a two-year period, even among patients with serious
illnesses. Systematic efforts are needed to eliminate gender
and racial disparities, integrate palliative care and train current
health care teams to improve ACP.
Keywords: advance care planning, electronic health record
A4-3:
Patient-Reported Outcomes Collected as Part of the
Medicare Annual Wellness Visit in the Health Care
Systems Research Network
Heather Tabano,1 Thomas Gill,2 Kathryn Anzuoni,3
Heather Allore,2 Ann Gruber-Baldini,4 Sascha Dublin,5
Thomas Elliott,6 David Ganz,7 Ming Tai-Seale,8 Jerry
Gurwitz,3 Elizabeth Bayliss1
Institute for Health Research, Kaiser Permanente
Colorado Denver, CO; 2Yale School of Medicine, New
Haven, CT; 3Meyers Primary Care Institute, Worcester,
MA; 4University of Maryland School of Medicine,
Baltimore, MD; 5Group Health Research Institute, Group
Health Cooperative, Seattle, WA; 6HealthPartners
Institute, Bloomington, MN; 7UCLA Department
of Medicine, Los Angeles, CA; 8Palo Alto Medical
Foundation Research Institute, Palo Alto, CA
1

Background/Aims: For seniors with multiple chronic
conditions, patient-reported outcomes (PROs) can provide
meaningful information on patients’ health, well-being
and effects of treatment that transcend specific conditions.
Effective use of PROs for clinical care and research requires
an understanding of their availability and accessibility.
Methods: The data and measures workgroup of the HCSRNOAIC Advancing Geriatric Infrastructure and Network
Growth (AGING) Initiative conducted an electronic survey
to inventory PROs available at each HCSRN site and to
understand their storage and accessibility. PRO domains
inventoried included: self-rated health, functional status,
mood, pain, cognition, fall risk and advance directives. For
each domain, sites were asked to list specific measures used
and to describe PRO data collection, storage and extraction.
The inventory was distributed through the HCSRN governing
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board to representatives at each site.
Results: To date, 15 of 19 HCSRN sites have fully or partially
completed the inventory. Four were unable to participate due
to lack of PRO data or resources. The majority of sites rely
on a combination of systematic outreach and patient initiation
to complete the annual wellness visit (AWV) questionnaire,
with the most complete data coming from the past 5 years.
The percentage of Medicare patients completing an AWV
questionnaire varies among sites, ranging from 5% to 43%.
The most common method of storage is via “Smart Text”
within text fields of the electronic health record. For the AWV,
most sites address three or more of the PRO domains included
in the inventory and many address additional domains as part
of the AWV such as oral health, diet, exercise, incontinence,
substance use and social needs.
Conclusion: Although there is some overlap, the method of
collection, storage and availability of PROs gathered as part of
the Medicare AWV vary widely across HCSRN sites. While
there has been an improvement in the availability of this
information in recent years, most sites’ AWV questionnaire
coverage remains low. The final inventory results will inform
data infrastructure development and data collection processes
across the HCSRN, and will facilitate engagement in multisite
aging research related to multiple chronic conditions.
Keywords: aging, patient-reported outcomes
A4-4:
Multiple Chronic Conditions Associated With Hip
Fracture Outcomes Among Males
Laurel A. Copelend,1 Charlene Quinn,2 Eileen M. Stock,1
Jinmyoung Cho,1 Rashmita Basu,1 John E. Zeber,1 Brian
K. Ahmedani3
Center for Applied Health Research, Baylor Scott &
White Health, Temple, TX; 2University of Maryland
School of Medicine, Baltimore, MD; 3Center for Health
Policy and Health Services Research, Henry Ford
Health System, Detroit, MI
1

Background/Aims: Driven by an agenda to reduce hospital
readmissions in integrated payer-provider systems, this study
examined the association of multiple chronic conditions
(MCC) with outcomes among hip fracture patients, including
30-day readmission and mortality. Models were developed in
the Veterans Health Administration (VA) and will be applied
to HCSRN sites in this collaboration among a Claude D.
Pepper Older American Independence Center, two HCSRN
sites and the VA.
Methods: The retrospective study used VA administrative data
including the Corporate Data Warehouse, a snapshot of the
VA’s all-electronic medical records system updated nightly.
Eligibility criteria were: age > 50, male, hip fracture diagnosis
(ICD-9 code 820) and inpatient hip fracture repair from
October 2008 to September 2009. The primary independent
variable of interest was number of chronic conditions per
the Charlson and Elixhauser indices of comorbidity. Logistic
regression modeled 30-day readmission, 1-year and 5-year
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mortality as a function of MCC, age, race/ethnicity, marriage
status and VA Priority (i.e. 50–100% disabled vs. other status).
Odds ratio (OR) with 95% confidence interval (CI) estimated
increased risk per MCC.
Results: The sample included 3,851 veterans with mean
age of 75 (SD: 11, range: 50–100); 18% were minority race/
ethnicity, 23% were 50–100% disabled and 45% were married.
The top five MCC were hypertension (67%), diabetes (31%),
chronic obstructive pulmonary disease (29%), deficiency
anemia (25%) and depression (24%). MCC per patient
averaged 4.1 (SD: 2.7, range: 0–15). Adverse outcomes ––
30-day readmission (16%), 1-year mortality (31%) and 5-year
mortality (65%) –– were common. MCC were associated with
greater risk of 30-day readmission (OR: 1.14, 95% CI: 1.10–
1.17), 1-year mortality (OR: 1.18, 95% CI: 1.14–1.21) and
5-year mortality (OR: 1.27, 95% CI: 1.23–1.31).
Conclusion: MCC greatly increased risk of adverse outcomes
following hip fracture repair among men, irrespective of
specific types of conditions. Each additional condition
increased risk of readmission by about 14% so that risk
would be doubled for a person with 7 disorders. Risk of
1-year mortality doubled at 5 MCC and of 5-year mortality
at 4 MCC. Supportive services for patients and families may
need to incorporate information regarding risks for patients
with MCC. Next steps include assessing the role of diabetes,
dementia and pharmacotherapy in the relationship between
MCC and hip fracture outcomes, and replicating the study
among private not-for-profit patients in HCSRN.
Keywords: hip fractures, chronic disease
PS1-18:
A Pilot Study of a Tailored Community Volunteer
Intervention for Isolated Older Individuals
Andrew L. Avins,1 Andrea Altschuler1
Division of Research, Kaiser Permanente Northern
California, Oakland, CA
1

Background/Aims: Socially isolated older individuals show
greatly diminished quality of life, poorer outcomes with
chronic medical conditions, greater and accelerated cognitive
decline and a higher incidence of depression. Social isolation
is also one of the strongest known predictors of mortality, with
risks equivalent to or greater than well-known risk factors
such as smoking, excessive alcohol consumption and obesity.
Observational evidence suggests community volunteer work
could help reduce these negative consequences, but a largescale intervention study of volunteer work tailored to the
interests and values of each individual has not been conducted
to date and the feasibility of conducting such a trial has never
been assessed.
Methods: We conducted a small, prospective, single-cohort
pilot study of community volunteer work tailored to each
participant’s interests in order to test its feasibility for use
in a fully powered clinical trial. Eligible patients were > 60
years old and scored > 40 on the UCLA Loneliness Scale
(Version 3). Participants were interviewed at baseline, and
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several relevant volunteer opportunities were identified
(using volunteermatch.com and local resources) from which
participants selected the most appealing opportunities. Study
staff handled all arrangements for initiating the participant’s
volunteer work, and participants were asked to volunteer at
least 4 hours per week. Participants were assessed after 2 and
4 months for social isolation, mood, self-esteem, quality of
life and positive states of mind.
Results: Of 12 patients who enrolled in the study, 8
participated in the volunteer intervention. All participants had
positive experiences, and almost all continued working in their
volunteer positions after study closeout. Significant withinperson improvements were identified in UCLA Loneliness
(-5.1, P<0.03) and the Rosenberg Self-Esteem Scale (+3.4,
P<0.01) at 4 months; nonsignificant improvements were
observed in all other measures. Qualitative data revealed
universally positive experiences, with some participants
expressing profoundly beneficial changes in quality of life.
Conclusion: A community volunteer intervention, tailored to
each individual’s interests and values, was found to be feasible
for testing in a future clinical trial, and the intervention
appears promising. Several important lessons were learned;
recruitment and other challenges were noted, and methods for
addressing these difficulties were identified.
Keywords: volunteerism, social isolation
PS1-19:
Multiple Chronic Conditions and Psychosocial
Limitations in a Contemporary Cohort of Patients
Hospitalized With an Acute Coronary Syndrome
Mayra Tisminetzky,1,2 Jerry Gurwitz,1,2,3 David D.
McManus,1,2,4 Jane S. Saczynski,1,2,3 Molly E. Waring,1
Nathaniel Erskine,1 Milena Anatchkova,1 David C.
Parish,5 Darleen Lessard,1 Catarina Kiefe,1 Robert
Goldberg1,2,4
Department of Quantitative Health Sciences, University
of Massachusetts Medical School, Worcester, MA;
2
Meyers Primary Care Institute, Worcester, MA; 3Division
of Geriatric Medicine, University of Massachusetts
Medical School, Worcester, MA; 4Division of
Cardiovascular Medicine, University of Massachusetts
Medical School, Worcester, MA; 5Department of
Community Medicine, Mercer University School of
Medicine, Macon, GA
1

Background/Aims: As adults live longer, multiple chronic
conditions have become more prevalent over the past
several decades. We describe the prevalence of and patient
characteristics associated with cardiac and noncardiac-related
multimorbidities in patients discharged from the hospital after
an acute coronary syndrome.
Methods: We studied 2,174 patients discharged from the
hospital after an acute coronary syndrome at six medical
centers in Massachusetts and Georgia between April 2011
and May 2013. Hospital medical records yielded clinical
information, including presence of 8 cardiac-related and 8
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noncardiac-related morbidities on admission. We assessed
multiple psychosocial characteristics during the index
hospitalization using standardized in-person instruments.
Results: The mean age of the study sample was 61 years,
67% were men, and 81% were non-Hispanic whites. The
most common cardiac-related morbidities were hypertension,
hyperlipidemia and diabetes (76%, 69% and 31%, respectively).
Arthritis, chronic pulmonary disease and depression (20%,
18% and 13%, respectively) were the most common noncardiac
morbidities. Patients with 4 or more morbidities (37% of the
population) were slightly older and more likely to be women
than those with 0–1 morbidity; they were also heavier and
more likely to be cognitively impaired (26% vs. 12%), have
symptoms of moderate/severe depression (31% vs. 15%), have
high perceived stress (48% vs. 32%), have a limited social
network (22% vs. 15%), have low health literacy (42% vs.
31%) and have low health numeracy (54% vs. 42%).
Conclusion: Multimorbidity –– highly prevalent in patients
hospitalized with an acute coronary syndrome –– is associated
with psychosocial characteristics. This emphasizes the
challenge of caring for these patients, which extends well
beyond acute coronary syndrome management.
Keywords: multimorbidity, acute coronary syndrome

clinical outcomes, including hospitalization and short- and
long-term mortality, in patients with cardiovascular disease,
and essentially no data on universal health outcomes (i.e.
health-related quality of life, symptom burden and function).
There is also a lack of consistency in the manner in which
the burden of multimorbidity is assessed and characterized.
Very few studies have addressed the true complexity of older
patients with cardiovascular disease; how best to characterize
multimorbidity in these patients and to relate this to clinical
outcomes remains a substantial challenge.
Keywords: multimorbidity, cardiovascular disease
PS-21:
New News From the Adult Changes in Thought
Study: A Long-Standing Living Laboratory of Aging
Funded for Five More Years
Eric B. Larson,1 Erin J. Aiello Bowles,1 Rod L. Walker,1
Melissa L. Anderson,1 Darlene White,1 KatieRose
Richmire,1 William W. Lee,1 Steven L. Balch,1 Andrea
Z. LaCroix,2 Dori Rosenberg,1 Sascha Dublin,1 Paul K.
Crane3
Group Health Research Institute, Group Health
Cooperative, Seattle, WA; 2Department of Family
Medicine and Public Health, University of CaliforniaSan Diego, San Diego, CA; 3Department of Medicine,
University of Washington, Seattle, WA
1

PS-20:
Impact of Multimorbidity on Clinical Outcomes
in Older Adults With Cardiovascular Disease: A
Literature Review
Mayra Tisminetzky,1 Robert Goldberg,1,3 Jerry H.
Gurwitz2
Meyers Primary Care Institute, Worcester, MA;
Department of Quantitative Health Sciences, University
of Massachusetts, Worcester, MA; 3Division of Geriatric
Medicine, University of Massachusetts, Worcester, MA
1
2

Background/Aims: We aimed to synthesize the current
literature on the magnitude and impact of multiple chronic
conditions on clinical outcomes, including total in-hospital
and postdischarge mortality and hospitalizations, in older
patients with cardiovascular disease.
Methods: A systematic review was conducted. Four
electronic databases and article bibliographies were searched
for publications from 2005 to 2015 that assessed the impact
of multimorbidity on clinical outcomes in the elderly with
cardiovascular disease. Identified studies were screened using
predefined criteria for eligibility.
Results: Fifteen studies met our inclusion criteria.
Multimorbidity was assessed by simply counting morbidities
and/or by the Charlson and Elixhauser indices. Most the
studies reported a significant association between number of
morbidities or selected morbidities and the risk of dying; the
most frequent conditions examined were diabetes, chronic
kidney disease, anemia, chronic pulmonary disease and
dementia/cognitive impairment.
Conclusion: There are limited data available on the
magnitude and impact of multiple chronic conditions on
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Background/Aims: Delivery system-based research in
enumerated populations provides a unique opportunity to
study complex chronic diseases as they develop. Studies of
disorders that affect people late in life can be particularly
valuable. The Adult Changes in Thought (ACT) study was
recently awarded five more years of funding. This makes ACT
one of the longest continually funded studies and establishes
it as a preeminent living laboratory for aging research.
Methods: Originally a joint project between Group Health
and the University of Washington, the ACT study recruited a
cohort of randomly selected Group Health enrollees over age
65 without dementia from 1994 to 1996. Initially 2,581 persons
were recruited, but in response to cohort shrinkage over time,
we developed expansion and ongoing replacement strategies
to maintain a currently active cohort of approximately 2,000
living persons who are followed every 2 years. The original
outcomes of interest in ACT were Alzheimer’s disease and
related dementias based on standardized diagnostic methods
supplemented by neuropathologic outcomes. This funding
cycle we’ve added a new outcome “resilience” to specifically
study persons who defy expectations by avoiding cognitive
decline and frailty well into late life.
Results: ACT has enrolled over 5,000 subjects to date and
includes over 1,000 cases of incident dementia (over 70%
Alzheimer’s disease) and over 600 autopsy cases, of which
about half have extensive frozen tissues from a rapid autopsy
protocol. The laboratory now includes a biobank with a vast
array of genomic information along with a population-based
neuropathology biobank that is unique worldwide. The new
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funding cycle will include state-of-the-art measures of physical
activity (e.g. accelerometers, inclinometers) to determine
how physical activity and sedentary time affect outcomes,
especially resilience, and also include unique neuropathologic
markers (synaptosomes and histelide) to better understand
brain aging. ACT has always supported other investigations,
and we are well equipped to support HCSRN scientists who
wish to use our living learning laboratory of aging.
Conclusion: The long-running ACT study in the new funding
cycle will focus on the science of aging and multimorbidity,
understanding resiliency and robust aging, and sharing data
from our extensive data repository for other studies of interest.
Keywords: aging, resiliency

preferences in the context of interpersonal, organizational and
community factors. It can be used to understand within-person
changes over time as well as between-person differences at a
single point in time. The Cycle of Complexity can be applied
to evaluation of multiple outcomes and acknowledges possible
health decline as well as resilience.
Conclusion: The Cycle of Complexity model may inform
studies on the etiology of and changes in patient complexity,
the relationship between complexity and patient outcomes,
and intervention development to improve modifiable elements
of care for complex patients. The model may be helpful in
applying big data resources to address research questions
relevant to medically complex populations.
Keywords: multimorbidity, resilience

PS-22:
A Systematic Review of Conceptual Frameworks of
Medical Complexity and New Model Development

CANCER

Leah Zullig,1 Heather E. Whitson,2 S. Nicole Hastings,1
Christopher Beadles,3 Julia Krauchanka,4 Igor
Akushevich,5 Matthew Maciejewski1

B3-1:
Survival After Recurrence of Stage I–III Breast,
Colorectal, and Lung Cancer

Health Services Research and Development, Durham
VA Medical Center, Duke University Medical Center,
Durham, NC; 2HCSRN-OAIC AGING Initiative, Durham
VA Medical Center, Duke University Medical Center,
Durham, NC; 3Health Services Research, University of
North Carolina at Chapel Hill, Chapel Hill, NC; 4Duke
University, Durham, NC; 5Center for Population Health,
Duke University, Durham, NC

Michael J. Hassett,1 Hajime Uno,2 Angel M. Cronin,1
Nikki M. Carroll,3 Mark C. Hornbrook,4 Debra Ritzwoller3

Background/Aims: Patient complexity entails multimorbidity
as well as interacting contextual factors that affect patient
risk for adverse outcomes. Our objective was to develop a
conceptual model of factors relating to patients’ medical
complexity by addressing gaps identified in a review of
published conceptual models.
Methods: We searched for English-language MEDLINE
papers published between Jan. 1, 2004, and Jan. 16, 2014.
Two reviewers independently evaluated abstracts. All authors
contributed to the development of the conceptual model in an
iterative process.
Results: From 1,606 identified abstracts, six conceptual models
were selected. One additional model was identified through
reference review. These models included works by Capobianco
and Lio (2013), Giovannetti et al. (2013), Grembowski et
al. (2014), Holzhausen et al. (2011), Piette and Kerr (2006),
Safford et al. (2007) and Shippee et al. (2010). Each model
had strengths, but several constructs were not fully considered:
1) contextual factors such as interpersonal, organizational or
community relations; 2) dynamics of complexity as a condition
that fluctuates over time; 3) patient preferences; 4) acute
health shocks and medical events that influence health; and 5)
resilience in the face of such stressors. To build on prior literature
while addressing these gaps, we developed a new model, the
“Cycle of Complexity.” This model illustrates relationships
between acute shocks and health events, health care access
and utilization, patient workload and capacity, and patient

Background/Aims: Cancer recurrence is common, costly
and lethal. Little is known about it in community-based
populations, in part because electronic health records and
tumor registries usually lack recurrence status. We examined
determinants of survival duration after recurrence of breast,
colorectal and lung cancers using two databases with excellent
recurrence and death data.
Methods: Recurrence data were abstracted from medical
records in the Cancer Care Outcomes Research and
Surveillance (CanCORS) study and by two Cancer Research
Network (CRN) sites — Kaiser Permanente Colorado and
Kaiser Permanente Northwest. Death data were extracted from
death certificates collected from the National Death Index or
health plans. Claims and utilization data provided information
on comorbidities and treatments. CanCORS enrolled only those
patients who consented, whereas the HCSRN-CRN sample
included all eligible patients who received care. This analysis
included 1,653 patients who developed recurrence after having
had definitive therapy for stage I–III cancer and were followed
for at least one day after recurrence.
Results: Restricted mean survival times (RMST) after
recurrence for breast, colorectal and lung cancer patients
were 34.0, 27.7 and 16.9 months, respectively. Multivariable
models revealed lower RMST in breast cancer was associated
with: age ≥ 70 (vs. < 55), higher comorbidity burden (2+ vs.
0), stage III (vs. stage 1), chemotherapy for primary tumor
(vs. no chemotherapy), and distant/regional recurrence vs.

1
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Dana-Farber Cancer Institute, Boston, MA; 2Harvard
Medical School, Boston, MA; 3Institute for Health
Research, Kaiser Permanente Colorado, Denver,
CO; 4Center for Health Research, Kaiser Permanente
Northwest, Portland, OR
1
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local. Higher RMST in breast cancer was associated with:
longer time to recurrence, and stage III and radiation for
primary tumor (vs. stage I or no radiation for primary tumor).
Lower RMST in colorectal cancer was associated with: age ≥
70 (vs. < 55), comorbidity burden ≥ 1 (vs. 0), distant/regional
recurrence (vs. local), and radiation therapy for recurrence
(vs. no radiation). Higher RMST in colorectal cancer was
associated with: chemotherapy for recurrence but not for
primary (vs. no chemotherapy for primary or recurrence).
Higher RMST in lung cancer was associated with: income ≥
$60,000 (vs. < $20,000). Lower RMST in lung cancer was
associated with: stage III (vs. stage I), and interaction of
income ≥ $60,000 and comorbidity burden ≥ 2 (vs. income <
$60,000 or comorbidity of 0).
Conclusion: Breast and colorectal, but not lung, cancer patients
with local recurrences had longer survival than those with
regional/distant recurrences. Shorter time to recurrence was
associated with inferior survival after recurrence among breast
cancer patients only. Original cancer stage was a predictor of
survival after recurrence; original cancer grade was not.
Keywords: cancer recurrence, cancer outcomes
B3-2:
Development of Data Infrastructure to Monitor
Lung Cancer Screening Use and Outcomes in Four
Cancer Research Network Sites
V. Paul Doria-Rose,1 Lori C. Sadoka,2 Christine M.
Neslund-Dudas,3 Debra P. Ritzwoller,4 Heather S.
Feigelson,4 Michael J. Simoff,5 Lawrence H. Kushi,2
Michael K. Gould6
Healthcare Delivery Research Program, National
Cancer Institute, Bethesda, MD; 2Division of Research,
Kaiser Permanente Northern California, Oakland,
CA; 3Department of Public Health Sciences, Henry
Ford Health System, Detroit, MI; 4Institute for Health
Research, Kaiser Permanente Colorado, Denver, CO;
5
Henry Ford Hospital, Henry Ford Health System,
Detroit, MI; 6Department of Research & Evaluation,
Kaiser Permanente Southern California, Pasadena, CA
1

Background/Aims: With the National Lung Screening Trial
finding a 20% reduction in lung cancer mortality among
individuals screened by low-dose computed tomography
(LDCT) versus chest radiography, and the subsequent
U.S. Preventive Services Task Force (USPSTF) grade B
recommendation, lung cancer screening is reemerging as a
priority area in cancer prevention research. Questions remain,
however, as to whether the ratio of benefits to harm observed in
the National Lung Screening Trial will differ in routine clinical
practice. Furthermore, in its National Coverage Determination,
the Centers for Medicare & Medicaid Services (CMS) required
that all facilities performing LDCT submit screening data to an
approved registry. To facilitate research, quality improvement
and compliance with CMS requirements, there is a need to
create data systems to monitor LDCT screening.
Methods: The Cancer Research Network (CRN) provides
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infrastructure support to promote cancer research within
integrated health care systems. Four CRN sites received pilot
funding from the National Cancer Institute starting in December
2014 to develop capacity to collect data regarding several
aspects of LDCT screening: eligibility (e.g. smoking status),
exam indication (e.g. screening or surveillance), exam results
(Lung-RADS category, nodule characteristics), and early
outcomes (lung cancer detection, follow-up diagnostic testing).
Results: The four sites include the Henry Ford Health
System and three Kaiser Permanente regions (Colorado,
Northern California and Southern California). All sites
use USPSTF recommendations (or slight variations) for
screening eligibility; collectively, approximately 150,000
health plan members within these systems are eligible for
screening. Implementation of screening ranged from a small
pilot program starting at two medical centers to more broad
availability at the other sites, with varying degrees of outreach
to promote screening. Strategies to collect information on
LDCT include referral templates that ascertain eligibility
and exam indication, use of hashtags for extraction of LungRADS category from radiology reports, retrieval of structured
data from electronic health records and natural language
processing to ascertain nodule characteristics.
Conclusion: Screening registry data collection is often laborintensive, requiring manual abstraction of medical record
information. The development of strategies and tools to
efficiently extract LDCT screening data from medical record
systems will facilitate research to assess the utilization and
outcomes of lung cancer screening as it is implemented in
community settings.
Keywords: lung cancer, screening
B3-3:
Feasibility of Establishing a Cohort in the Setting of
U.S. Health Care Systems
Amanda Black,1 Amy Berrington de Gonzalez,1 Robert
Hoover,1 LeeAnn M. Rohm,2 Andrew Sterrett,2 Nicolas
Wentzensen,1 Michelle Wrenn,2 Hannah P. Yang,1
Heather Spencer Feigelson2
Division of Cancer Epidemiology and Genetics, National
Cancer Institute, Bethesda, MD; 2Institute for Health
Research, Kaiser Permanente Colorado, Denver, CO
1

Background/Aims: Epidemiologic cohorts have contributed
substantially to our understanding of potential risk factors
and biological markers for cancer and other chronic diseases.
Integrated health care systems offer a promising setting to
establish a new large-scale prospective biospecimen-based
cohort for research on disease etiology and outcomes. Health
care systems with electronic medical records provide some
unique advantages for establishing the next generation of
cohort studies. Our objective in this Kaiser Permanente
Colorado (KPCO) pilot study was to assess the feasibility
of leveraging existing health care system infrastructure to
establish a prospective cohort.
Methods: In 2014, a total of 1,350 eligible KPCO members
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(aged 40–74 years, cancer-free, KPCO member for at least
12 months) were invited to participate, 850 via email and 500
via mail. Participants were asked to provide a blood sample
and to complete a self-report risk factor survey. An interactive
voice response system was used for participant reminders.
Results: Of those randomized to receive an email invitation to
participate, 630 (74%) had a valid email address; 98% (n=490)
in the mail arm had a valid mailing address for a total of 1,120
contactable members. Overall, 115 individuals consented to
participate, with greater recruitment success in the email arm
(12%) than in the mail arm (8%). Of those who consented,
86 (75%) provided a blood sample and 94 (82%) completed
and returned the survey by mail. In both arms, more females
than males consented, with the highest consent rate among
60–69-year-olds and the lowest among 40–49-year-olds.
The majority of participants in both arms were non-Hispanic
white. Compared to the mail arm, there was a greater consent
rate among women (68% vs. 57%), African-Americans (5%
vs. 3%) and Hispanics (22% vs. 17%) in the email arm. There
was a lower consent rate in the email arm among members
over 70 years old (9% vs. 20%).
Conclusion: The success of this study demonstrates the
feasibility of implementing a biospecimen-based cohort in a
health care system setting. The study also served to highlight
potential problems as well as solutions to these issues.
Keywords: feasibility study, cancer
B3-4:
Rapid Case Ascertainment –– Two Algorithms to
Identify Newly Diagnosed Cancer
Christina L. Clarke,1 Sheila Weinmann,2 Stephen K.
Van Den Eeden,3 Don Bachman,2 Jun Shan,3 Michelle
Wrenn,1 Heather S. Feigelson1
Institute for Health Research, Kaiser Permanente
Colorado, Denver, CO; 2Center for Health Research,
Kaiser Permanente Northwest, Portland, OR; 3Division
of Research, Kaiser Permanente Northern California,
Oakland, CA
1

Background/Aims: The Kaiser Permanente Research Bank is
a biobanking effort that includes a general cohort, a pregnancy
cohort and a cancer cohort. A priority of the cancer cohort is
rapid case identification (RCA) of newly diagnosed members.
Because of the large volume of cancer cases diagnosed each
year across Kaiser Permanente, this method must be automated
and utilize electronic files; manual review of records is not
feasible. We developed two algorithms using pathology reports
that could identify most newly diagnosed cancers within days
of diagnosis.
Methods: We developed two RCA algorithms; one utilized
systematized nomenclature of medicine (SNOMED) codes
and one used natural language processing (NLP) to read
directly from the pathology report. All available pathology
reports with SNOMED coding for 2013 were analyzed with
SAS software at Kaiser Permanente Northwest (KPNW),
Colorado (KPCO) and Northern California (KPNC), and all
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available 2013 pathology reports from KPCO were analyzed
for NLP and processed using Linguamatics I2E. Cancer cases
that were flagged using SNOMED or NLP were compared to
the 2013 Virtual Tumor Registry (VTR, the gold standard) at
each participating site to obtain sensitivity and specificity of the
algorithm. We analyzed the data against all reportable cancers
as well as against those that were diagnosed within a Kaiser
Permanente facility and through pathology (limited VTR).
Results: Using the full VTR, the sensitivity for the SNOMED
algorithm was 54%, 60% and 85% for KPCO, KPNW and
KPNC, respectively. Specificity was 94%, 94% and 90%,
respectively. When using the limited VTR, the sensitivity
increased to 75%, 74% and 94%, respectively. The NLP
algorithm at KPCO resulted in a higher sensitivity (58% full
VTR, 80% limited VTR) than the SNOMED algorithm but a
lower specificity (89%). Importantly, the RCA methods capture
a wide range of cancer types across all stages.
Conclusion: Our two RCA algorithms are able to capture up
to 80% of all cancer cases diagnosed while minimizing the
number of people falsely identified as having cancer. These
methods should help us minimize survival bias in the cancer
cohort and possibly allow us to collect pretreatment blood
samples on a portion of our cohort members.
Keywords: algorithm, cancer
PS2-41:
Process-Related Quality Measures of Early- and
Late-Stage Laryngeal Cancer Care
Steven Chang1
Department of Public Health Sciences, Henry Ford
Health System, Detroit, MI
1

Background/Aims: The purpose of this study was to evaluate
the quality measures established by the American Head and
Neck Society (AHNS) quality committee. The measures were
intended to assess quality care in treating laryngeal cancer
beyond the traditional measures of survival and locoregional
control. This study also attempted to identify specific measures
from within AHNS guidelines that may relate to locoregional
control and/or survival.
Methods: Retrospective review of patients with laryngeal
cancer at a tertiary, academic center between 1991 and 2012.
Patients were divided into early stage and late stage based on
American Joint Committee on Cancer staging and analyzed
separately. The major measures of quality, including overall
survival, proper staging of the tumor prior to initiation of
treatment, documentation of adverse pathology features
(perineural invasion, lymphovascular invasion, positive
margin, extracapsular spread), appropriate referral for
adjuvant therapy (radiation and/or chemotherapy) and proper
adherence to follow-up per National Comprehensive Cancer
Network guidelines, were examined. The influence of these
measures on survival also was analyzed.
Results: A total of 806 cases of laryngeal cancer were
identified. Of those, 76.9% had proper documentation of
tumor-node-metastasis staging. Of the 602 staged, 56% were
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early stage and 44% were late stage, 55% had documentation
of adverse pathology, 52% were given appropriate referral
for radiation therapy and 70% had appropriate follow-up.
There was a statistically significant difference in survival for
those patients who received appropriate initial staging when
compared to nonstaged cases. This significance persisted
when controlling for early- versus late-stage cases.
Conclusion: This study supports the validity of processrelated quality measures from the AHNS. This is the first
study of head and neck cancers suggesting that processrelated measures can influence outcome measures such as
overall survival.
Keywords: head and neck cancer, outcomes and quality
PS2-42:
Multiple Myeloma Data in the Cancer Research
Network
Rebecca A. Ziebell,1 Jessica Chubak,1 Mara M. Epstein2
Group Health Research Institute, Group Health
Cooperative, Seattle, WA; 2Meyers Primary Care
Institute, Worcester, MA
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Background/Aims: Multiple myeloma is a rare plasma
cell cancer that disproportionately affects men and blacks/
African-Americans. Research supported by initiatives such as
the Cancer Research Network (CRN) is needed to advance
knowledge about this uncommon but increasingly prevalent
disease. The CRN is a consortium funded by the National
Cancer Institute to support cancer research among a subset
of HCSRN sites. The data collected and maintained by
CRN sites facilitate a variety of multiple myeloma research
opportunities.
Methods: Data from eight funded and three affiliate CRN
sites were included in this analysis. Counts and characteristics
of multiple myeloma diagnoses during 2003–2012 were
obtained from the CRN Cancer Counter, an informatics tool
that provides aggregate data to assist in study planning. Sitespecific descriptive analyses included annual counts of incident
cases as well as demographic distributions. Updated counts,
enrollee retention metrics and cancer treatment information
will be obtained from each site’s Virtual Data Warehouse in
early 2016 via a centrally developed SAS software program.
Results: During 2003–2012, 5,137 multiple myeloma cases
were diagnosed among 11 CRN sites. Annual diagnoses
increased steadily from 405 cases in 2003 to 610 in 2012.
The majority of diagnoses (61%; n=3,117) occurred among
persons age 65 or older, although that percentage ranged from
37% to 70% across sites. Males accounted for 57% (n=2,920)
of diagnoses with a range of 49–63% across sites. Blacks/
African-Americans comprised 13% (n=686) of total diagnoses,
although two sites contributed > 80% of those cases. Among
persons with known ethnicity, Hispanics accounted for 7%
(n=289) of diagnoses, with one site contributing nearly 80%
of those cases.
Conclusion: The CRN supports the infrastructure to maintain
high-quality data (from tumor registries as well as internal health
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plan systems) on patients diagnosed with cancer at participating
sites. Furthermore, the multisite CRN environment allows
for the study of rare cancers among a large, demographically
diverse patient population. Thus, the CRN provides a setting
that is well suited for research in what is potentially one of the
largest multiple myeloma cohorts with longitudinal data.
Keywords: multiple myeloma, cancer
PS-43:
Determinants of Patient Choice of Health Care
Providers for Breast Cancer Treatment
Ashish Rai,1 Caroline A. Thompson,2 Allison W. Kurian,3
Harold S. Luft1
Palo Alto Medical Foundation for Health Care, Research
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Background/Aims: Unless they are constrained by their
insurance coverage, patients routinely seen within an
integrated delivery system (IDS) have choices as to where
they will be treated. If the IDS provides a reasonably broad
range of cancer services, a major alternative will be an
academic medical center (AMC). We hypothesize that among
breast cancer patients initially diagnosed in a communitybased IDS, the likelihood of seeking cancer-related care in
a nearby AMC will be related to: a) cancer severity, b) other
comorbidities, c) geographic proximity to the AMC vs. the
IDS — likely more important for interventions requiring
frequent visits (e.g. chemo vs. surgery), d) sociodemographic
factors, e) “connectedness” of the patient to the IDS, and f)
enrollment in a capitated plan.
Methods: The Oncoshare database includes all patients
diagnosed with or treated for breast cancer between 2000 and
2013 at Palo Alto Medical Foundation (PAMF), a community
IDS, or Stanford University Medical Center, a neighboring
AMC. The database links electronic health records from both
institutions with data from the California Cancer Registry. We
will examine treatment venues for patients initially diagnosed
at PAMF using electronic health records data to determine
baseline health, comorbidities and breast cancer treatments
and California Cancer Registry data for tumor characteristics,
sociodemographic factors (based on census tract) and primary
payer at diagnosis. Patient “connectedness” is measured by
duration with the primary care provider and number of other
specialists seen at PAMF. We will use multiple variable
logistic regression models to examine determinants of choice
of IDS vs. AMC providers for breast cancer treatment.
Results: During the studied period, 3,784 women were
newly diagnosed at PAMF; 80% received all their treatment
at PAMF, 5% received all their postdiagnostic care at the
AMC, and 4% received treatment at both sites during their
initial cancer episode. Treatment sites were unknown for 11%
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of patients. Analyses to understand these patterns of where
patients seek care are underway.
Conclusion: Observational studies often contrast resource
use and outcomes across delivery systems. If patients have
choices among systems, however, it is critical to understand
whether their reasons for seeking care at different sites may
partially account for observed differences in performance.
Keywords: patterns of care, breast cancer
PS-44:
Restructuring Oncology Payments: Estimates of
Resource Use by Phases of Oncology Care in Breast
Cancer Patients
Ashish Rai,1 Su-Ying Liang,1 Caroline A. Thompson,2
Harold S. Luft1
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Biostatistics, Graduate School of Public Health, San
Diego State University, San Diego, CA
1

Background/Aims: Under the fee-for-service system,
oncologists do not get paid for many high-value and potentially
cost-saving services, but may generate revenue from markups
on certain chemotherapy drugs. The inappropriate incentives
were at the core of an alternative payment model proposed
by American Society of Clinical Oncology (ASCO). ASCO
proposed new payment groups to support vital diagnostic,
treatment and care management services not compensated
under the current system. The aims are to: a) estimate the cost
of oncology care by types of services for each payment group
proposed by ASCO; b) estimate time and resource use for
each payment group; and c) assess whether cost, resource use
and clinician time varies by clinical measures.
Methods: We will use electronic health records (EHR)
data to identify breast cancer patients diagnosed or treated
from 2012 to 2014 at a large health care system in Northern
California. Billings will be assigned to payment groups (e.g.
new patient, treatment month, transition month, monitoring
month) following ASCO’s proposed algorithm. Costs will
be stratified by service types (e.g. infusion, drug expenses,
lab tests) and payment groups. We will use EHR access log
data to estimate clinician time by service or activity type
(e.g. treatment planning, patient education, etc.) within each
payment group. Comorbidities and treatment regimens will be
ascertained from patient encounter data for relevant diagnosis
codes. Natural language processing algorithms will be used
to extract patient performance status (Eastern Cooperative
Oncology Group or Karnofsky functional status). Drug
toxicity and drug administration factors will be calculated
according to the Moffitt scale and the Michiana Hematology
Oncology patient acuity scale. Average cost, time and resource
use from aims (a) and (b) will be adjusted by a composite
factor comprising of comorbidity score, performance status,
drug toxicity factor and drug administration factor.
Results: We have obtained IRB approval and are extracting
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EHR data for the study. Based on past annual averages, we
expect to have data on approximately 2,500 breast cancer
patients diagnosed or treated at the health care system.
Conclusion: This study will provide preliminary but critical
evidence needed for consideration and implementation of
ASCO’s payment model.
Keywords: payment reform, episodes of care
PS-45:
Health Care Utilization and Cancer Incidence
Following Solid Organ Transplant
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Background/Aims: Population-based registry studies have
found increases in lung, kidney, skin and thyroid cancers
among organ transplant recipients compared with the general
population. These studies link data from national transplant
services and state cancer registries, thereby limiting the
ability to describe recommended health care utilization,
including preventive services (e.g. influenza vaccinations)
and outpatient visits (9 within transplant year), and incident
diagnoses of hypertension and diabetes (estimated to be
50% and 18%, respectively). The goal of this study was to
characterize health care utilization and cancer incidence
among solid organ transplant recipients in Kaiser Permanente
Southern California (KPSC).
Methods: KPSC transplant registry data was linked to
electronic medical records on solid organ transplants from
1990 to 2014. Data was stratified by kidney, liver, heart and
lung transplants.
Results: Among 4,336 transplant recipients, 62% (2,703/4,336)
were white, 80% (3,621/4,336) were > 35 years old, 27%
(1,158/4,336) were past smokers and the mean membership
length was 5.6 years. Past smoking was highest for lung transplant
recipients (34%, 63/185) and liver transplant recipients (33%,
418/1,271). Survival among all transplant recipients was 89%
at 2 years posttransplant yet decreased to 65% at 10 years, with
the lowest survival among lung recipients (35% at 10 years).
Within the first year posttransplant, recipients had a mean
number of 5 primary care visits, 7 nephrology visits and 2 visits
each for dermatology, urology, and obstetrics and gynecology
(women). Influenza vaccination rates have increased over time
and were as high as 96% among lung recipients during the 20142015 influenza season. Roughly, 12% (322/2,601) and 14%
(151/1,082) of transplant recipients had an incident diagnosis of
hypertension and diabetes. Finally, there was increased risk of
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all cancers excluding nonmelanoma skin cancer (standardized
incidence ratio: 2.15, 95% confidence interval: 1.93–2.39), with
the largest incidence for non-Hodgkin’s lymphoma, lung cancer
and kidney cancer.
Conclusion: Transplant recipients in KPSC met the recommended
number of outpatient visits, including specialty care visits, within
the first year posttransplant. Incidences of hypertension and
diabetes were lower than expected, and influenza vaccination
rates were high. There was a twofold increase in cancer incidence
among the solid organ transplant population.
Keywords: transplant, cancer incidence
ECI Awardee:
The Impact of Clinical Guidelines on Prostate
Cancer Screening Practices in a Population-Based
Setting, 2000–2013
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decline from 2008 to 2013 (7,151 of 23,749 men in 2013). At
both sites, this decline was attenuated among high-risk men.
Conclusion: This analysis of two population-based electronic
health datasets provides evidence of decreasing use of PSA
testing over time, although high-risk populations experienced a
lesser decline. Although we are unable to determine causality, it
is plausible that results of recent screening trials and/or restrictive
changes to the USPSTF guidelines have impacted PSA testing
practices over the past 14 years. As a next step, we will investigate
trends in medical follow-up to elevated PSA test results.
Keywords: prostate cancer, screening

CARE IMPROVEMENT
B4-1:
Impact of a Medically Complex Patient Care Model
on Cost and Utilization Among Adolescents and
Young Adults With Special Health Care Needs
Daniel D. Maeng,1 Susan R. Snyder,1 Thomas W. Davis2
Center for Health Research, Geisinger Health System,
Danville, PA; 2Department of Internal Medicine,
Geisinger Health System, Danville, PA

2

1

Background/Aims: Controversial clinical guidelines have
recommended against widespread prostate-specific antigen
(PSA) testing, despite evidence suggesting a benefit in certain
populations. This study evaluates the impact of the publication
of prostate cancer screening trial results in 2009 and changes to
the U.S. Preventive Services Task Force (USPSTF) guidelines
in 2012 on temporal trends in the use of PSA tests among men
40–80 years old, with follow-up through 2013.
Methods: Men aged 40–80 without a history of prostate
cancer who sought care at Fallon Health (Meyers Primary
Care Institute [MPCI]) or Henry Ford Health System (HFHS)
contributed to this analysis. We counted one PSA test per
person per calendar year, with rates defined per 1,000 personyears. Men were censored based on prostate cancer diagnosis,
PSA test results ≥ 4 ng/mL, disenrollment, death or end of
follow-up (Dec. 31, 2014). We also examined trends in PSA
testing among high-risk men (African-American, family
history of prostate cancer). Test rates were compared among
three time periods: 2000–2008, 2009–2012 and 2013–2014.
Results: On average, 17,144 men at MPCI and 16,733 men
at HFHS had a PSA test each year. Mean age at PSA test
was 57 years, which increased over time at both sites. PSA
test rates at MPCI declined 33% over the study period from
an average of 474 tests/1,000 person-years (2000–2008) to
391/1,000 person-years (2009–2012) to 317/1,000 personyears (2013). At HFHS, PSA test rates rose gradually from
2000 to 2008, with between 30% and 52% of the eligible
population (20,838 of 69,550 men in 2000 and 19,366 of
37,434 men in 2008) undergoing ≥ 1 test, followed by a 21%

Background/Aims: New evidence supports complex care
management teams to improve outcomes and reduce costs for
the small proportion of patients who account for a majority of
health care expenditures. However, there is a lack of evidence
specific to the adolescents and young adults with special health
care needs in the transition age group, most of whom are covered
by Medicaid. Geisinger has implemented a new care model
–– the Comprehensive Care Clinic (CCC) –– focused on such
patients. The CCC is comprised of a care team consisting of a
super-generalist physician, advanced practitioner, pharmacist
and a nurse case manager who provides close follow-up. Its
clinical redesign includes advanced visit types, clinic hours
for emergent situations and provider time outside of visits to
coordinate interactions of the CCC team members with the
patient, family caregiver and other health care providers. A
central feature of the CCC is its reliance on a single care plan
tailored to each patient to plan collaboratively for preventive
and routine care as well as managing exacerbation and
facilitating self-management education.
Methods: Geisinger Health Plan claims data covering a 19-month
period ending September 31, 2014, were obtained for the 83
Medicaid patients enrolled in CCC as of April 2015, yielding
1,425 member-month observations. The dependent variables
were total expenditure (allowed amounts including prescription
drugs) and acute care utilization (inpatient admissions and
emergency room [ER] visits). The key explanatory variable was
an indicator for whether the member was enrolled in CCC in a
given month of the study period. Multivariate regression models
with patient fixed effects were estimated to obtain adjusted
differences in cost and utilization between months in which the
patients were enrolled and not enrolled in the CCC.
Results: CCC enrollment was associated with 28% reduction
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in per-member-per-month total cost ($3,931 observed vs.
$5,451 expected, P=0.028), driven by large reductions in
acute inpatient admissions and ER visits.
Conclusion: A clinical redesign involving longer visits,
clinic time for emergent needs, a coordinated care plan and a
partnership among super generalists, nurse care manager and
pharmacists can potentially reduce total cost and acute care
utilization during transition from pediatrics to adult medicine.
Keywords: medically complex, Medicaid
B4-2:
Hepatitis C Virus Infection and Increasing Screening
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Background/Aims: With increased national focus on
diagnosing and linking patients to care or treatment, we
describe trends in hepatitis C virus (HCV) screening and
linkage to care in the Kaiser Permanente Mid-Atlantic States
health system, particularly among those born between 1945
and 1965 (birth cohort). We observed 665,345 adults enrolled
in Kaiser Permanente Mid-Atlantic States from 2003 to 2015.
Methods: We used survival methods to describe factors
associated with time to antibody and confirmatory (RNA/
genotype) testing. Logistic regression was used to describe
odds of HCV infection and gastroenterology/infectious
disease visit or treatment (linkage).
Results: The annual screening rate increased steadily from
23.6 to 70.8 per 1,000 person-years, with the sharpest increase
after 2013. Overall, 19% (123,572 of 665,345) were screened
for HCV. Screening among the birth cohort was lower than
among noncohort members. However, the gap shrank in later
years of study. Significant positive predictors of screening
included drug use, hepatitis B and human immunodeficiency
virus (HIV) status, female sex, living in lower-income areas and
elevated alanine aminotransferase (ALT). Among antibodypositive adults, 86% (3,643 of 4,242) received confirmatory
testing. A prior gastroenterology/infectious disease visit
and being seen in Baltimore clinics were associated with
increased rates of confirmatory testing. We identified 3,310
with chronic HCV by RNA or genotype (2.7% of the 124,841
persons ever antibody-tested, RNA-tested or genotyped).
Blacks, birth cohort members, males, those with history of
illicit drug use and those with elevated ALT were associated
with higher odds of HCV infection. Hispanics, patients with
HIV or hepatitis B, and those from higher-income areas were
at lower risk. Among patients with chronic HCV, 86% (2,844
of 3,310) were linked to care. Predictors of linkage include
elevated ALT, HIV status and black or Hispanic race.
Conclusion: We report higher rates of HCV screening,
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confirmatory testing and linkage compared to similar cohorts.
Although HCV screening is still predominantly risk-based,
birth cohort screening is increasing in concert with national
guidelines. Our data support other studies that suggest that
sexual intercourse, even among men who have sex with men,
is not a primary means of HCV transmission, and that risk
of HCV is higher in low-income areas. These data provide
important parameters from which to base and compare future
interventions to increase screening, care and treatment.
Keywords: hepatitis C, epidemiology
B4-3:
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Background/Aims: De-implementing commonly used but
ineffective clinical practices is an important component of
quality. Oncology offers several opportunities to reduce
use of ineffective practices based on guidelines from the
American Society of Clinical Oncology (ASCO). We studied
the use of one such practice, biomarker blood tests for breast
cancer surveillance, within an integrated health care system.
We documented utilization patterns and explored provider
perceptions and attitudes to inform de-implementation efforts.
Methods: Using a sequential explanatory mixed-methods
design, we identified a cohort of early-stage breast cancer
survivors and calculated the number and frequency of biomarker
tests during an 18-month posttreatment period. We identified
high- and low-utilizing medical centers and conducted semistructured qualitative interviews with oncologists in both types
of centers, guided by the Theoretical Domains Framework.
Interviews were transcribed, coded and analyzed.
Results: Among 7,363 patients diagnosed during 2009–2012,
40,114 biomarker tests were ordered for 41% of patients. We
found significant variation by medical center: 5–78% of eligible
patients received a test. We interviewed 18 oncologists in highand low-utilizing centers. Several themes emerged, including:
1) Awareness of nonadherence: oncologists reported awareness
of current ASCO guidelines and agreed that biomarkers are
not clinically useful; high utilizers acknowledge intentional
nonadherence (“We all know we shouldn’t do this but do it
anyways.”); 2) Anxiety: despite agreeing that biomarkers
aren’t useful, some oncologists are anxious about missing a
recurrence and want to do “all possible” to prevent this; high
utilizers perceive that patients are highly anxious and desire
a quantitative test for reassurance (“They need a number.”);
and 3) Perceived patient expectations: oncologists perceive
competition from other systems and are concerned about
perception of withholding care (“If [competitor] does it …
patients expect it.”) and implications for patient satisfaction.
Conclusion: Barriers to de-implementation are numerous and

www.aurora.org/jpcrr

177

complex. Traditional strategies of practice change based on
increasing awareness and knowledge (provider education,
electronic alerts) are unlikely to be effective. Multifaceted,
multilevel strategies deployed to address consumer-, clinicianand system-related barriers are required. Research-based
development and evaluation of multilevel de-implementation
strategies is critical and will help develop valuable insights
and theories regarding the determinants of clinical practices
and opportunities to influence them.
Keywords: implementation science, mixed-methods research
B4-4:
Care Redesign in Joint Care
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Background/Aims: The goals of population health are to
improve the health status of defined populations by focusing
on quality, cost and experience of care (Triple Aim). With the
Centers for Medicare & Medicaid Services’ development of
bundled payment programs (e.g. Bundled Payments for Care
Improvement, Comprehensive Care for Joint Replacement) as
well as other quality-focused advances in the industry, there
are increased avenues to incentivize physician and hospitals
to collaborate to achieve common goals around quality,
experience and cost.
Methods: The efforts focused on leveraging a 9-step care
redesign model to evaluate best practices in joint care across
11 state health care systems. Workflows were evaluated
and opportunities for care improvement were identified
and implemented. The Total Knee Best Practice Change
Assessment brought about enhancements, which included the
engagement of care management/navigation beginning at the
preoperative stage and continuing through the entire episode
of care. These efforts included robust patient optimization,
education and engagement while leveraging effective
analytics to inform our efforts.
Results: Programs that significantly lowered post-acute care
costs (specifically, costs related to admission to skilled nursing
facilities) achieved substantial savings in post-acute care. In
addition, we observed a decrease in readmissions, a decrease
in skilled nursing facility utilization and an increase in patient
satisfaction. Key lessons learned include: a) the significance
of physician leadership in implementing organizational
change, and b) the importance of 24/7 patient access to care
management to reduce emergency department utilization.
Conclusion: Findings from this study have direct implications
for ongoing episode-based payment initiatives aimed at
improving quality and decreasing costs, as they suggest that
episode-based payment models have the potential to decrease
total costs per episode.
Keywords: care redesign, value
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Background/Aims: Appropriate clinical management
of major depression and comorbid medical conditions
represents a significant challenge for providers. Adopting
a patent-centered treatment perspective, qualified
nonphysician behavioral health specialists can support
monitoring complex needs, enhance care provision and
satisfaction with medical encounters, and improve costeffective outcomes. This demonstration project evaluated
a depression management program, examining effects on
depressive symptoms, chronic disease and medication
management, utilization and treatment costs.
Methods: Beginning January 2015, the program offers
enrollment to primary care patients scoring above 15 on
the Patient Health Questionnaire-9 (PHQ-9). Individuals
receive an integrated, holistic health care plan, psychiatric
consultations as needed, education concerning medications
and side effects, and proactive follow-up. Besides
facilitating team communication, the care manager
provides evidence-based brief counseling (e.g. motivational
interviewing, behavioral activation) and initiates treatment
modifications to optimize clinical gains. As participants
complete 6 months or achieve remission of depression, we
evaluate changes in PHQ-9 and satisfaction ratings while
linking to administrative data on utilization, prescriptions
and costs.
Results: To date, 58 patients are enrolled, with mean age
of 51.5 (range: 12–88) and 72% women. Among early
notable findings, substantial improvements were observed
in abatement of clinical depression. Of 48 individuals with
subsequent PHQ-9s, their mean decline was 7.7 points; 50%
exhibited remittance and 86% showed clinical improvement.
Other analysis suggests a slight drop in emergency visits and
fewer prescriptions across most psychotropic and medical
drug classes, controlling for program duration. Patient
satisfaction with the program is quite positive, especially
perceived inclusion when discussing treatment strategies
and provider attention to patient mood. Ongoing work will
examine changes in specialty mental health care, admissions
and costs in comparison to a similar clinic cohort, matching
for demographics and clinical characteristics.
Conclusion: Consistent with national efforts to better engage
patients in their health care decisions, this care management
program employs highly qualified, lower-cost providers for
most encounters. Such personalized, coordinated treatment
of comorbid conditions within a primary care environment
offers tremendous promise for improving depression and
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quality of life while proactively reducing unnecessary
treatment and system costs. Further longitudinal analyses
will monitor these impressive short-term benefits as we fully
examine implementation of a truly patient-centered, feasible
care approach.
Keywords: depression, care management

Conclusion: Our findings suggest improvements are needed
to increase rates of follow-up colonoscopy completion,
especially among females and Hispanic patients. Future
research might explore the role that clinic- and patient-level
factors play in colonoscopy completion.
Keywords: federally qualified health center, colorectal cancer

PS1-24:
Timeliness of Follow-Up to a Positive Fecal
Immunochemical Test Result Among Community
Health Center Patients

PS1-26:
Understanding Asian Patients’ Lower Satisfaction
With Health Care
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Tanya Kapka,2 Jennifer S. Rivelli1
1

1

1
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Background/Aims: Colorectal cancer is the fourth most
common cancer and the third-leading cause of cancer
death in the United States. Fecal testing, including fecal
immunochemical testing (FIT), has been proven to reduce
mortality from colorectal cancer. Such mortality reductions
can only be achieved, however, if those with abnormal test
results receive follow-up colonoscopies. Completion rates
for follow-up colonoscopy are low, especially in community
health centers, where many Hispanics receive care. As part
of the Strategies and Opportunities to STOP Colon Cancer
in Priority Populations (STOP CRC) project, we examined
rates of adherence to follow-up colonoscopy, time to
colonoscopy completion and characteristics of patients who
complete colonoscopy after abnormal FIT results compared
to those who do not.
Methods: Virginia Garcia Memorial Health Center was the
clinic partner in this project. Project staff reviewed charts
from patients who had abnormal FIT results following the
STOP CRC outreach program. Reviews of electronic medical
charts ascertained patient demographic characteristics,
referral to colonoscopy (yes/no), date of referral and reason
(if not made), colonoscopy completion (yes/no) and date
of colonoscopy and reason (if not completed). Bivariate
analyses and regression analyses were used to examine
associations and complete mediator analysis.
Results: A total of 56 patients had abnormal FIT results;
29 (52%) were Hispanic and 31 (55%) were female. Fortyfive (80%) patients received referral for colonoscopy, with
a median time to referral of 2 days. Of the 56 patients, 32
(57%) had evidence of a completed colonoscopy in their
medical charts. Latinos were less likely than non-Latino
whites to have completed a colonoscopy (44.8% vs. 70.4%).
The median time to colonoscopy completion was 62 days.
Females were less likely than males to complete their
colonoscopy within 60 days of a positive FIT result (odds
ratio: 0.21, 95% confidence interval: 0.05–0.96). Mediation
analysis indicated that time to referral was not a mediator
between patient-level factors and completion of follow-up
colonoscopy.
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Background/Aims: Asians now exceed Latinos as the highest
proportion of new immigrants in the United States, totaling
over 18 million. Asian patients report lower satisfaction
with their health care than do non-Hispanic white (NHW)
patients. The goal of this comparative, mixed-methods study
was to explore Asian patients’ expectations and experiences
with health care compared to NHW patients as well as how
cultural norms related to evaluation may contribute to lower
patient satisfaction among Asians.
Methods: From July 2014 to August 2015 we conducted
a comparative mixed-methods study with Chinese, South
Asian and NHW patients from a large multispecialty clinic
in Northern California. Electronic health records were used
to select patients for recruitment, and invitations were sent
via letter, phone and/or email. Chinese patients include
those whose preferred language was Mandarin, Cantonese
or English. As English is widely spoken among the South
Asian patient population, these patients were screened for
acculturation at recruitment to include equal numbers of
high- and low-acculturation patients. Patients participated
in either a focus group or cognitive interview, and all
participants completed surveys including demographics
and standardized measures of acculturation, health care
expectations and satisfaction. Focus group participants
discussed their expectations and experiences of care,
while cognitive interview participants shared the cognitive
processes underlying their evaluation of a standardized
health care visit vignette. Focus groups and surveys
for Chinese patients were conducted in their preferred
language. All cognitive interviews were conducted in
English.
Results: We conducted focus groups with 58 Chinese (21
English-, 21 Mandarin-, and 16 Cantonese-speaking), 27
South Asian (14 high and 13 low acculturation) and 12 NHW
patients, and cognitive interviews with 11 Chinese, 13 South
Asian and 10 NHW patients (total N = 131). A comparative
mixed-methods analysis is currently underway, employing
descriptive and bivariate statistics and an integrated
deductive and inductive thematic analysis. Results will
compare subgroups of Asian and NHW patients in terms
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of: 1) expectations and experiences with health care, and
2) cognitive processes underlying evaluation of health care
experiences.
Conclusion: Pending results will provide a comparative
examination of differences between Asian and NHW patients’
reported satisfaction with care and the factors underlying
these differences.
Keywords: patient satisfaction, racial/ethnic differences

clinical and demographical characteristics alone. More
studies are necessary to explore the underlying mechanism
that explains such an apparent care-seeking behavior.
Keywords: emergency department, claims data

PS1-27:
Patterns of Multiple Emergency Department Visits:
A Discretionary Care-Seeking Behavior?
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Background/Aims: Identifying an effective strategy
to reduce emergency department (ED) visits remains
challenging. This study seeks to empirically identify patient
characteristics and utilization patterns that are significantly
associated with multiple ED visits by patients within a
1-year period. The rationale is that a single ER visit is likely
to be subject to random variation that is inherently difficult
to predict. This study focuses only on Geisinger Health Plan
members who had at least one ED visit in a 2-year period
(2013–2014) across all plan types for which Geisinger Health
Plan was “at risk” (i.e. Medicaid, Medicare, commercial,
the Exchange) and identifies patient characteristics and
other care utilizations (e.g. high-end diagnostic imaging,
outpatient surgery, physician office visits) that are associated
with multiple ED visits within a 12-month period.
Methods: The sample was restricted to adult Geisinger
Health Plan members (≥ 18 years old) and included 67,997
unique members. Two multivariate logistic regression
models were estimated: 1) a model that includes primary
care physician (PCP) fixed effects, and 2) another model that
does not include PCP fixed effects. The PCP fixed effects
were used to examine if the PCP influences the likelihood of
multiple ED visits.
Results: More frequent physician office visits were
associated with greater likelihood of multiple ED visits
(P<0.001). Multiple use of high-end diagnostic imaging
(computed tomography and/or magnetic resonance imaging)
and multiple outpatient surgeries also were both associated
with greater likelihood of multiple ED visits (P<0.001).
These associations remain significant even after controlling
for age (older patients were less likely to make multiple
ED visits), gender, plan types (Medicaid members were
more likely to have multiple ED visits than members with
other plan types) and chronic conditions. The odds ratios
obtained with and without PCP fixed effects were similar,
indicating that PCPs do not contribute significantly to
patients’ likelihoods of multiple ED visits.
Conclusion: These patterns suggest that some patients may
be seeking outpatient care that is not explained by their
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Validation of Colorectal Cancer Screening in the
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Due for Screening in a Pragmatic Trial
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Background/Aims: In 2015 an estimated 143,000 adults in
the United States will be diagnosed with colorectal cancer,
and 52,000 will die from the disease. Despite this knowledge,
colorectal cancer screening rates remain low. Electronic
health records (EHR) hold much promise for helping to close
this gap by identifying eligible individuals who are overdue
for or have never completed colorectal cancer screening;
however, important shortfalls to this approach remain.
Records of colonoscopy completion are frequently missing
in the EHR. Variation in workflow and documentation can
lead to incomplete capture of colorectal cancer screening
and testing events. Through the Strategies and Opportunities
to STOP Colon Cancer in Priority Populations (STOP CRC)
study, we conducted a data validation to understand the data
being captured in the EHR and completeness of the data.
Methods: We selected a stratified random sample of 800
study participants from 26 participating clinics to compare
the EHR to chart audit data. A trained validation specialist
completed the abstraction qualifying data of eligible and
ineligible patients.
Results: Comparing EHR data to chart audits, we found 88%
(459/520) of individuals were correctly classified as eligible
for program inclusion. EHR data correctly identified 96%
(269/280) of excluded patients. Of the patients incorrectly
classified as eligible, 83.6% (51/61) of disagreements were
due to evidence of a prior colonoscopy or referral that was
not captured in recognizable fields in the EHR.
Conclusion: If our goal to increase CRC screening uptake
is achieved, there will be an even greater need to improve
data capture of all screening events, document completion of
diagnostic testing after a positive test, conduct surveillance
exams and provide appropriate outreach to patients needing
repeated screening. While the need for better populationbased data is not unique to CRC screening, it provides an
important example of using population-based data for not
only tracking needed care but also directly delivering needed
interventions.
Keywords: validation, electronic health record
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A1-2:
Five-Year Weight Change Trajectories in Roux-en-Y
Gastric Bypass Patients

A1-1:
Relation of Change in Weight Status to the
Development of Hypertension in Children and
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Background/Aims: This study examined the association
of body mass index (BMI) percentile and change in BMI
percentile to change in blood pressure (BP) percentile and
development of hypertension in children and adolescents.
Methods: This retrospective cohort included 101,725
subjects aged 3–17 years from three health systems across
the United States. Height, weight, age, sex and BP measures
were extracted from electronic health records, and then age/
sex/height-adjusted BP percentiles and BMI percentiles
were computed. Mixed linear regression estimated change in
systolic BP percentile, and proportional hazards regression
was used to estimate risk of incident hypertension associated
with BMI percentile and change in BMI percentile.
Results: The largest increases in BP percentile were observed
among children and adolescents who became obese or
maintained obesity. Over a median 3.1-year follow-up, 0.4% of
subjects developed hypertension. Obese children aged 3–11 had
3.5-fold increased risk of developing hypertension compared
with normal weight. Obese adolescents aged 12–17 had 3.2fold increased risk of developing hypertension compared with
normal weight. Children and adolescents who stayed obese had
5.4- and 4.8-fold increased risk of developing hypertension,
respectively, compared with those who maintained a normal
weight. Children who became obese and adolescents who
became overweight had 2.6- and 2.3-fold increased risk of
developing hypertension, respectively.
Conclusion: We observed a strong, statistically significant
association between increasing BMI percentile and increases
in BP percentile, with risk of incident hypertension primarily
associated with obesity. The adverse impact of weight gain
and obesity in this young cohort over a short period of time
underscores the need for effective strategies for prevention of
overweight and obesity in youth to slow progression toward
diabetes and cardiovascular disease later in life.
Keywords: pediatrics, obesity
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Background/Aims: Roux-en-Y gastric bypass (RYGB) is a
popular weight-loss procedure, but not all patients experience
optimal long-term outcomes. Previous studies indicate that
bariatric surgery patients with similar preoperative profiles
may respond differently to the same surgical intervention
for severe obesity. This study’s primary aim was to identify
long-term weight change trajectories in a large cohort of
RYGB patients over 5 years.
Methods: This longitudinal study followed adult RYGB
patients preoperatively to 5 years postoperatively. Patients
were recruited from 2004 to 2014 from the bariatric surgery
program of a large comprehensive rural medical center.
Demographic and weight information was obtained through
the electronic medical record. The study’s primary outcome,
percent total body weight loss (% TBWL), was calculated
using the weight at time of surgery and all weights available
in the electronic medical record as part of routine clinical
care through 5 years after surgery. Weight loss trajectories
were then estimated using a semiparametric latent class
growth modeling approach.
Results: The majority of RYGB participants (N=3,215)
were female (80%, 2,575 of 3,215); mean preoperative body
mass index was 49.4 ± 8.8 kg/m2. Four distinct weight loss
trajectories were identified for the 5 years following RYGB.
In our sample, 16.8% (541 of 3,215) of participants failed
to maintain 20% of their initial weight loss, representing a
“suboptimal” weight loss trajectory group. Two additional
groups (combined 15.9%, 513 of 3,215) reached similar
weight loss endpoints at 5 years (approximately 40%
TBWL), with a subset of these participants following a
slower but steady trajectory (7.6%, 245 of 3,215). Finally,
a fourth group (67.2%, 2,161 of 3,215) reached a weight
loss nadir of about 30% and maintained 25% weight loss
at Year 5.
Conclusion: Weight change trajectories after RYGB are not
uniform, with some patients experiencing suboptimal weight
loss of less than 20% by Year 5. Greater understanding of the
individual-level characteristics that distinguish patients with
suboptimal weight change may help to improve patient and
procedure selection.
Keywords: obesity, bariatric surgery
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A1-3:
Improving Confidence to Eat Better Among Young
Adults –– Gender Differences in 3-Month Results of
the MENU GenY Online Intervention

A1-4:
Qualitative Data from a Trial of Home Blood Pressure
Telemonitoring and Pharmacist Management
(Hyperlink)
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Background/Aims: Improving food choices requires
both internal resources, particularly confidence in ability
to change, and external challenges or temptations. Selfefficacy and social influence, especially through informal
close relationships, play important roles in health behavior.
We assessed dietary and self-efficacy changes related to
dietary choices by gender and initial fruit and vegetable
intake among young adults enrolled in a randomized online
intervention trial to improve food choices.
Methods: Young adults, 21–30 years old, from integrated
health systems in urban Michigan and rural Pennsylvania
enrolled and were randomized into Arm 1 (control website),
Arm 2 (tailored and age-targeted website) or Arm 3 (Arm
2 website + email coaching). Baseline and 3-month online
surveys included questions assessing fruit and vegetable
(F/V) intake, and confidence about eating healthy foods in
a number of circumstances (e.g. when really hungry, tired,
with friends). Repeated measures ANOVA and F-tests
compared overall and groups by study arm, gender and
baseline F/V intake.
Results: Of 1,390 (81% of baseline, 71% women)
completing the 3-month survey, mean gain in F/V intake was
1.0 (SD: 1.4), 1.0 (SD: 1.5) and 1.2 (SD: 1.5) servings by
Arms 1, 2 and 3, respectively; those with low (1 or fewer)
F/V at baseline (n=153) improved by 2+ servings, across
arms, with no differences by gender. Greatest self-efficacy
improvement, regardless of gender, was in eating well in
front of friends (P<0.0001), making good choices eating
out (P<0.0001) and eating healthy when depressed/in a bad
mood (P<0.0001); men also gained in self-efficacy to eat
healthy around junk food (P<0.001). The low baseline F/V
group resembled men and gained self-efficacy to prepare
healthy meals (P<0.001) and avoid higher-fat foods.
Conclusion: Internal perceptions of self-efficacy across a
number of social situations and internal conditions in both
men and women corresponded to personal experience of
working to eat more F/V. More self-confidence improvements
occurred in those starting with lowest rates of healthy eating,
and those who ultimately made the greatest gains in dietary
change, regardless of gender.
Keywords: nutrition, young adults
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Background/Aims: Hyperlink was a cluster-randomized
intervention trial in HealthPartners clinics from 2009 to 2013
with nonintervention follow-up through 2015 (60 months).
Participants had uncontrolled hypertension. Telemonitoring
intervention patients had improved blood pressure control
at 6 months compared with usual care patients (72% vs.
45%, P<0.001). Intervention effects narrowed at 12 (72%
vs. 53%, P=0.005) and 18 months (72% vs. 57%, P=0.003);
60-month blood pressure data will be complete in October
2015. We conducted a mixed-methods analysis combining
our quantitative results with patient, clinical and other
organizational stakeholder perspectives to learn how to
optimize the intervention for the most patients and implement
this intervention in our care setting.
Methods: We collected three sources of qualitative data: seven
patient focus groups stratified by 6–18-month blood pressure
outcomes, four structured interviews with intervention
pharmacists, and interviews (currently being collected) with
key organizational stakeholders. Focus group and structured
interview data were analyzed by a team of five using grounded
theory. Initial themes were identified and coded in NVivo10.
Results: Qualitative data revealed several initial themes.
First, patients valued trust in the patient-provider
relationship and good communication between providers.
Second, patients have varying goals with medications and
successfully initiating/adhering to treatment is better when
provider understands and respects the patient’s perspective
on medications. Finally, intervention patients benefited from
seeing their own blood pressure data (reinforcement) and a
trusted provider seeing their data (accountability). Pharmacist
interviews agreed with these themes, revealing key insights
about intervention design including: length of intervention,
addressing relapse, and meeting individual patient’s needs
with effective use of data and lifestyle counseling. Results
of 60-month blood pressure outcomes will be analyzed in
the context of these initial findings, and qualitative findings
will be further refined. Stakeholder interview results about
implementation are forthcoming.
Conclusion: Findings suggest the need for several adaptations
to the intervention before implementation in practice:
provision of blood pressure monitors for ongoing use, a
shorter duration with ability to re-engage if blood pressure
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becomes uncontrolled, more tailoring of the intervention to
individual needs, and better communication and handoffs
between pharmacists and physicians.
Keywords: telemonitoring, hyperlink
B1-1:
Preventive Service Use Among People With Serious
Mental Illnesses: Results From the PRIME Study
Bobbi Jo. Yarborough,1 Nancy Perrin,1 Elizabeth
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A. Green1
Center for Health Research, Kaiser Permanente
Northwest, Portland, OR

mental illnesses received more preventive services than
individuals without mental illnesses. Adjusting for number
of health care visits reduced, but did not eliminate, these
differences.
Keywords: preventive service use, serious mental illness
B1-2:
Abdominal Aortic Calcification on Lateral Spine
Bone Density Test Images: Potential Role in
Cardiovascular Disease Risk Screening
John T. Schousboe,1 Mary Sue Beran1
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Background/Aims: People with serious mental illnesses
(SMI) experience excess morbidity and premature mortality
resulting from preventable conditions. In response, concerns
have been raised that people with SMI may not receive
adequate preventive services. Understanding preventive
service use patterns may help improve care delivery and
reduce health disparities in this population.
Methods: Participants included all adults ≥ 18 years with at
least one prior 12-month health care visit in a large integrated
service system (Kaiser Permanente Northwest [KPNW],
n=366,194) or in participating federally qualified health centers
and safety-net clinics in 18 states (OCHIN, n=437,082). We
used electronic medical record data to examine receipt of
needed preventive care, measured by 12 services (e.g. flu
shots, mammogram screening). We computed proportion of
needed care by dividing the number of out-of-date services by
the number of eligible services and multiplying by 100. Mean
rates for four diagnostic groups –– schizophrenia spectrum
disorders, bipolar disorders/affective psychoses, major
depressive disorders, anxiety disorders –– were compared to
patients without SMI diagnoses. All models were adjusted for
patient characteristics (e.g. age, gender, Medicaid/Medicare
status) and service use.
Results: At OCHIN, all SMI groups had lower rates of needed
preventive services (schizophrenia: 34.12, bipolar disorders/
affective psychoses: 35.68, major depressive disorders:
36.30, anxiety: 38.53) than non-SMI patients (39.97).
Similarly, needed services did not differ or were lower among
KPNW members with SMI, with bipolar disorders/affective
psychoses (18.64) and major depressive disorders (18.63)
showing significantly lower needed services than non-SMI
members (20.64). Proportions of individuals with SMI
completing cholesterol and diabetes screening were higher
than those without SMI at both sites. At KPNW, individuals
with SMI were more likely to have a recorded body mass
index than individuals without SMI, but at OCHIN the reverse
pattern was observed. Colorectal cancer screening did not
differ by diagnosis but was more likely to occur at KPNW
than at OCHIN. Blood pressure screening was common
across diagnostic groups and sites. Flu vaccinations were
uncommon, particularly at OCHIN.
Conclusion: Contrary to hypotheses, individuals with serious

Background/Aims: Abdominal aortic calcification (AAC)
is associated with incident clinical cardiovascular disease
independent of other clinical risk factors. The aorta lies
immediately anterior to the lumbar spine, and AAC can be
accurately scored on bone density lateral spine images. Our
objective was to estimate the proportion of individuals 65–80
years old undergoing bone densitometry who are not known
a priori to be at high risk of cardiovascular disease (based on
prior diagnoses and Framingham hard coronary heart disease
[CHD] 10-year risk score), but who have a high level of AAC
(AAC-24 Framingham score ≥ 5).
Methods: AAC was scored on lateral spine bone density
images for 1,499 randomly selected patients age 65–80 at
a large urban community health care delivery organization,
blinded to patient characteristics. Established diagnoses of
cardiovascular disease or diabetes mellitus were determined
by identification of appropriate ICD-9 diagnosis codes at
provider visits. Framingham 10-year hard CHD risk scores
were calculated from clinical data (systolic blood pressure,
total and high-density-lipoprotein cholesterol, smoking
status, use of antihypertensive medication) extracted from the
electronic health record.
Results: Mean age of the study cohort was 71 years; 92.9%
were female, 94.1% were Caucasian, 14.0% had preexisting
cardiovascular disease, 10.7% had preexisting diabetes
mellitus, and 24.7% had a Framingham hard CHD risk score
≥ 7.5%. A total of 490 patients (32.7%) had no AAC, 603
(40.2%) had mild to moderate AAC (AAC-24 score of 1 to
4), and 406 (27.1%) had a high level of AAC; 184 patients
(12.3%) had both a high level of AAC and were not previously
known to be at high risk based on preexisting clinical
cardiovascular disease, diabetes mellitus or a Framingham
hard CHD risk score ≥ 7.5%.
Conclusion: The proportion of those age 65 to 80 undergoing
bone densitometry who are not known to be at high risk of
incident cardiovascular disease but who have high AAC
is sufficient that densitometric lateral spine imaging at the
time of bone densitometry may have a role in cardiovascular
disease risk screening, considering bone densitometry is
recommended at least once for all women ≥ 65 years old and
men ≥ 70 years.
Keywords: abdominal aortic calcification, incident clinical
cardiovascular disease
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Overuse and Underuse of Aspirin for Primary
Prevention of Cardiovascular Events in Primary Care
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Background/Aims: The U.S. Preventive Services Task Force
(USPSTF) currently recommends aspirin for primary prevention
of coronary heart disease in men 45–79 years old and strokes
in women 55–79 years old when the potential cardiovascular
disease benefit outweighs the potential harm of gastrointestinal
hemorrhage. The complexity and time required to assess risks
and benefits for primary prevention can be a barrier for providers
to giving patients USPSTF-consistent recommendations,
resulting in potential overuse and underuse.
Methods: As part of a National Institutes of Health-funded
randomized trial to lower cardiovascular risk, we developed
a sophisticated web-based electronic health record (EHR)integrated tool to guide aspirin recommendations as
determined by algorithms assessing USPSTF criteria and
major bleeding risks. Baseline data was collected for whether
aspirin was algorithmically indicated (or not) for all patients
at their first eligible primary care encounter in 20 clinics over
18 months. The analysis included patients age 18–75 (mean
58.4) with elevated cardiovascular disease risk (mean 10-year
ASCVD risk 24.7%) and excluded patients with congenital
heart defects or diabetes. Aspirin overuse and underuse
was determined by comparing concordance with: a) the
algorithm’s aspirin recommendation, and b) EHR-medication
documentation of aspirin.
Results: Of the 11,682 patients meeting eligibility criteria
at baseline, aspirin was indicated in 8,722 (74.7%) and
not indicated in 2,960 (25.3%). Among patients with an
aspirin indication, 6,493/8,722 (74.4%) did not have aspirin
documented (underuse). Among patients without an aspirin
indication, 1,021/2,960 (34.4%) had aspirin documented
(overuse).
Conclusion: Overall, 7,514/11,682 (64.3%) of patients who
met study inclusion criteria for age and cardiovascular risk
exhibited either potential overuse or underuse of aspirin
for primary cardiovascular disease prevention. Despite
expected missing documentation of aspirin due to its overthe-counter availability, which would result in measures
of greater underuse and lower overuse than actuality, it is
clear that patient aspirin use is very commonly inconsistent
with USPSTF guidelines. The recommendation to consider
colorectal benefits in the latest USPSTF draft could make
decisions about aspirin appropriateness even more complex.
EHR-based tools to help providers assess individualized risks
and benefits of aspirin could greatly improve the quality
of aspirin recommendations and potentially reduce costly
cardiovascular disease events while simultaneously reducing
rates of aspirin-related hazards.
Keywords: aspirin use, primary prevention
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Background/Aims: The economic burden of diabetes
mellitus is high in the United States, increasing health care
utilization and reducing workforce participation. Worker
productivity is adversely impacted by complications related
to diabetes. Estimating rates of absenteeism, presenteeism
and other productivity measures can quantify the impact of
diabetes in the U.S. workforce.
Methods: We used data from the Value-Based Benefit Design
Health and Wellness Study Phase II (VBD), a multiyear
prospective study of employees surveyed from Group Health
Cooperative and Kaiser Permanente Colorado from Jan.
1, 2010, to Dec. 31, 2013. The VBD survey questionnaire
includes self-reported data on physical activity at work and
at home, the SF-12® Health Survey, and self-reported data on
absenteeism, presenteeism and lost productivity. These data
were linked to the Virtual Data Warehouse (VDW) from both
sites to determine whether respondents were diagnosed with
diabetes. We applied the standardized relative resource cost
algorithm to the VDW utilization data to calculate total health
care costs per respondent.
Results: Across both sites 3,891 respondents to the baseline
survey, all of whom provided consent to have their data
included in the study, were analyzed. Of these, 286 (7.4%)
were identified as having diabetes. Compared to respondents
without diabetes, respondents with diabetes had lower rates
of positive overall health status (74% vs. 92%), higher mean
days worked while not feeling well (1.6 days vs. 0.9 days)
and lower average physical health composite scale scores (46
vs. 52.6). Respondents with diabetes reported higher rates of
presenteeism (1.1 vs. 0.7 hours per week), absenteeism (1.4
vs. 1.1 hours per week) and productivity due to illnesses (2.5
vs. 1.8 hours per week) compared to respondents without
diabetes. Crude odds ratios for respondents with diabetes
were higher for absenteeism (1.35, 95% confidence interval
[CI]: 0.97–1.87), presenteeism (1.63, 95% CI: 1.27–2.08) and
lost productivity (1.51, 95% CI: 1.18–1.92). Average total
health care costs were $1,222.98 higher for respondents with
diabetes.
Conclusion: Our preliminary results suggest employees
with diabetes experience higher rates of presenteeism and
lost productivity compared to employees without diabetes.
Linking patient-reported outcomes to VDW and human
resources data provides a detailed understanding of patient
experience in the workforce.
Keywords: productivity, diabetes
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Factors Associated With Longevity Among OldestOld Male Patients With Hip Fractures
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Analysis of an Integrated Diabetes Care Program
and Impact on Health Outcomes and Utilization
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Background/Aims: Few studies address the management
and mortality of oldest-old male patients with hip fractures,
although such events are increasing. This study identified
factors associated with survival among male patients with
surgically repaired hip fractures applying classification
techniques to multiple chronic conditions (MCC), focusing
on differences between patients ≥ 85 years old and younger
patients age 50–84.
Methods: Data from the Veterans Health Administration
identified 4,059 male patients age 50–100 with both hip
fracture diagnosis and repair (index event) during fiscal years
2005–2009 (i.e. October 2004–September 2009). MCC was
defined by Charlson and Elixhauser comorbidity conditions
after eliminating overlapping diagnoses. A preliminary Cox
regression model examined the association of MCC with
survival. Latent class analysis produced classes using MCC,
medications, use of physical therapy and demographic
covariates (age, race/ethnicity, marital status, VA Priority
denoting highly disabled). Cox proportional hazards modeled
association between class and 5-year survival.
Results: The sample included 942 patients of age ≥ 85 years
(23%). Survival censored at 5 years postoperation averaged
1,030 days, or almost 3 years. The oldest patients were
more likely to be married (48% vs. 41%) and to die within 6
months (36% vs. 17% younger); minority race/ethnicity was
similar, as was mean MCC (3.9 [SD: 2.8; median: 4.0] vs. 3.9
[SD: 2.7; median: 4.0]). Preoperative physical therapy was
equivalent (24% vs. 24%), but postoperative physical therapy
was less common for those age ≥ 85 (20% vs. 32%). Oldest
patients also averaged fewer medication classes (5.1 vs. 5.5
preop; 6.4 vs. 7.4 postop). In a preliminary adjusted model,
mortality risk increased by 13% per additional MCC (hazard
ratio: 1.13, 95% confidence interval: 1.11–1.15). After latent
class analysis with three classes identified, 43% of oldest-old
were classified primarily white and healthier, 43% white and
sicker with more medication classes and 14% primarily black
with alcohol abuse. Similar trends were observed for younger
patients (36%, 53% and 11%, respectively).
Conclusion: Although the oldest-old male population
represents a relatively small proportion of patients, their
longevity may be related to various health care factors. Close
investigation of classification of individuals with MCC and
hip fractures may help target interventions within health care
settings and contribute to healthy aging.
Keywords: oldest-old male patients, chronic conditions
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Center for Health Research, Geisinger Health System,
Danville, PA
1

Background/Aims: For the past decade, Geisinger Health
System has coordinated care for patients with diabetes using
an integrated diabetes care model. This model utilizes the
electronic health record to coordinate a program to improve
physician adherence to nationally recommended diabetes
measures. The aim of this study is to assess which patient
level factors are associated with improved health outcomes
for patients who receive care in this integrated diabetes
program compared to patients with diabetes who receive
nonintegrated diabetes care.
Methods: Study population consists of Geisinger Health
Plan members with diabetes in the year 2013. Geisinger
Health Plan is a private nonprofit insurance provider in
Pennsylvania. The study examined 1,692 patients with
diabetes (866 in the intervention group, 826 in the control
group). This cross-sectional study uses survey data matched
to administrative claims data to assess factors associated
with health outcomes and costs. Chi-squared tests were
used to determine whether there is a significant difference
between patients with diabetes in an integrated program
compared to patients in nonintegrated programs.
Results: Mean age of the study population was 67.8
years, and 45.4% were female. There were no significant
differences between study cohorts regarding demographic
characteristics including smoking and exercise habits.
Subjects in the intervention group (i.e. received care in the
integrated diabetes program) had statistically significantly
higher scores for patient activation and for follow-up care
coordination from their respective primary care provider.
Subjects in the treatment group were more likely to feel
that their doctor listens attentively to them (P=0.019) as
well as more likely to be referred to a diabetes education
class (P=0.001). There were no significant differences on
emergency department use by each group. Cost results are
pending.
Conclusion: Preliminary results show that patients who
received care in the integrated diabetes care program score
higher on patient activation measures as well as goal setting
and follow-up coordination compared to patients who are
not within the integrated diabetes program. Subsequent
analyses will be conducted to study the relationship between
outcomes and health care utilization.
Keywords: integrated care, diabetes
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PS2-04:
Human Resource Costs of Implementing a Tiered
Team Care Model for Chronically Ill Patients
According to Lean Management Principles
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Durbin,2 Ming Tai-Seale2
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Background/Aims: The published literature on managing
chronic conditions includes mostly randomized controlled
trials, but is silent on implementation in real-world practice.
We documented the Palo Alto Medical Foundation’s (PAMF)
human resource costs of developing and implementing a new
chronic care model called Champion. Champion includes
proactive outreach to patients with uncontrolled diabetes
and hypertension, a redesigned primary care visit and health
coaching. Champion aimed to improve patient and provider
experience and outcomes, as well as cover costs, through
expanding the role of nonlicensed personnel.
Methods: One clinic with 38 physicians serving 29,000 adult
patients implemented Champion. We used an “activity-based
costing” approach to investigate the organizational process.
Activity-based costing divides indirect human resource costs,
which dominate health system transformation, into specific
activities. We searched the Microsoft Outlook calendars of key
informants to determine time spent on Champion activities.
Activity cost was calculated as the sum of hours spent by
employees multiplied by their actual wages. The time period
analyzed covered development, rollout and stabilization (July
2012 through May 2014).
Results: Implementation involved 162 employees –– 30
managers, 46 physicians, 54 staff and 32 consultants –– and
cost $1,309,883 (17,102 hours). Activities followed lean
management principles: management guidance meetings, rapid
process improvement workshops, value stream mapping, and
final performance review. The 32 consultants were the most
expensive employee-type: $402,190, 6,343 hours. The 54 staff
were the least expensive: $262,210, 6,183 hours. The most
expensive activity was the 15 employees who worked full time
on implementation (3 managers, 5 consultants, 4 physician
piloteers, 3 health coaching program staff). The health coaching
staff worked 5,328 hours and cost $210,348. Frontline provider
trainings, which included all physicians and medical assistants,
extended over 3 days (2,352 hours total) and cost $225,307.
Conclusion: PAMF invested significant resources ($1,309,883)
to Champion. The standard work developed is fundamental for
future spread. PAMF may recover some of the implementation
costs from additional revenues as physicians address unmet
needs of chronic care patients. Champion’s long-term financial
sustainability should be evaluated as PAMF moves further into
the era of accountable care, in which value of services brings
more reward than volume of services.
Keywords: chronic conditions, cost
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The Burden of Hidradenitis Suppurativa in Maccabi
Healthcare Services: Real-World Data Analysis
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1

Background/Aims: Hidradenitis suppurativa is a chronic,
recurrent, inflammatory skin disease that presents with painful
inflamed lesions in the apocrine gland-bearing areas of the
body. Little is known on its medical and economic burden.
Methods: This retrospective cohort study was conducted
in Maccabi Healthcare Services (MHS) using de-identified
datasets. Included in this analysis were all MHS members with
hidradenitis suppurativa diagnosed from Jan. 1, 2004, to Dec.
31, 2014. Data included sociodemographic details, chronic
comorbid conditions and health care services utilization as
well as prescriptions dispensed within 14 days after visits
with hidradenitis suppurativa diagnosis.
Results: A total of 14,700 MHS members were detected to
have at least one hidradenitis since 2004. Included in this study
are 3,506 patients age 20 years and older with hidradenitis
suppurativa (mean age: 38.5 ± 12.8; 63% female). Among
study patients, 25.4% were obese, 24.7% suffered depression
and 35.3% were treated with antidepressive therapy. In 2013,
39% and 29% of the patients visited a dermatologist and a
surgeon, respectively. Medications frequently prescribed and
purchased are topical antibiotics, topical steroids combined
with antibiotics and systemic antibiotics minocycline.
Medical procedures most common among study patients were
wound treatment, incision and drainage, both during first year
after index hidradenitis suppurativa diagnosis and annually.
Conclusion: The present study is one of the first to use realworld data on the burden of hidradenitis suppurativa. Results
indicate that hidradenitis suppurativa is a relatively common
inflammatory skin disease in Israel with a considerable
medical and economic burden.
Keywords: hidradenitis suppurativa, burden
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B5-1:
Large-Scale Implementation of Alcohol SBIRT in
Adult Primary Care in an Integrated Health Care
Delivery System: Lessons From the Field
Stacy A. Sterling,1 Thekla B. Ross,1 Constance Weisner1
Division of Research, Kaiser Permanente Northern
California, Oakland, CA
1

Background/Aims: Screening, Brief Intervention, and
Referral to Treatment (SBIRT) has been shown to be
186 JPCRR • Volume 3, Issue 3 • Summer 2016
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an efficacious intervention for risky drinkers and is
recommended by numerous national organizations (NIH,
USPSTF, SAMHSA, CDC). Nevertheless, large-scale
implementation of SBIRT has proven to be challenging.
Methods: The roll-out of systematic adult alcohol
SBIRT in Kaiser Permanente Northern California built
on and scaled up the findings from a National Institute
on Alcohol Abuse and Alcoholism-funded clusterrandomized implementation trial (ADVISe) of different
modalities of SBIRT delivery –– primary care provider
(PCP)-delivered versus delivery by nonphysician provider.
Based on findings from ADVISe, a hybrid SBIRT model
was chosen for implementation in which evidence-based
alcohol screening instruments and clinical decision support
tools were developed for the health system’s electronic
health record, medical assistants were trained to screen
all patients in adult medicine and PCPs were trained in
brief intervention and referral to treatment techniques.
Curricula and procedures were developed for medical
assistant and PCP training, skills reinforcement and
troubleshooting. Structures and protocols were created for
communicating provider- and facility-level screening and
brief intervention performance. We developed a network
of “alcohol champions” across the health system within
adult medicine and established collaborative relationships
between medicine and chemical dependency programs to
facilitate the seamless referral to and receipt of patients in
specialty substance abuse treatment.
Results: Since the initial roll-out in July 2013, there have
been 2,502,455 alcohol screenings on unique adult primary
care patients; 3,575,039 total screenings have occurred
including follow-up screenings for risky drinkers. The 86%
regional rate of alcohol screening has exceeded tobacco and
exercise screening. Brief intervention rates across the 15
medical centers in the region range from 31% to 71%, with a
current regional mean brief intervention rate of 54%.
Conclusion: We will discuss the challenges to and
critical stakeholder involvement in the successful largescale implementation of research findings and make
recommendations for structures and approaches that may
facilitate adoption of SBIRT within health systems.
Keywords: SBIRT, implementation
B5-2:
Evaluating Shared Decision-Making Across Clinical
Topics in Primary Care: An Exploratory Study Using
the OPTION5 Observer Measure
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Background/Aims: Shared decision-making (SDM) is vital
in primary care because it is the most common setting for

Supplement

patients to seek medical care and is typically the first point
of contact with health services. The recently developed
OPTION5 observer measure evaluates SDM during visits
but has only been previously used to evaluate one topic
per visit. In this study, we apply OPTION5 to analyze the
extent of SDM across the spectrum of topics presented in
primary care visits. OPTION5 allows observers to assess the
following five items: how physicians 1) present options, 2)
establish a partnership with the patient, 3) describe pros and
cons of options, 4) elicit patient preferences, and 5) integrate
patient preferences into the decision.
Methods: OPTION5 was used to evaluate SDM at four
primary care clinics that are part of a large multispecialty
group practice in northern California. Two researchers
jointly identified “topics” requiring decisions, scored each
item and then averaged across raters to create overall scores
to indicate the level of SDM occurring for each topic. We
used descriptive statistics and linear regression with clusterrobust standard errors to analyze the OPTION5 items in 40
audio-recorded visits. The models controlled for clinics and
patient background characteristics.
Results: The 40 visits included 200 distinct topics (mean
topics per visit: 5.03, min: 1, max: 13, SD: 2.62). The mean
overall OPTION5 score was 27.2 (on a scale of 0–100),
and scores ranged from a minimum of 2.5 to a maximum
score of 75 (SD: 15.15). Lower patient education levels
were significantly associated with lower OPTION5 scores
across all five items (item 1 coefficient: -0.91, P<0.05;
item 2 coefficient: -1.68, P<0.01; item 3 coefficient: -2.04,
P<0.01; item 4 coefficient: -1.49, P<0.01; item 5 coefficient:
-1.36, P<0.01) and with the overall score (coefficient: -7.48,
P<0.001).
Conclusion: The relatively low overall scores suggest much
room for improvement in SDM in primary care visits. The
consistent association between patient education and SDM
in visits suggests it is imperative to find methods to better
engage patients with less education and that these patients
should be a priority vulnerable population for SDM support
and engagement strategies.
Keywords: shared decision-making, evaluation
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Background/Aims: Noninvasive ventilation (NIV) is
an important component of treatment for patients with
respiratory failure due to exacerbations of chronic
obstructive pulmonary disease (COPD). Proven benefits
include reduced need for invasive ventilation, complications,
mortality and hospital length of stay. Despite these wellestablished benefits and strong recommendations in clinical
guidelines, utilization of NIV varies widely across hospitals.
The purpose of this study was to identify approaches used by
hospitals that have been successful in implementing NIV to
treat respiratory failure among patients with COPD.
Methods: In-depth interviews were conducted with key
stakeholders from a sample of high-performing hospitals
selected from a large and representative network of 386
U.S. hospitals. High performers were defined as hospitals
in which a high proportion of patients with COPD requiring
mechanical ventilation were treated with NIV, and that
achieved low risk-adjusted mortality. Interviews were audiorecorded and transcribed verbatim. Themes and subthemes
were identified through iterative readings of the transcripts,
generation of preliminary lists of themes and discussion
among team members until the team reached consensus
that all important themes and subthemes present in the first
sample of 25 interviews had been identified.
Results: Interviews have been conducted with 25 participants
from five hospitals, including respiratory therapists (n=12),
physicians (n=8) and nurses (n=5). Preliminary analyses reveal
three domains related to effective NIV use: 1) processes, 2)
structural elements, and 3) contextual factors. Key processes
included timely identification of appropriate patients and
early initiation of NIV, frequent assessment of patient status
and attention to patient comfort on NIV. Necessary structural
elements included adequate equipment, sufficient numbers
of qualified respiratory therapists and flexibility in staffing.
Important contextual factors included achieving “buy-in”
from key stakeholders, respiratory therapist autonomy,
interdisciplinary teamwork and ongoing staff education.
Hospital leaders, policies and protocols were identified as
playing a supporting role in promoting essential elements.
Conclusion: These preliminary findings suggest elements of
effective NIV use that characterize the experience of highperforming hospitals. By describing strategies to promote
these elements, this study advances the understanding of how
to successfully implement a complex intervention like NIV.
Keywords: chronic obstructive pulmonary disease,
implementation science
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Background/Aims: Periodic health examinations (PHEs) are
the most common reason adults see a physician. The Affordable
Care Act mandates one “free” PHE per person per year. We
examine if there may be a potential value of PHE due to its role
as a “safe portal” by which some patients seek mental health care.
Methods: Study data came from audio recordings of 255 PHEs
with patients likely to need mental health care. Coding the
audio recordings and their transcripts enabled us to examine
the timing of a mental health discussion (MHD), its quality
and the relationship between MHD quality and physician
practice styles, patient health and patient preparedness for the
visit. The quality of MHD was measured by concordance with
evidence-based practices as a three-level variable (evidencebased, perfunctory or none). Physician practice styles were
measured from multiple visits of each physician with other
patients: 1) length of visit; 2) talk time by the physician and
the patient, which enabled us to measure the physician’s verbal
dominance; and 3) how fully the physician elicited the patient’s
agenda for the visit. We used electronic health records, patient
surveys and direct observation to measure patient health
status. The quantitative analysis used a generalized ordered
logit model with partial proportional odds for the three-level
ordinal dependent variable of MHD quality.
Results: Many patients came to their PHEs with mental health
concerns, as over 50% of the MHDs occurred in the first 5
minutes of the visit. Only a third had an evidence-based MHD,
another third had a perfunctory MHD, and the remaining third
had no MHD. The analyses identified significant effects of
physician practice styles. Visits with physicians who tend to
spend more time with patients, fully elicit patient agendas and
let patients talk (as opposed to being verbally dominant) were
more likely to have a MHD.
Conclusion: If done well the PHE could be a safe portal for
patients to raise mental health concerns, but most PHEs may not
meet this standard. Improving the quality of PHEs may require
reimbursement for longer visits, enabling physicians to more
fully elicit patient agendas and to listen more attentively.
Keywords: patient-physician communication, mental health
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Background/Aims: “Beyond the Publishable Paper: Finding
the Story in Your Research” was a workshop developed
by the Colorado Clinical and Translational Sciences
Institute Partnership of Academicians and Community
for Translation to inspire the research community to think
beyond journal publication as a means for translating
and disseminating research findings. Aimed at attracting
researchers, community research partners (present or
in the future), health sciences students and trainees, the
workshop objectives were to: a) demonstrate how the arts
can be incorporated into the translation and dissemination
process of research; b) identify elements of a good story; c)
guide participants in creating a story from research results;
d) identify strategies for sharing research results through
storytelling; and e) practice performance art for storytelling.
Methods: The 3-hour interactive, hands-on workshop
taught participants the art of effective storytelling by kicking
off with a performance of Loose Change, a research-based
theatrical production developed from a Care Equity Project
by Kaiser Permanente Colorado’s Arts Integrated Resources
Team. After learning about the elements of good storytelling,
participants broke into groups and developed stories based
on research findings in the two-page “Middle School
Overview of 2013 Data” reported by Healthy Kids Colorado
Survey. The workshop finale was a 5-minute performance
by one of the groups illustrating the story they saw in the
middle school data on “unintentional injury and violence.”
Results: Participant postevaluation of the workshop was
positive: a) The majority of respondents agreed or strongly
agreed the workshop was a valuable use of their time (18 of
20); b) Most (15 of 20) thought the workshop was somewhat
or very relevant to their work; and c) Holding the workshop
in a community space, Su Teatro Cultural and Performing
Arts Center, Denver, rather than on campus, supported
participant learning and was worth additional effort to get
there (17 of 20 respondents agreed or strongly agreed).
Conclusion: The workshop successfully modeled performance
art as a tool for research dissemination, outlined a format for
drawing stories out of data and provided hands-on practice in
story development, theatrical performance and sharing.
Keywords: story, community-based participatory research
PS1-30:
Peer-to-Peer Toolkits Enhance Sharing of Best
Practices Across an Integrated Delivery System
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Background/Aims: A peer-to-peer approach to develop
and disseminate online packages (“toolkits”) of locally
developed system improvement resources (“tools”) at
Veterans Affairs (VA) medical centers across the country.
Toolkits were launched between 2010 and 2015. Tools
consisted of medical record-based templates, decision
support resources, patient-tracking databases and service
agreements intended to improve the quality and timeliness
of care.
Methods: Series of online questionnaires and semistructured telephone interviews about tool use, targeting
clinicians, quality managers and others involved in veteran
care or quality improvement (QI).
Results: We evaluated uptake and use of the cancer/
palliative care, primary care, specialty care and emergency
services for women toolkits. Since first toolkit launch in
2010, more than 30,000 unique individuals have visited
with nearly 19,000 visitors to the primary care toolkit
alone. We identified facilitators of toolkit awareness and
use across all four titles, including: 1) presence of facility/
workgroup-level champions, 2) participation in learning
collaboratives and the presence of other social networks,
3) engagement in QI initiatives, and 4) awareness of the
facility’s performance on quality metrics/reports. Among
respondents to the cancer care toolkit questionnaire,
those who were aware of their facility’s performance on
a VA-sponsored lung cancer study were significantly
more likely to have visited the toolkit (odds ratio: 3.10,
95% confidence interval: 1.91–5.01). Respondents to the
emergency services for women toolkit questionnaire who
were involved in other QI activities were more likely to
report toolkit use (odds ratio: 0.312 for uninvolved in QI,
95% confidence interval: 0.14–0.69). Barriers to uptake
included strained personnel and financial resources as
well as complicated approval processes to support tool
implementation.
Conclusion: User-driven online toolkits have broad appeal
to providers and staff. They are a low-cost complement
to other QI approaches, including gold standard toolkits
whereby organizations rigorously design, test and
disseminate tools. Additional work is needed identifying
“less engaged” facilities and promoting toolkit use to them
and others less closely tied to existing social networks.
Increased opportunities for participation in learning/QI
collaboratives and local support for the use of new tools may
enhance uptake. Additional research is needed to increase
our understanding of the link between toolkit use and clinical
outcomes.
Keywords: quality, toolkit
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PS1-31:
Using the HCSRN Private Web Portal to Support
Collaboration: Project-Based Experiences and User
Insights
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Background/Aims: The Health Care Systems Research
Network launched a password-secured web portal (HCSRN
Portal) in October 2014 at www.hcsrn.org/share/. The
HCSRN Portal allows project teams, scientific interest
groups and committees to maintain online work and archival
space, with access restricted to project-specific staff. The
HCSRN Portal enables the manager of each private portal
site to add or remove a variety of functions including a
document library, calendar, wiki, blog, discussion board,
data lists (e.g. action logs, contact directories, etc.) and
quick links. To date, eight collaborative projects have
established private project-specific sites within the HCSRN
Portal. We describe the basic functionality available in the
portal, functionality most used by project teams, and user
experience and satisfaction.
Methods: We will survey individual users and site managers
of the eight project-specific sites to assess their motivation
for establishing a private site in the HCSRN Portal, perceived
usefulness of the various portal functions, and perceived
pros and cons of the portal overall as well as general user
experience, degree of use, desired new or improved features
and overall satisfaction with the portal.
Results: The survey is in progress; results are pending.
Conclusion: HCSRN leaders and project teams have
desired a private web portal for many years. Now that this
resource is available, an evaluation of its utility and general
user experience could help enhance uptake and spread of
the resource to other HCSRN teams in need of a system for
securely sharing information across collaborating sites and
identify potential improvements to support project-based use.
Keywords: web portal, project communications
PS1-32:
Design Features of Successful Outpatient Chronic
Disease Care Clinical Decision Support Systems
Patrick J. O’Connor,1 JoAnn M. Sperl-Hillen,1 Stephen E.
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Minneapolis, MN
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Background/Aims: To identify key design features of pointof-care diabetes clinical decision support (CDS) that have
high use rates and high provider satisfaction rates, and that
have improved control of major cardiovascular risk factors.
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Methods: Based on a series of National Institutes of Healthfunded projects to develop point-of-care electronic health
record-linked, web-based CDS systems, we have identified
design features that contribute to observed high use rates
(60–80%) at targeted visits, high primary care provider
satisfaction rates (94–95%) and positive effects on glucose
and blood pressure control in adults with diabetes.
Results: The ideal outpatient chronic disease care CDS
system would include the following features: a) co-designed
by primary care physicians (PCPs) and researchers,
b) supported by clinic and medical group leaders, c)
designed to improve publicly reported quality measures, d)
introspective identification of targeted encounters, e) total
target encounters limited to about 20% of all adult visits, f)
rooming nurse launches CDS early in encounter workflow,
g) PCP sees CDS early in workflow and uses for visit
planning, h) patient reviews CDS before PCP enters room,
i) simple visual display of potential benefits for patients, j)
prioritization of treatment options based on potential benefit
to patient, k) automated feedback to PCP and clinics on CDS
use rates at targeted encounters, l) compensation to clinics
to cover training costs, m) location of algorithms in web
service to facilitate updates and scalability, and n) built-in
SmartSet to facilitate clinical actions.
Conclusion: These design features may inform future
iterations of chronic disease CDS systems.
Keywords: clinical decision support, population health
PS1-33:
Operationalizing a National Research Network
Andrea D. Buchmeier,1 Christine Cameron,1 Krista
Bradley,1 Jan Lowery1
Center for Clinical Research, CHI Institute for Research
and Innovation, Englewood, CO
1

Background/Aims: Catholic Health Initiatives (CHI) is one
of the largest faith-based health care systems in America. In
2009, CHI established the CHI Institute for Research and
Innovation (CIRI). CIRI is the research service line for CHI
and works closely with CHI hospitals and physicians across
the nationwide health system to: a) centralize administrative
operations to reduce costs, b) provide training and standardize
best practices to improve quality and compliance, c) increase
community and physician awareness on the value of clinical
research, and d) build research disease site portfolios to
increase patient volumes.
Methods: The initial step in building a national research
network is to establish a vision, which is then implemented
through operationalizing many systematic steps to build a
national network. Important stages include building the
research team, the administrative infrastructure at the
national level and the boots-on-the-ground clinical research
staff at each local site. Standardization and streaming of
processes are key to establishing a quality program and
mitigating risk.
Results: The formation of CIRI was intended to improve
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the administrative management of clinical trials and reduce
redundancy of functions at each site by centralizing and
further streamlining these processes. One of the key results
from this centralization has been a significant reduction
in site research expenses; even with the addition of the
centralized function expenses to the site expenses, total
expense has been reduced from the original site expense by
40%. This reflects that the centralized model has proven to
be much more cost-effective than having multiple research
sites operating independently.
Conclusion: Many lessons have been learned since the
initial launch of the national network: a) National and local
administrative champions are essential to success; b) Take
time and build the network right –– no shortcuts; c) Set
SMART goals as envisioned by all stakeholders; d) Try to
overcommunicate; e) Engage communities through outreach
and education efforts; f) Engage industry and government
partners early and often; g) Information technology
infrastructure should include a clinical trial management
system and website presence; and h) Standard operating
procedures provide the foundation for standardization and
quality monitoring.
Keywords: health services research, research administration

GENETICS, GENOMICS, PRECISION MEDICINE

results process. Community members are engaged through
research focus groups, newsletters and as members of the
two committees.
Methods: MyCode is visible via signage throughout
Geisinger clinics and system website. Approximately 20
MyCode consenters are stationed in outpatient clinics
throughout the system. Samples are collected at the time of
clinical blood draws. Consented participants who have not
had clinical bloodwork may arrange to provide a MyCode
sample if desired. Saliva collection may also be requested. In
May 2015, an educational campaign was launched to ensure
that all Geisinger employees can answer patient questions
about biobank participation.
Results: At this time, approximately 1,000 patients consent
per week, 90,000 patients have consented (85% response
rate), 55,000 have at least one sample in the biobank, and
50,000 exomes have been sequenced thus far. The population
of consented patients is 97% white, 62% female and 50%
aged 50–79 years.
Conclusion: Whole exome sequence information combined
with patient medical record data is allowing Geisinger
researchers and research partners to investigate new
approaches to prevention, diagnosis and treatment of disease.
Strong community engagement programs maintain trust in the
system, keep participants engaged in research and continue to
guide the evolution of the MyCode program.
Keywords: biorepository, genomic sequencing

A5-1:
The Geisinger MyCode® Community Health Initiative:
Experiences in Patient Recruitment, Genomic
Sequencing, and Patient Engagement in a
Population-Based Biobank

A5-2:
Parental Expectations and Attitudes Towards
Receiving Genomic Information About Children
Participating in a Population-Based Biorepository

Alanna Kulchak Rahm,1,2 Samantha Fetterolf,2 Ryan
Colonie,2 Michael Murray,1 David J. Carey2

Alanna K. Rahm,1 Audrey Fan,1 Lindsay Bailey,1 Kara
Fultz,1 Janet L. Williams,1 F. Daniel Davis2

1

Genomic Medicine Institute, Geisinger Health System,
Danville, PA; 2Center for Health Research, Geisinger
Health System, Danville, PA

1

Background/Aims: Geisinger’s MyCode® Community
Health Initiative is a population-based biorepository that
began in 2007. Participants give broad consent for research
use of their samples and electronic health record data,
including genomic analysis, and permission to re-contact for
additional studies. Participation in MyCode is open to all
Geisinger patients, with a goal to enroll 250,000 participants.
In 2013, consent was revised to allow for return of medically
actionable information discovered through genomic studies
to patients and providers and to include the information
in the electronic health record. In 2014, a collaboration
was initiated with the Regeneron Genetics Center to
perform whole exome sequencing on biobank samples.
The Governing Board approves all research conducted
on biobank specimens, the Return of Results Oversight
Committee monitors the return of clinical findings, and the
External Ethics Advisory Committee provides independent
feedback on MyCode operations and the clinical return of

Background/Aims: Guidelines published by the American
College of Genetics and Genomics recommend, when
clinical sequencing studies are performed, returning
genetic results in 56 genes, regardless of patient age. The
American Academy of Pediatrics and standard clinical
genetic testing practice recommend neither testing nor
providing results to children for adult-onset conditions with
no childhood manifestations or screening guidelines, such
as hereditary breast and ovarian cancer (HBOC) and Lynch
syndrome. Geisinger’s MyCode® biorepository aims to
collect samples and whole exome sequence data on 250,000
adult and pediatric participants. Consent to participate
in MyCode includes consent to receive genomic results.
Some genomic results have medical implications and
management guidelines for children; however, the six genes
related to HBOC and Lynch syndrome have no immediate
health implications or recommended medical management
for children. Prior studies have indicated that our adult
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Genomic Medicine Institute, Geisinger Health System,
Danville, PA; 2Bioethics, Geisinger Health System,
Danville, PA
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participants are interested in genomic results regardless of
medical actionability; however, few studies have reported on
parental attitudes towards receiving results for their children
that are medically actionable in childhood versus those that
do not have implications until adulthood.
Methods: Multiple focus groups are being conducted with
adult MyCode participants who have at least one child
enrolled in the biorepository. Participants are selected on the
basis of child age (0–8 or 9–17) and geographic location. A
semi-structured guide was developed to elicit expectations
regarding their children’s participation in the biorepository
and opinions and reactions to different return of results
scenarios. Parents are first introduced to the issues through
a scenario in which they learn that a child has a genetic
condition that can be medically managed in childhood
(Marfan syndrome), and then they are challenged to think
about receiving genetic information about adult-onset
conditions in their children, specifically HBOC and Lynch
syndrome.
Results: Results from in-depth thematic analysis of focus
group transcripts will be presented.
Conclusion: In developing pediatric biorepository consent
processes and return of results protocols, it is crucial to elicit
and understand both parental and, to the extent possible,
pediatric participant attitudes and responses to different
types of genomic information — specifically information
that has childhood implications versus information that is
medically actionable only during adulthood.
Keywords: whole exome sequencing, biorepository
A5-3:
Universal Screen for Lynch Syndrome in an
Integrated Health Care System: Assessment of
Patient Perspectives and Sharing Results With
At-Risk Relatives
Jessica Ezzell Hunter,1 Jamilyn M. Zepp,1 James V.
Davis,1 Kellene M. Bergen,1 Kristin R. Muessig,1 Susan
K. Peterson,2 Sapna Syngal,3 Louise S. Acheson,4
Georgia L. Wiesner,5 Jacob A. Reiss,1 Katrina A.B.
Goddard1
Center for Health Research, Kaiser Permanente
Northwest, Portland, OR; 2Department of Behavioral
Science, University of Texas MD Anderson Cancer
Center, Houston, TX; 3Division of Medical Oncology,
Department of Medicine, Dana-Farber Cancer Institute,
Brigham and Women’s Hospital, Harvard Medical
School, Boston, MA; 4Departments of Family Medicine
and Community Health and Reproductive Biology, Case
Western Reserve University and University Hospitals
Case Medical Center, Cleveland, OH; 5Hereditary
Cancer Program, Department of Medicine, VanderbiltIngram Cancer Center, Vanderbilt University, Nashville, TN

tumor screening for LS among all new cases of CRC over
selective screening based on family history or age of
diagnosis. Maximal reduction in morbidity and mortality
from universal tumor screening depends on patients with
a positive screen following up with genetic counseling and
testing to confirm a diagnosis of LS and sharing results
with at-risk relatives.
Methods: Participants included 165 Kaiser Permanente
Northwest members aged 39 to 91 years who had undergone
surgery for CRC. Tumor samples were screened for
microsatellite instability and participants surveyed before
and after receiving screening results to assess perspectives
on screening and sharing results with at-risk relatives.
Results: Most patients reported no family history of CRC;
14.1% had a first-degree relative and 7.4% had a secondor third-degree relative with CRC. However, most (93%)
wanted to know their risk for hereditary CRC. Overall,
most patients endorsed potential benefits and few barriers
to screening, though 62% indicated a worry about the cost
of additional testing and surveillance. Before receiving
screening results, most patients indicated they would likely
share their result with their parents (90%), siblings (96%)
and children (97%), where applicable. Of the 25 patients
with a positive microsatellite instability screen, 96.0%
reported they shared their results with at least one relative.
Most patients endorsed motivations to share results, namely:
so family members could act to reduce their risk of CRC
(76%) and it was their responsibility to let family members
know they might be at higher risk of CRC (68%). None
of the patients indicated that strained family relationships
would prevent them from sharing results, and few indicated
that they would not share their results because it would
worry relative(s) (8%) or because discussing their results
could hurt relationship(s) (4%).
Conclusion: Given universal tumor screening will target all
new cases of CRC, it is important to understand motivations
among patients not identified via high-risk factors such as
family history or age of diagnosis. These findings provide
insight into patient attitudes and perspectives toward LS
screening to guide successful implementation of screening
programs.
Keywords: Lynch syndrome, genetic screening

1

Background/Aims: Lynch syndrome (LS) is the most
common cause of hereditary colorectal cancer (CRC).
Evidence-based recommendations promote universal

192 JPCRR • Volume 3, Issue 3 • Summer 2016

A5-4:
High-Risk Breast Cancer Clinic –– A New RiskStratified, Evidence-Based, and Efficient Patient
Care Model
Susan R. Snyder,1 Rosemary Leeming,2 Alanna K.
Rahm,1 Jing Hao,1 James M. Pitcavage1
Center for Health Research, Geisinger Health System,
Danville, PA; 2Geisinger Medical Center, Geisinger
Health System, Danville, PA
1

Background/Aims: There is considerable variation in
adherence to available evidence-based recommendations
for risk assessment, screening, genetic counseling and
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testing, surveillance and preventive care for women at
risk for breast cancer. To improve adherence and patient
outcomes and to facilitate appropriate referral to genetic
testing, Geisinger implemented a new care model in February
2015 to systematically and efficiently deliver appropriate
risk assessment and management services using midlevel
providers. This “high-risk breast cancer clinic” provides
any interested woman with a personal risk assessment
and care plan. Validated risk assessment approaches are
used to stratify women into differing risk levels. This new
approach focuses on the large moderate-risk (5-year risk ≥
1.7% and/or lifetime risk ≥ 20%) and average-risk (5-year
risk ≤ 1.7%) populations, who comprise the majority of
women and who are typically underserved with usual care. It
provides them with evidence-based counseling, surveillance
and chemoprevention care services. This clinic also serves
women with dense breasts (density > 50%, which includes
about half of all women) who also are known to be at
increased risk for breast cancer.
Methods: For women at moderate risk of developing breast
cancer, a decision-analysis model compares care, outcomes
and costs for the high-risk breast cancer clinic’s approach to
usual care. Assumptions for the model are based on Geisinger
patient data, literature and expert opinion to develop estimates
for clinical and economic outcomes.
Results: A decision-analysis model comparing Geisinger’s highrisk breast cancer clinic to usual care is used for a budget impact
analysis to show the estimated effects of differences in patient
care on outcomes and costs, including benefits of delivering riskbased prevention and treatment at earlier stages to moderate-risk
patients. This analysis is used to make a business case for this
new care model in an integrated health system.
Conclusion: A new targeted care model providing evidencebased evaluation and services to women at moderate and
average risk for developing breast cancer offers the potential
to improve delivery of appropriate care, patient experience
and health outcomes with a favorable impact on cost.
Keywords: breast cancer, risk
PS-46:
Effects of Systematic Referral to Genetic Counseling
in High-Risk Women With and Without a College
Degree
Sarah Knerr,1,2 M. Robyn Andersen,3 Charles W.
Drescher,3,4,5 Robert Resta,6,7 Michelle Hager,3 Carole
Shaw,3 Kate Watabayashi,3 Nicole Urban1,3
Department of Health Services, School of Public Health,
University of Washington, Seattle, WA; 2Group Health
Research Institute, Seattle, WA; 3Public Health Sciences,
Fred Hutchinson Cancer Research Center, Seattle, WA;
4
Pacific Gynecology Specialists, Seattle, WA; 5Obstetrics
and Gynecology, School of Medicine, University of
Washington, Seattle, WA; 6Swedish Cancer Institute,
Swedish Medical Center, Seattle, WA; 7Hereditary Cancer
Clinic, Swedish Medical Center, Seattle, WA
1
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Background/Aims: Systematically identifying and referring
women at high risk of hereditary breast and ovarian cancer
to genetic counseling may minimize disparities in genetic
services utilization. Our aims were to examine the effect of
systematic referral on changes in testing-related cognitions
and genetic services utilization and to test for effectmodification by education level.
Methods: In this secondary analysis of a randomized
controlled trial, high-risk women (n=625) were identified
through electronic medical record data and mailed riskassessment questionnaires. Women that provided informed
consent were randomized to either referral to genetic
counseling (n=228) or standard clinical care (n=230).
Results: Referral was associated with a 78% higher
probability of participation in genetic counseling (95%
confidence interval: 72%–83%, P<0.01) and a 23% higher
probability of undergoing genetic testing (95% confidence
interval: 16%–30%, P<0.01) compared to standard clinical
care. There was no evidence of differential intervention
effects by education level, though exploratory analyses
showed women with at least a college degree had larger
increases in ovarian cancer relative risk perceptions from
baseline to directly following genetic counseling.
Conclusion: Systematically identifying and referring highrisk women to genetic counseling using electronic medical
record data and mailed risk-assessment questionnaires
increased genetic services utilization, regardless of education
level. Widespread dissemination of similar approaches may
lead to more equitable genetic services delivery and improve
cancer-related outcomes for high-risk women.
Keywords: genetic services utilization, health care disparities
PS2-47:
Insurance Coverage Policies for GuidelineRecommended Genetic Testing for Targeted
Cancer Therapies: Preliminary Results
Christine Y. Lu,1 Rachel Ceccarelli,1 Kathy Mazoe,2
Ann Wu1
Department of Population Medicine, Harvard Pilgrim
Health Care, Boston, MA; 2Meyers Primary Care
Institute, Worcester, MA
1

Background/Aims: Modern medicine is transitioning from
empirical treatment to treatment on the basis of the underlying
biology of the disease through the use of genomics-based
technologies. Genomic tests are the fastest growing sector
of medicine and medical science and have the potential to
improve clinical practice. This study examined differences
in patient access to guideline-recommended genetic tests
that guide cancer treatment.
Methods: We reviewed publicly available coverage policies
for 20 gene-cancer drug pairs (e.g. HER2, EFGR, BRAF
tests), including 10 large private insurers and 12 Medicare
contractors. We searched gene and drug names and key
terms including gene, genomic and biomarker. We reviewed
and extracted the following features: type of policy (gene-
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specific, drug-specific, generic policy for genetic testing);
medical condition for which the test is covered; requirements
for prior authorization; test methods and test result definition;
and evidence basis for coverage.
Results: Across 10 private insurers, we identified 18
gene-specific policies, 63 drug-specific policies, 41 prior
authorization requirements (for genetic test, drug or both) and
16 general policies for groups of genetic tests. Overall, some
insurers have established gene-specific coverage policies that
guide use of such tests, while most relied on policies guiding
coverage of genetic testing more generally that may or may
not include guideline-recommended genetic tests of interest.
A few insurers only have drug coverage policies, and some
of these did not recommend use of evidence-based genetic
testing. Further analysis of policies is underway.
Conclusion: These preliminary findings of substantial
variation in how insurers address guideline-recommended
genetic tests underscore the need for additional research into
the impact of these variations on cancer care and utilization.
Keywords: pharmacogenomics, targeted cancer therapies
PS2-48:
Perspectives From Enrollees of a Large U.S. Health
Care System on Informed Consent for Genetic
Research
Monica M. Fuji,1 Lee Barr,1 Wylie Burke,2 Kenneth E.
Thummel3
Group Health Research Institute, Seattle, WA;
Department of Bioethics and Humanities, University
of Washington, Seattle, WA; 3Department of
Pharmaceutics, University of Washington, Seattle, WA
1
2

Background/Aims: To understand patient views about
consent for secondary use and sharing of genetic data and
specimens in the context of U.S. requirements for broad
data sharing from the National Institutes of Health and the
Department of Health and Human Services.
Methods: We surveyed 523 members of a large integrated
health care system who previously participated in genetic
research. We asked closed-ended questions about their
perspectives on informed consent and biobanking.
Results: Of eligible participants, 273 completed the survey.
Overall, sharing of genetic information and samples was
acceptable in our participant population. Results about consent
type were mixed –– no single type of consent was overwhelmingly
preferred. However, stratification by demographics showed
that nonwhites, persons with higher income and men preferred
study-specific over broad consent.
Conclusion: For most research participants, the broad sharing
of information and biospecimens was acceptable. More work
to better understand the consent preferences of populations
by demographic factors may help in recruiting diverse study
populations to generate more generalizable research results
that benefit all members of society.
Keywords: human research subject protection, informed
consent
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ECI Awardee:
An Innovative Patient-Centered, Multidisciplinary
Approach for the Delivery of Genomic Sequencing
Results and Pharmacist-Led Lipid Management to
Patients With Familial Hypercholesterolemia
Laney K. Jones,1 Eric A. Wright,2 Michael Evans,1 Mark
S. Williams,3 Michael F. Murray3
Enterprise Pharmacy, Geisinger Health System,
Danville, PA; 2Center for Health Research, Geisinger
Health System, PA; 3Genomic Medicine Institute,
Geisinger Health System, Danville, PA
1

Background/Aims: Recent advances in genomic sequencing
have provided new opportunities to identify individuals with
familial hypercholesterolemia. The accessibility and usage
of sequencing data for diagnosis and treatment of disease
states has been scarce in medical practice but promises to be
more widely available in the near future. Models for how to
deliver genomic results to unsuspecting patients and provide
postreturn care are needed. Our aim is to describe the first-ofits-kind multidisciplinary patient-centered model to deliver and
provide care for patients with familial hypercholesterolemia
identified through the MyCode® Community Health Initiative.
Methods: At Geisinger the return of genomic sequencing
results has been made possible through MyCode. The
initiative began in 2006, and so far more than 50,000 patients
have had exome sequencing completed. Over the next few
years Geisinger aims to return results for certain actionable
genetic conditions. An early-targeted population is those with
familial hypercholesterolemia identified by analyzing exome
sequence data obtained from MyCode participants. A review of
current literature and internal care processes at Geisinger was
conducted to determine the most appropriate delivery of care.
Results: Based on review of current literature and
Geisinger care processes, there was substantial evidence
to support a patient-centered multidisciplinary care team
approach. Geisinger has previously seen excellent results
in collaborative hyperlipidemia clinics. Our proposed
multidisciplinary team will be comprised of two groups:
1) a core team (provider, pharmacist, dietician), and 2)
an auxiliary team (cardiologist, primary care physician,
obstetrician/gynecologist, genetic counselor). An initial visit
will include a discussion of genetic results with patients,
cascade testing of family members, baseline assessment,
determination of patient-specific treatment goals and referral
to cardiology if necessary. Subsequent visits will be led
by clinical pharmacists and focus on maximizing familial
hypercholesterolemia therapy, targeting treatment goals and
responding to patient concerns. Initial qualitative feedback
will be collected from team members and patients.
Conclusion: The development of this novel multidisciplinary
team will allow us to provide patients with vital information
about their health in a supportive environment. Future
analysis will include a comparison of pharmacist-led team
management to management provided by usual care on
clinical, social and economic outcomes.
Keywords: familial hypercholesterolemia, patient-centered care
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HEALTH DISPARITIES
C3-1:
Capturing Sex Partner Information in the Electronic
Health Record: Implications for Research on
Sexual Minorities Within an Integrated Health Care
Delivery System
Mark A. Schmidt,1 Alexandra M. Varga,1 Phillip M.
Crawford,1 Sanchita Sengupta,1 Suzanne E. Gillespie,1
Judy L. Donald,1 Mary A. McBurnie1
Center for Health Research, Kaiser Permanente
Northwest, Portland, OR
1

Background/Aims: To better characterize and reduce health
disparities faced by sexual and gender minorities (SGM),
efforts to collect sexual orientation and gender identity within
the electronic health record (EHR) are currently burgeoning
across the United States. In 2006, Kaiser Permanente
Northwest (KPNW) began collecting information about
sexual activity of patients and the sex of their partners in the
social history module of its EHR. The aims of our work were
to describe trends in the capture of this information over a
9-year period and discuss the relevance of these findings to
current sexual orientation and gender identity data collection
and SGM health research efforts.
Methods: We included all KPNW members with at least
one day of health plan enrollment and at least one in-person
encounter (outpatient, inpatient or emergency department)
from Jan. 1, 2006, to Dec. 31, 2014. We analyzed sexual
activity and sex partner variables at encounter and individual
levels over the study period.
Results: From 2006 to 2014, the proportion of encounters at
which a patient’s sexual activity was recorded increased from
1.2% to 15.1% for males and from 2.9% to 27.4% for females,
with an increase among primary care encounters from 2.8% to
29.6% for males and 4.6% to 49.1% for females. Of our study
population still enrolled in 2014, 37,890 males (22.1%) had a
sex partner recorded, 94.6% of which had female only, 5.1%
male only and 0.3% both. At the same time, 87,851 females
(40.7%) had a sex partner recorded, 96.8% of which had male
only, 2.8% female only and 0.4% both.
Conclusion: Our findings suggest an increasingly systematic
capture of sexual activity and sex partner information within
the KPNW EHR. Sexual behavior is only one component of
sexuality orientation. As such, we are likely underestimating
the size of our SGM population, especially for those reporting
both male and female partners, based on previously published
estimates. However, our research supports the idea that
successful routine capture of sexual orientation and gender
identity data within the EHR is possible. We argue that
inclusion of these data would lead to a better understanding of
the size and representativeness of the SGM population, more
robust research studies and better interventions to reduce
SGM health disparities.
Keywords: sexual orientation and gender identity, LGBT
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C3-2:
A Qualitative Exploration of Perceived Health Issues
Among Transgender Individuals in Atlanta and San
Francisco
Ashli A. Owen-Smith,1 Cory Woodyatt,2 R. Craig
Sineath,2 Enid Hunkeler,3 La Tasha Barnwell,4 Ashley
Graham,1 Michael Goodman2
Department of Health Management and Policy,
Georgia State University, Atlanta, GA; 2Department of
Epidemiology, Emory University, Atlanta, GA; 3Division
of Research, Kaiser Permanente Northern California,
Oakland, CA; 4Department of Behavioral Sciences and
Health Education, Emory University, Atlanta, GA
1

Background/Aims: To date, health literature concerning lesbian,
gay, bisexual and transgender (LGBT) persons has grouped
these individuals into a single LGBT community. Lack of
knowledge about transgender or gender-nonconforming (T/
GNC) individuals, specifically, precludes T/GNC health
from the public health agenda. To address this gap, we
undertook a qualitative exploratory study to examine the
perceptions of health issues among T/GNC individuals,
including the perceived barriers to accessing health care and
reliable information about health care services.
Methods: Data were drawn from 12 focus group discussions
with 75 self-identified T/GNC men and women in Atlanta
(n=37) and San Francisco Bay Area (n=38). Focus group
discussions were stratified by gender and project site and
were audio-recorded. The resulting transcripts were then
reviewed for potential conceptual categories. Emergent
themes were identified based on recurrence and on
similarities/differences noted across the transcripts.
Results: Preliminary analyses suggest that T/GNC
participants are most concerned about HIV/AIDS, mental
illness related to trauma and depression, cancer risk and
the long-term effects of hormone use. Participants reported
experiencing many barriers to receiving timely and effective
health care services. These barriers included: 1) poor access
to affordable care (primarily due to cost/lack of health
insurance coverage), 2) poor availability of culturally
competent care, 3) perceived discrimination by health
care providers, 4) difficulties navigating complex health
care systems, and 5) lack of reliable information about
transgender health care services. Though participants felt
that the Internet can be a helpful resource for identifying
information about providers and services, many participants
expressed concerns that online information was not always
accurate and was frequently confusing and inadequate.
Word-of-mouth and social media resources were perceived
to be most helpful. Additional analyses using MAXQDA
software will be conducted prior to the conference.
Conclusion: Prior research demonstrates a deficiency in
information regarding long-term health outcomes for T/
GNC individuals. Our preliminary results indicate that T/
GNC participants express concerns regarding the longterm effects of cross-sex hormones and surgery on chronic
conditions like cancer, diabetes and cardiovascular disease.
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Additionally, despite recent advances in transgender
care, many individuals experience significant barriers to
accessing affordable, timely and culturally competent care
and reliable information. Lessons learned from this study
may inform future behavior-, health system- and policylevel interventions.
Keywords: transgender, health status
C3-3:
Perceptions of Barriers to and Facilitators of
Participation in Transgender Health Research
Ashli A. Owen-Smith,1 Cory Woodyatt,2 R. Craig
Sineath,2 Enid Hunkeler,3 La Tasha Barnwell,4 Ashley
Graham,1 Michael Goodman2
Department of Health Management and Policy,
Georgia State University, Atlanta, GA; 2Department of
Epidemiology, Emory University, Atlanta, GA; 3Division
of Research, Kaiser Permanente Northern California,
Oakland, CA; 4Department of Behavioral Sciences and
Health Education, Emory University, Atlanta, GA
1

Background/Aims: Research regarding the health
of transgender and gender-nonconforming (T/GNC)
individuals and, moreover, methodological considerations
for recruitment of this population, is scarce. As part of a
larger effort to understand the feasibility of developing
a cohort study to examine long-term health outcomes of
hormonal therapy, we conducted focus group discussions
to qualitatively explore attitudes toward health research
involving T/GNC individuals. Specifically, we aimed to
explore the potential facilitators and barriers to recruitment
and enrollment and to identify points of influence that would
aid future recruitment.
Methods: Data were drawn from 12 in-person focus group
discussions with 75 self-identified T/GNC men and women
in Atlanta (n=37) and San Francisco Bay Area (n=38).
Discussions were stratified by gender and project site and
were audio-recorded. The resulting transcripts were then
reviewed for potential conceptual categories using the focus
group discussion questions as initial categories. Emergent
themes were identified based on both recurrence and
similarities/differences noted across transcripts.
Results: Preliminary analyses suggest that individuals who
identify as T/GNC experience several barriers to research
participation. These include: 1) being unaware of the
research, 2) having transportation and financial challenges,
3) believing that the research questions are irrelevant to the
lives of T/GNC individuals, and 4) feeling distrustful of the
medical and research community. Suggestions for how to
improve research participation by individuals in the T/GNC
community include: 1) recruiting in diverse communitybased locations using face-to-face referral/snowball-based
methods; 2) scheduling research visits in locations accessible
via public transportation and offering a variety of days/times
to accommodate personal and professional responsibilities;
3) providing incentives including cash/gift cards, food
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and free/discounted health services; and 4) prioritizing
transparency regarding the research questions and how
the results will benefit the T/GNC community. Additional
analyses of the transcripts using MAXQDA software will be
conducted prior to the conference.
Conclusion: T/GNC individuals form a sizeable, unique
and underserved community. Understanding the barriers
and facilitators of successful enrollment and retention in
research studies is critical to addressing health disparities
experienced by this community. Results from these analyses
will help to identify points of influence that would aid
recruitment of T/GNC individuals into future observational
studies and intervention trials.
Keywords: transgender, research participation
C3-4:
Mobile Technology and Promoting Health Equity for
Low-Income Patients
Sharon S. Laing,1 Cindy P. Mendez-Hernandez,2 Carlota
Ocampo,3 Stacy Baugh3
Nursing and Healthcare Leadership Programs,
University of Washington Tacoma, Tacoma, WA;
2
Women’s Collective, Washington, DC; 3Trinity
Washington University, Washington, DC
1

Background/Aims: Mobile health promotion (mHealth) is
health practices supported by mobile devices like smartphones
and wireless technology. mHealth delivers health information
to increase awareness, provides guided instructions about
healthy behaviors and offers self-monitoring of health status.
Approximately 58% of adults and 43% of individuals earning
less than $20,000/year own smartphones; pervasiveness
of mobile devices provides opportunity for patient selfcare management. A majority of low-income patients
access services in community health centers (CHCs), thus
an opportunity exists to evaluate how mobile devices can
promote continuity of care in CHCs. The objectives are as
follows: 1) Assess attitudes and practices concerning mobile
technology; and 2) Evaluate how mobile devices can promote
equity in health care access for low-income populations.
Methods: Researchers recruited a convenience sample of
103 low-income patients from CHCs in Washington State
by approaching patients in waiting areas of two CHCs.
After consenting, patients completed a 47-item survey in a
private room and received a $10 gift certificate. Survey items
queried about: 1) knowledge and practices concerning mobile
technology, and 2) perception about access to care in CHCs.
Results: Study population was 55.6% white, 67% women and
had median household income of $21,192. In terms of health
care access, 80% and 83% reported easy access to specialists
and health information, respectively. Approximately 89%
emphasized the importance of making healthy lifestyle
choices, yet only 56% and 66% received the CDC’s
recommended weekly physical activity and healthy eating
guidance, respectively. In terms of technology knowledge and
practices, 79% used mobile devices for health information.
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Barriers to information access were: 1) lack of knowledge
about use (52%), and 2) preference for care providers’ advice
(42%). Fifty-eight percent reported no knowledge about
medical-based mobile apps (e.g. blood pressure monitoring),
and 66% never used these devices. If medical-based apps
were recommended, top preferred uses were: 1) prescription
refills (80%), 2) medication reminders (66%), and 3) mental
health monitoring (55%).
Conclusion: Some gaps in preventive care information
dissemination do exist for patients receiving care in CHCs.
However, patients appear ready to use technology in
sophisticated ways for self-care management. Mobile devices
might supplement care by providing health information and
health status self-monitoring, thus helping to reduce health
disparities.
Keywords: health care access, mobile technology
PS2-49:
Geographic Disparities in Influenza Vaccination
Among Patients at Kaiser Permanente Mid-Atlantic
States, 2014–2015
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Background/Aims: Yearly influenza epidemics can result
in increased morbidity and mortality, absenteeism and
productivity losses, and can overwhelm clinics and hospitals
during peak illness periods. While safe and effective vaccines
are available, disparities in influenza vaccinations rates are
reported. The goal of this study is to examine geographic
patterns of influenza vaccinations at Kaiser Permanente
Mid-Atlantic States (KPMAS) (and assess the relative
contribution of select covariates –– data not presented here).
Methods: We included members ≥ 18 years old as of May
1, 2014, with continuous enrollment through May 31, 2015.
Influenza vaccination was defined by diagnosis, procedure
or medication codes, or documentation in the immunization
table. Characteristics of those who did and did not receive
the vaccine were reported. Vaccination rates were examined
by county for Maryland (MD), District of Columbia
(DC) and Virginia (VA). We will use the Blinder-Oaxaca
decomposition method to determine what proportion of the
geographic disparity could be reduced by equalizing select
characteristics (data to be presented later).
Results: We identified 348,666 adult KPMAS members,
of whom 141,238 (40.5%) received the influenza vaccine.
Vaccinated, compared to nonvaccinated, members were
younger (mean age 55 [SD: 16.7] vs. 43 [SD: 16.2]), more
likely to be white (56,123 [39.7%] vs. 49,435 [23.8%]) and
less likely to be African-American (47,028 [33.3%] vs.
80,819 [39.0%]). Education, mean distance to a medical
center, body mass index and current smoking status were
similar across the two groups. Vaccinated members were
more likely to have had a primary care visit in the study year
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(126,677 [89.7%]) than nonvaccinated members (134,011
[64.6%]). Geographically, the lowest rates of influenza
vaccinations (< 30%) were clustered in six adjacent counties
located in DC and southern MD. Northern VA counties had
the highest rates of vaccination. By race, vaccination rates
were lower for African-Americans compared to whites in
every county; however, a similar geographic pattern of low
vaccination rates was observed in both races.
Conclusion: Among KPMAS members, a cluster of
counties in DC and southern MD show the lowest rates
of vaccinations. Examination of possible reasons for
this disparity are needed. In subsequent analyses we will
determine how specific characteristics contribute to the
geographic disparity.
Keywords: influenza, disparities
PS-50:
Using Emergency Room Visitation Data to Identify
Health Improvement Opportunities for Medicaid
Enrollees
Scott B. Ode1
1
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Background/Aims: Medicaid enrollees face many
unique barriers when it comes to maintaining their health.
Unfortunately, it is not always easy to identify these barriers and
measure their consequences. One approach to understanding
these disparities is to examine emergency room (ER) visitation
patterns. By comparing ER utilization for individuals enrolled
in Medicaid versus commercial insurance products, this study
hopes to identify disparities in order to direct future research
and shape public policy.
Methods: Claims for all ER visits in 2011 were obtained from
a regional health plan for individuals enrolled in Medicaid or
commercial fully insured products. Data from over 130,000 ER
visits were captured. Diagnostic grouping software was used to
determine the reason for each visit and visit frequencies for these
groupings were calculated and compared across populations.
Results: The percentage of visits among Medicaid versus
commercial enrollees was substantially larger for upper
respiratory infections (URI; 10.3% vs. 5.9%), otitis media (OM;
4.7% vs. 2.2%) and disorders of the teeth and jaw (DTJ; 3.3%
vs. 1%). Follow-up analysis examining these differences by
age found that URI and OM accounted for the first and second
highest disparity for individuals aged 0-12 years (18% vs. 14%
and 11% vs. 8%, respectively), but this difference quickly
dropped as age increased. Visits for DTJ were low among the
0–12 age group (< 1% vs. < 1%) but were responsible for the
largest visitation disparity for individuals age 13–25 (1% vs.
5%) and 26–38 (2% vs 6%). DTJ accounted for the secondlargest disparity for individuals age 39–64 (4% vs. 1%).
Conclusion: A number of avenues for future research can be
drawn from these findings, particularly those involving DTJ.
Though patterns involving children may indicate environmental
influences, they also may be a result of parents using the ER for
primary care. Differences involving DTJ, however, are highly
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suggestive of unmet needs –– most likely a mix of access to
adequate dental care and treatment for drug addiction. Future
research and policy implementation in this area will be crucial to
improving the health and well-being of low-income populations.
Keywords: emergency room utilization, dental care

providers. Greater diversity in demographics of health care
professionals may not necessarily lead to improved patient
experience unless truly culturally concordant care is provided.
Keywords: race/ethnicity/language concordance, patient
satisfaction

ECI Awardee:
Does Patient-Provider Racial/Ethnic and Language
Concordance Impact Patient-Reported Experience
of Care?
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Validation of a Model
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Background/Aims: Patient-provider race/ethnicity or language
(REL) concordance can influence quality of communication and
thus patient experiences of care. We explored this relationship
among the largest and fastest growing immigrant populations
in the United States –– Asian Indian, Chinese and Latinos ––
compared to non-Hispanic whites (NHW).
Methods: Patient survey data (2013-2014) from the Consumer
Assessment of Healthcare Providers and Systems (CAHPS)
Clinician & Group Survey were linked to electronic health
records of patients in a large mixed-payer ambulatory care setting
in northern California. We used multivariate logistic regressions
to evaluate the effect of patient-provider REL concordance on
patient experience of “Provider explanation understandable” (Yes,
definitely vs. Yes, somewhat or No) and “Overall assessment
of provider” (9 or 10 vs. 0–8 on scale of 0 [worst possible] to
10 [best possible]) after controlling for other visit and provider
characteristics influencing patient experience of care.
Results: Among 51,401 and 51,168 patients who provided
answers to the two measures, respectively, 3% were Asian
Indians, 7% Chinese, 8% Latinos and 82% NHW. Asian Indian
and Chinese gave lower ratings for both outcomes compared
to NHW, and patients with limited English proficiency gave
lower ratings on “Provider explanation understandable” than
English-proficient patients. Chinese providers were not rated
differently from non-Chinese providers among both Chinese
patients with and without limited English proficiency.
Spanish-speaking Latinos gave lower ratings on “Overall
assessment of provider” to non-Latino providers who speak
Spanish (self-reported) (odds ratio: 0.17) compared to
non-Latino providers who don’t speak Spanish. Englishspeaking Latinos gave higher ratings on the measure to
Latino providers (odds ratio: 2.54) than non-Latino providers.
Conclusion: The impact of REL concordance on patient
satisfaction is not uniform across racial/ethnic groups. Asians
rate communication and overall assessment of providers
lower than NHW in the same setting, and REL concordance
did not improve their ratings. Latinos may prefer racial/ethnic
concordant providers for better cultural sensitivity and a sense
of shared beliefs and experiences, but Latinos with limited
English proficiency may perceive a discrepancy between
expectation and experience with language concordant-only
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Background/Aims: We developed and validated a model
to predict the risk of emergency department (ED) visits in
adult Medicaid members so that case-managers can identify
the highest-risk patients and intervene. We then validated
the model on newly enrolled Medicaid patients.
Methods: To develop the prediction model, we assembled
a retrospective cohort of adult Medicaid members (18–
64 years old) enrolled at Kaiser Permanente Northwest
between 2010 and 2013. We measured patient characteristics
during the 90 days before the start of follow-up that might
predict ED visits. We followed patients for up to 180 days
to identify the first ED visit. To validate the model, we
assembled a distinct cohort of adult Medicaid members
who joined Kaiser Permanente Northwest in the first
quarter of 2014. We developed and validated separate
models for men and women using Cox regression.
Results: We observed 2,587 patients who visited the ED
during the 180-day follow-up. The overall 180-day risk of an
ED visit was 13.9 per 100 (men) and 17.4 per 100 (women).
The models discriminated the high- and low-risk patients
adequately: concordance or c-statistic was 0.72 (men) and
0.71 (women), respectively. The model’s 10 predictor
characteristics explained 35.2% of the variation in ED
visits in men and 29.6% of the variation in women. Model
calibration (agreement between observed and predicted)
revealed that the mean predicted risks in the highest-risk
patients underestimated the observed risks of an ED visit by
approximately 11 per 100. The model for women validated
adequately in the newly enrolled cohort because the c-statistic
remained constant while the model for men disappointed
because the c-statistic dropped by 0.05. For both men and
women, the models continued to underestimate the absolute
risk of an ED visit in the highest-risk patients.
Conclusion: The models identified the highest-risk patients
with only 90 days of clinical history, and the models validated
on new Medicaid patients. Time invested in managing the
highest-risk patients may offer a superior return on investment
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compared with a strategy that does not stratify because the
highest-risk patients suffer a disproportionate excess risk. The
return on time invested may be even higher if recurrent ED
visits are considered.
Keywords: prediction modeling, emergency department
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Background/Aims: Innovative web-based methods of
delivering wide-scale mental health interventions in an
efficient and sustainable manner have the potential to
overcome barriers to care and increase access. Herein we
describe lessons learned using an integrated informatics
architecture developed to support implementation of two
large randomized mental health pragmatic trials that are
currently underway at three HCSRN sites. The Strategies for
Overcoming Residual Depressive Symptoms (SOAR) study
is evaluating the effectiveness of an online mindfulnessbased cognitive therapy (MBCT) program in 460 patients.
The Suicide Prevention Outreach Trial (SPOT) is evaluating
the effectiveness of two separate interventions –– an online
dialectical behavior therapy skills training program or risk
assessment/care management using the Columbia Suicide
Severity Rating Scale with secured messaging through Epic
–– in preventing suicide attempt/death in 16,000 patients.
Each study integrates software tools for targeted patient
outreach, retention and monitoring of suicide risk.
Methods: Both studies leverage real-time patient-reported
outcomes data from Epic questionnaires for cohort identification
and recruitment. Patients are then invited via email to visit
websites to learn about the study and provide informed consent.
REDCap, DatStat or Epic questionnaires are used to collect
follow-up data from participants with real-time, item-level
email alerts to notify study staff of suicide risk. An email service
delivers study incentives to patients on survey completion.
A dashboard was developed in Epic to facilitate population
management for a large volume of high-risk patients.
Results: The integrated informatics architecture allows the
study team to enroll patients efficiently and to maintain high
patient retention with survey completion rates of 70% in the
MBCT study at 6 months. We tested several approaches for
suicide risk monitoring using web-based surveys to encourage
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patients’ acceptance of subsequent outreach. Each HCSRN site
adapted an Epic dashboard function that alerts care managers to
high-risk patients and tracks appointment compliance.
Conclusion: Creative problem solving and effective
partnerships among study staff, software and data
programmers, care delivery teams, external collaborators
and institutional review boards are essential for effective
implementation of large pragmatic trials using multiple
technologies. The integrated informatics architecture created
here is essential to realize scalability, increase efficiency and
support effectiveness of the interventions.
Keywords: technology, mental health
A3-3:
Visual Approaches to Bring Population Data Insights
at Your Fingertips
Ketan Mane,1 Jackie Blank,1 Michael Hornberg1
Mid-Atlantic Permanente Research Institute, Kaiser
Permanente Mid-Atlantic States, Rockville, MD
1

Background/Aims: The data surge in electronic medical
records offers a tremendous potential to leverage it to impact
population/patient care delivery. However, to make sense of
large data volume requires significant time commitment and
attention –– both of which are scarce resources for stakeholders
in decision-making roles. Thus, a need exists to use technology
that improves our ability to make faster inferences and
decisions from data. At Kaiser Permanente Mid-Atlantic
States, we are exploring novel ways to combine computational
cycles and human intuitions in a learning loop to enhance care
delivery experience. Our aim is simple: Instead of spending
hours trying to gather information, we wanted to come up
with a more user-intuitive approach that offers an easy way to
sift through multidimensional data –– to have the information
right there at your fingertips for insights.
Methods: We focused on human immunodeficiency virus
(HIV) cohort data from Kaiser Permanente Mid-Atlantic
States. In contrast to our current approach of disseminating
the report in tabular format, we adopted a visual data-driven
strategy to best support user’s tasks and to yield more
information in less time. For rapid development, we used
Tableau to build visual interface. From project inception,
stakeholders were part of the design process to bring important
perspectives. Data views that can be snapped together in a
dashboard interface were built. Visual data encoding was used
to reduce user’s cognitive effort, and filters were added to help
customize views to user’s needs.
Results: The built HIV dashboard offered at a glance overview
of population. Supporting interaction offered flexibility to
instantly update data view to different inclusion/exclusion
combinations as they came to user’s mind. It offers decision
makers macro-to-micro level population insights like: how
the population is doing at the regional/service area/medical
center level, how the population is distributed among different
sites, and others.
Conclusion: The designed, visual, data-driven tool attempts
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to augment decision makers’ cognition, support their ability
to gather data insights and facilitate decision-making.
Leveraging computational tools and designs, we show
an approach to divide and conquer data, where the best of
both human intuition and knowledge can be augmented by
interaction with tools to boost performance.
Keywords: visualization, decision-making
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Background/Aims: Electronic health records (EHRs)
represent an opportunity for real-time early risk prediction.
EHRs were used to determine the extent to which machine
learning tools and a purely data-driven approach to modeling
could detect heart failure (HF) subtypes, i.e. preserved ejection
fraction (HFpEF) and reduced ejection fraction (HFrEF), 12
months before a clinical diagnosis.
Methods: Incident HF cases were identified from Geisinger
Clinic primary care patients aged 50–85 years, diagnosed
between 2001 and 2010 and further defined as HFrEF if left
ventricular ejection fraction ≤ 40 and HFpEF if left ventricular
ejection fraction > 50. Controls were chosen to match HF cases
by age, gender, location and primary care physician. EHR data
were extracted on demographics, ICD-9 codes, medication
orders, clinical and behavioral measures. Modeling was
completed to detect HF using data from a 24-month observation
window 12 months before the HF diagnosis. Patient feature
vectors were generated from the data and summarized by one
or more aggregation functions (e.g. counts, means). For the
HF endpoint, modeling was done with and without patients
who had an acute coronary syndrome event within 12 months
of the diagnosis. Regularized logistic regression was applied
using information gain feature selection and 10-fold cross
validation. Model performance was assessed by area under
the receiver operating characteristic curve and complexity by
the number of selected features.
Results: Performance for HFpEF was better than for HFrEF.
The HFpEF model was more complex than the HFrEF model
as indicated by more EHR information that was needed to
discriminate the HFpEF cases from controls. Performance
with and without acute coronary syndrome cases was similar,
though models including acute coronary syndrome cases were
more complex than models excluding them.
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Conclusion: Purely data-driven approaches to modeling can be
used to detect HF 12 months before clinical diagnosis. Model
performance and complexity varies with the HF subtypes,
indicating differences in the complexity of modeling the HF
subtypes.
Keywords: electronic health record, machine learning
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Physician Documentation Behaviors in Electronic
Health Records as a Potential Source of Noise for
Early Detection of Heart Failure
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Background/Aims: Electronic health records (EHRs) are
a potentially rich source of data for developing predictive
models for early detection of heart failure. But, EHR data
can vary because of both patient health and variation in
clinical practice and behavior among physicians. The
“noise” contributed by variable physician behaviors, such as
differences in frequencies of documentation, could potentially
confound predictive models for detection of heart failure. In
this study, we characterized the documentation behaviors
of primary care physicians (PCPs) in an effort to better
understand this potential source of noise.
Methods: We used longitudinal EHR data on a stratified
random sample of 5,187 patients who were: 1) 50 years of age
or older, and 2) without a history of heart failure. PCPs (N=144)
were identified and paired with the patients that they had
treated for a minimum of 6 months. We derived 28 measures to
characterize PCP behaviors –– with documentation frequencies
of assertions and denials of selected Framingham heart failure
signs and symptoms (FHFSS) in office visit encounter notes
adjusted for patient comorbidities. Hierarchical clustering
analyses were performed on PCP documentation behaviors.
Results: PCPs were clustered into three groups with distinct
documentation behaviors. Group 1 PCPs (n=63) documented
10 out of 15 assertions and 11 of 13 denials of FHFSS,
significantly more frequently than Group 3 PCPs (n=20);
Group 2 PCPs (n=61) had significantly more frequent denial
documentation behaviors than the other two. No significant
differences were found among patients’ chronic, episodic and
cardiometabolic chronic disease counts (comorbidities) in each
of the groups (P<0.05).
Conclusion: This study identified PCP groups with distinct
documentation behaviors unrelated to patient complexity.
This source of noise and potential confounder should be taken
into account for predictive modeling.
Keywords: electronic health record, machine learning

Supplement

PS2-53:
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Background/Aims: The population health management
movement requires key strategies be employed by some of
the nation’s largest and most prestigious physician groups and
health systems (most included in the HCSRN) to automate the
management of their populations and improve health outcomes.
Watson Health represents a health information technology (IT)
and big data insights approach to enhance patient experience,
management and outcomes. We bring together common
data sources for evidence that is consistent across platforms,
including payers, providers and pharmaceuticals.
Methods: Utilizing advanced analytics and IT structures,
Watson Health data infrastructure management allows
physicians and researchers to gain insights from existing data
assets. Built on top of the enterprise data warehouse, interface
strategies such as Explorys and Phytel have been built and
instituted at several organizations. We have established trusted
data for all stakeholders in the health care ecosystem to provide
evidence that is needed for the collaboration between all aspects
of health management and life sciences development.
Results: With the Explorys and Phytel tools, we were
able to build tools to assist physicians and other care-team
members. Data from registries, other providers, pharmacies,
claims and laboratory sources was used to identify gaps in
care that needed to be filled. Identification of specific patient
populations can easily be identified for care alerts, clinical
trial eligibility, research enrollment or follow-up at a huge
time savings for the care team and research staff.
Conclusion: To create a sustainable health care system
that provides affordable, high-quality health care to all, a
population health management approach like that offered
by Watson Health needs to be adopted by physicians and
outcomes validated by health care research. Current electronic
health records lack many of the features required to improve
population health; therefore, new technologies are important
to reach the overarching goal to improve population health.
Keywords: big data, population health
PS2-54:
OpenNotes® –– Building Relationships With Patients
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Background/Aims: OpenNotes® is a nationwide initiative
supported by Robert Wood Johnson Foundation that offers
patients ready access to progress notes of doctors and other
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clinicians after an office visit. In the original OpenNotes
demonstration and evaluation project, patients were invited
over email to read a note once it was signed by a primary
care physician. The majority of patients in the study viewed
notes and reported clinically relevant benefits. We know
little about how many patients will view notes in the absence
of a notification from a provider once the note is signed. The
objective of this poster is to perform descriptive study on
Epic/Clarity page views data and provide insights on how
many notes are hidden and viewed using desktop/mobile
devices.
Methods: We tracked all the face-to-face visits to the providers
and associated notes data in the electronic health record
(EHR) from April 10, 2015, to Sept. 10, 2015. We then linked
EHR data to web server activity log based on medical record
number and date to quantify notes accessed via desktop/mobile
devices and mobile applications. We used Venn diagrams and
Microsoft Excel graphs for visualization of results.
Results: Of the 679,111 outpatient visits during the period,
90% (610,625) had any associated note, 10% (68,486) did not,
96% (608,249) were accessible and 4% (2,376) were hidden
from patient. Only 5.7% (34,780) of notes were viewed at
least once during study period. Overall, there were 104,071
note views, i.e. 54,755 notes viewed at least once during the
5 months regardless of visit date, of which 19,975 notes were
related to visits prior to April 10, 2015. We were able to match
104,019 (99.95%) EHR data to web activity log data. There
were 52 (0.05%) unmatched records specific to Epic/Clarity
alone. Web browsers accounted for 91.7% (95,473) of views
[80.4% (83,662) desktop, 11.35% (11,811) mobile], 4.7%
(1,470) were AVS views on Group Health mobile application
and 6.8% (7,076) were viewed on unknown device.
Conclusion: Desktop and mobile browsers continue to be
popular platforms for viewing clinicians’ notes. One of the
reasons for low progress notes views is attributed to lack
of active promotion on availability of EHR notes by Group
Health Cooperation at that time. Group Health clinicians will
continue to inform their patients that they can review the
after-visit notes online.
Keywords: progress notes, after visit summary
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Background/Aims: Electronic health record (EHR)based messaging allows communication of important
patient information to primary care providers, but high
message burdens may limit effectiveness and safety of this
communication mode.
Methods: We analyzed EHR data for 1,282 discharges of
elderly patients (age ≥ 65) from a Massachusetts hospital
in 2010–2011. For 799 of these discharges, time-sensitive
automated EHR messages were generated on Day 3
postdischarge. These messages highlighted actionable
concerns associated with medication changes and were sent
to secure EHR In-Baskets belonging to the patients’ primary
care physicians. We tracked timing of message reviews and
calculated associations between primary care physician InBasket message burden (i.e. number of messages in In-Basket
at time of message delivery) and time to message opening. We
also examined whether messages were opened by the intended
physician, by a covering physician or by staff members.
Results: Of the 799 messages, 376 (47.1%) were opened by
the intended primary care physician within one business day,
with an additional 2.0% (16) opened by covering physicians.
In some cases, staff members opened messages and generated
follow-up communication. These follow-up communications
were read by the intended provider (2.8%, n=22 messages) or
a covering provider (0.9%, n=7) within 24 hours of delivery.
Overall, 41.1% of these time-sensitive messages were not
opened by anyone within 24 hours; an additional 6.3% were
opened by staff within the first 24 hours with no evidence
that communications were passed along within the EHR.
Rates of opening within 24 hours were inversely related to
size of In-Basket at the time of message delivery, with 61.8%
of messages opened within 24 hours among providers whose
total number of In-Basket messages were in the bottom
quartile (157 messages) (P<0.0001).
Conclusion: Rates of opening of time-sensitive In-Basket
messages were suboptimal; less than two-thirds of messages
were opened within 24 hours. In-Basket message burden
may impact physicians’ ability to devote timely attention to
patient-related messages. Reducing In-Basket volume should
be explored as a means of improving quality and safety of
patient care.
Keywords: electronic health records, health care
communication
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Background/Aims: The HCSRN Virtual Data Warehouse
has geocoded data on all of its members and associated data
from the U.S. Census and American Community Survey. We
wish to show several novel ways of using that information to
benefit health care research.
Methods: We will be using SAS software data from our
Virtual Data Warehouse, geographic information systems
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(GIS) software and scripting languages to display existing data
in ways that elucidate patterns of health care utilization and
health outcomes that would otherwise be difficult to visualize.
Results: Results of this study are pending.
Conclusion: Our project will determine whether geographical
displays of data can be an important way to show data
relationships and visualize those relationships in the clearest
and most meaningful manner.
Keywords: geography, Virtual Data Warehouse
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Background/Aims: Sulfonamide antibacterials are widely
used in pregnancy, but evidence about their safety is mixed.
Our aim was to assess the association between first-trimester
sulfonamide exposure and risk of specific congenital
malformations.
Methods: This retrospective cohort study included 1.2
million live born deliveries between 2001 and 2008 at 11
U.S. health plans participating in the Medication Exposure in
Pregnancy Risk Evaluation Program, which has linked health
plan with birth certificate data. Deliveries to mothers with
first-trimester sulfonamide exposure were randomly matched
1:1 to those exposed to penicillins or cephalosporins (primary
comparator) or no antibacterials (secondary comparator).
We examined anomalies that in prior studies were associated
with sulfonamide use: cardiovascular abnormalities, cleft lip/
palate, clubfoot, neural tube defects (NTDs), and urinary tract
abnormalities. Outcomes were validated by medical record
review. Analyses used conditional logistic regression.
Results: There were 6,688 deliveries in each exposure group
included in primary analyses. Cardiovascular defects occurred
in 1.6%, urinary system defects in 0.7%, clubfoot in 0.2%
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and cleft lip/palate in 0.1%. NTDs were too rare for further
evaluation (n=5). Sulfonamide exposure was not associated
with significantly elevated risks for these anomalies. The
adjusted odds ratio (OR) for cardiovascular defects was
0.94 (95% confidence interval: 0.71–1.23) for sulfonamide
exposure compared to penicillin/cephalosporin exposure. The
comparable odds ratios were 0.83 (0.18–3.88) for cleft lip/
palate and 1.08 (0.70–1.65) for urinary defects. For clubfoot,
the odds ratio was elevated but not statistically significant
(1.58 [0.71–3.50]). In comparison, analyses comparing
sulfonamide exposure to no antibiotic use yielded estimates
that were further from the null though still statistically
nonsignificant.
Conclusion: First-trimester sulfonamide exposure was not
associated with a higher risk of the congenital anomalies
studied compared to exposure to penicillins or cephalosporins.
Our results highlight the need to use active comparator groups
exposed to medications with the same indication to minimize
confounding.
Keywords: pregnancy, medication safety
PS2-59:
Division of Research Data-on-Demand: The
Development Process for a Research Data
Warehouse Rapid-Querying Tool
Daniel Ng,1 Dimitri Buzkov,1 Srivardhan Chimmula,1
Jamila Gul1
Division of Research, Kaiser Permanente Northern
California, Oakland, CA
1

Background/Aims: Even simple Virtual Data Warehouse
(VDW) queries require writing a program in SAS (or other
software). While this is a necessary part of a study’s overall
analytical effort, investigators often need answers to basic
questions prior to undertaking a formal study to develop
hypotheses, estimate the population for a potential study, and
ascertain other “what if” scenarios. Engaging an analyst can
slow down the researcher’s initial explorations and distract the
analyst from more complex duties. A means for researchers to
run their own simple VDW queries can enhance the efficiency
of both researchers and analysts and contribute to faster,
higher-quality research.
Methods: The DOR Strategic Programming Group engaged
in a process that took over a year to develop a VDW rapidquerying tool for researchers. This involved a process of
gathering user requirements, development of technical
requirements, assessment of technology alternatives, creation
of conceptual solution architecture, logical data model and
physical solution architecture, interface design, security
design, user training, user beta testing and enterprise security
assessment.
Results: The result of this development process was the
successful implementation of DOR Data-on-Demand (D3)
within the Division of Research. D3 has nearly three dozen
active users. Based on user testing and feedback, D3 has been
enhanced with additional data domains beyond HCSRN’s
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VDW data model, including custom metadata (e.g. text
description search for diagnoses and procedures, a custom
medication list), medication orders, vaccine data and disease
registry data. D3 also has been adopted by medical group
analysts to provide rapid response to urgent research questions
impacting clinical operations and quality of care. We continue
to explore other ways that such a rapid-querying tool can be
used to improve the health of Kaiser Permanente Northern
California members.
Conclusion: The creation of D3 has given researchers the
means to create and run their own rapid VDW queries. In
addition, research analysts and data managers have found it
useful for running more complex queries, validating data and
improving data quality. Beyond research, it can enhance the
analytic capabilities of quality and operations support groups.
Finally, it can potentially assist clinicians in providing better
evidence-based care.
Keywords: Virtual Data Warehouse, analytics
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Background/Aims: The Framingham Risk Score (FRS) and
the ACC/AHA Pooled Cohort Score (PCS) are widely used
in clinical practice to guide individual patient care decisions.
However, these risk scores have been estimated and validated
mostly using data from longitudinal cohort studies; their
performance when applied to patient data extracted from
electronic health records is less well-established.
Methods: Risk factor data were obtained from the electronic
medical record and insurance claims of 84,116 adults receiving
care at a large health care delivery and insurance organization
from 2001 to 2011. We assessed calibration and discrimination
for four risk scores: the published versions FRS and PCS, and
versions obtained by refitting the FRS and PCS using Cox
regression models. Population subgroups in which the various
models gave highly divergent risk predictions were identified
using recursive partitioning techniques.
Results: The original FRS was well-calibrated (calibration
statistic K=7.4), but the original PCS was not (K=39).
Discrimination was similar in both models (C-index C=0.740
vs. C=0.747 for original FRS and PCS). The refitted FRS
(K=4.6, C=0.754) yielded better calibration and discrimination
than the original FRS; the refitted PCS (K=15.1, C=0.746)
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was better calibrated than the original PCS. Individual risk
predictions differed between original and refitted models for
some subgroups, but were similar when comparing refitted
models.
Conclusion: Both the FRS and PCS are appropriate for use in
clinical decision support systems that rely on electronic health
data, though it may be advisable to refit the models they are
based on using available data from the target population to
optimize performance.
Keywords: cardiovascular risk, risk prediction
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A2-1:
Assessing the Capacity of Primary Care Providers to
Care for Vulnerable Populations After the Affordable
Care Act Using Geoanalytical Spatial Mapping in a
Large Hospital System in Northern California
Maria R. Moreno, Dale Ainsworth
1

2

Research, Development, and Dissemination, Sutter
Health, San Francisco, CA; 2California State University,
Sacramento, CA

number of people who do not have a medical home postACA. Within Sutter Health’s 23 counties, approximately 2.1
million residents will be enrolled in Medi-Cal post-ACA,
with approximately 610,000 (29%) of these without access
to a PCP.
Conclusion: While many Northern California communities
have sufficient primary care, others have substantial shortages.
Among nationally high emergency room usage for low acuity
care, results of this analysis are being used by Sutter Health
to facilitate the expansion of primary care capacity into these
highly vulnerable communities.
Keywords: Affordable Care Act, GIS mapping
A2-2:
Who Are the Users of Medicare’s New Preventive
Visits Under the Affordable Care Act?
Sukyung Chang,1 Jia Pu,1 Robert Romanelli,1 Hal Luft1
Palo Alto Medical Foundation Research Institute, Palo
Alto Medical Foundation for Health Care, Research and
Education, Palo Alto, CA
1

1

Background/Aims: The Affordable Care Act (ACA)
was enacted to provide increased health care access to
uninsured populations, many of whom represent the most
vulnerable communities. Health insurance coverage does not
automatically equate to access to health care. Understanding
where capacity shortages are most pronounced, especially for
low-income residents, gives community benefit professionals
tools to make impactful, strategic decisions to facilitate the
expansion of capacity in the most underserved communities.
Methods: Total number of Medi-Cal beneficiaries for Sutter’s
23 counties pre- and post-ACA was estimated using California
Department of Health Care Services state statistics. Total
number of primary care physicians (PCP) was obtained from
an online database through a customized search of primary
specialties that included family medicine, general practice,
internal medicine, obstetrics and gynecology, and pediatrics.
Each physician was researched to establish accepted insurance
types and eligibility criteria. We compared the distribution of
PCP capacity and Medi-Cal populations at the ZIP code level
using the allocation tools for ArcGIS geoprocessing toolbox
with ESRI’s ArcGIS 10.1 geographic information systems
(GIS) software and the Network Analyst extension.
Results: Approximately 36.5% of the uninsured population
became Medi-Cal eligible following ACA implementation
for the Sutter communities. This location/allocation model
identified the number of Medi-Cal patients per ZIP code that
could not be assigned to any PCP because of the capacity
limit for any PCP that was both within the county and within
a 30-minute drive time. A series of maps were made that
show the number of underserved patients within a 30-, 45and 60-minute drive time of each of Sutter’s 24 hospitals.
There is a considerable clinician shortage and a substantial
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Background/Aims: We found previously that under the
Affordable Care Act’s new Medicare preventive visit
coverage, called “Annual Wellness Visit,” preventive visits
among Medicare fee-for-service (FFS) beneficiaries nearly
doubled from 18% to 34%. The new coverage, however,
may have differentially impacted subgroups of seniors. We
hypothesized that preventive visit uptake would be greater for
seniors who previously had frequent primary care visits, as
they may have been “squeezing” preventive issues into office
visits for acute and chronic care needs.
Methods: Medicare FFS beneficiaries aged 65–75 years who
were primary care patients in a large, mixed-payer outpatient
organization in northern California were studied. We examined
patient characteristics associated with increased preventive
visits between the period prior to (2007–2010) versus post
(2011–2013) Medicare’s coverage expansion. The unit of
analysis was patient-years (N=112,888). Logistic regression
was used with a dependent variable of “any preventive visit,”
including both Medicare-covered and any privately paid
preventive visits. Random effects model was used to account
for multiple observations per patient. To identify subgroups
of seniors who were more likely affected by the coverage
expansion, we used interactions between “post period” and
key patient characteristics: age 70–75 (vs. 65–69), frequency
of nonpreventive primary care visits (1, 2, or 3+ vs. 0), and
comorbidity by Charlson index (1 or 2+ vs. 0).
Results: Older seniors (odds ratio [OR]: 0.57 for age 70–75
vs. 65–69), males (OR: 0.92), and those who previously made
frequent primary care visits (OR: 0.18 for 1 vs. 0; OR: 0.13
for 2 vs. 0; OR: 0.11 for 3+ vs. 0) and had more comorbidities
(OR: 0.80 for 1 vs. 0; OR: 0.78 for 2 vs. 0; OR: 0.51 for 3+ vs.
0) were less likely to use annual preventive visits (P<0.01 for
each) during the study period (2007–2013). In contrast, after
Medicare coverage expansion there was a significantly larger
increase in the likelihood of using annual preventive visits
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among older seniors (OR: 1.5), males (OR: 1.1) and those
who previously made frequent primary care visits (OR: 1.2
for 1 vs. 0; OR: 1.3 for 2 vs. 0; OR: 1.2 for 3+ vs. 0; P<0.01
for each).
Conclusion: Seniors who were older and frequent users
of primary care had been underutilizing preventive care.
Medicare’s preventive service coverage expansion particularly
benefited such seniors with needs for preventive care, but who
may not have made separate preventive visits due to prior lack
of coverage.
Keywords: Affordable Care Act, preventive care
A2-3:
Emergency Department Use in Alameda County,
California, Before and After the Implementation of
the Coverage Provisions of the Affordable Care Act
Alice Pressman,1 Anjali Franco,1 Sarah Robinson,1 Lisa
Dean-Gilley1
Research, Development, and Dissemination, Sutter
Health, Walnut Creek, CA
1

Background/Aims: Hospital emergency departments (EDs)
across the United States struggle with overcrowding, a
problem reported to be associated with decline in quality of
care and patient satisfaction, decreased revenue and increased
patient mortality. The 2010 Affordable Care Act (ACA),
upon its full implementation on Jan. 1, 2014, extended
health coverage to 32 million Americans. Initial studies have
reported a rise in ED utilization post-ACA, but no formal
analysis has been conducted in the Sutter Health system. We
sought to characterize the change in ED use at two Sutter
Health hospitals before and after ACA.
Methods: We reviewed demographic and hospital accounts
data from California’s Office of Statewide Health Planning
and Development (OSHPD) as well as electronic health
records for patients at two Sutter Health hospitals in Alameda
County, California. We compared utilization and health care
costs during comparable 6-month periods before and after the
ACA expansion, and also examined trends over time from
2010 to 2014.
Results: From 2010 to 2013, encounters from OSHPD not
resulting in a hospital admission were steady at the two
hospitals; in 2014, they rose by 9%. This was comprised
of a 2% increase in commercial, 44% increase in Medicaid
and 32% decrease in self-pay encounters. From records
comparing the last 6 months of 2013 to the last 6 months of
2014, total encounters rose by 11%. While there were 3,143
fewer encounters by uninsured individuals, there were 7,478
more encounters by the insured (including individuals with
Medicare, Medicaid and commercial). Charges increased by
20% (commercial 29%, Medicaid 59%, Medicare 23%, selfpay -52%) between the time periods.
Conclusion: ED use at the two hospitals increased after
the implementation of the ACA’s coverage expansions.
The jump in aggregate ED visits came after at least three
years of relatively stable ED use and was attributable to a
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shift in uninsured patients gaining Medicaid or commercial
insurance coverage. Further research is required to determine
the mechanism behind the increased utilization specific to
insurance type and the possible implications for this extra
burden on an already overcrowded ED.
Keywords: Affordable Care Act, emergency department
overcrowding
A2-4:
Provider-Level Variation and Determinants of
Outpatient Generic Drug Prescribing in a MixedPayer Health Care System
Robert Romanelli,1 Vani Nimbal,1 Jodi B. Segal2
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Background/Aims: While 86% of all drugs in the United
States are dispensed as generics, this rate is not uniform
across all therapeutic classes and drug products. The role
of the health care provider in influencing generic use is not
well understood. We sought to quantify variation between
providers and provider-specific determinants of generic
prescribing in an outpatient setting.
Methods: This was a cross-sectional analysis of electronic
health record data from a mixed-payer health care
system in northern California in 2013. We focused on 12
therapeutic classes that had the potential for suboptimal
generic utilization, including stimulants, antidepressants,
thyroids, vasodilators, vascular 5HT1 agonists, antiplatelets,
sympathomimetics, smooth-muscle relaxers, eyes/ears/nose/
throat drugs, estrogens, antigout agents and cardiac agents.
Generic prescribing rates for each class were calculated,
regardless of generic availability. For each class, we applied
mixed-effect logit regression models with generic prescribed
(yes/no) as the dependent variable and random effects
(intercepts) for providers. Models included provider-level
determinants: provider type (specialist vs. primary care), and
continuous measures of average weekly prescription count
and patient visits over the previous 3 months. We further
adjusted for patient-level characteristics (age, sex, race/
ethnicity, insurance, comorbidities, prescription burden). For
each model we calculated the intraclass correlation (ICC) as a
measure of random provider-level variation and adjusted odds
ratio (OR) for provider-level fixed-effect covariates.
Results: We identified 162,819 prescriptions in 2013 for
150,881 patients in the 12 therapeutic classes of interest.
Generic prescribing rates across therapeutic classes ranged
from 9.3% (sympathomimetics) to 95.1% (antidepressants).
After controlling for provider and patient characteristics,
significant between-provider variation in generic prescribing
was observed; ICC ranged from 7.6% (vasodilators) to 72.9%
(eyes/ears/nose/throat drugs). Specialists had lower odds
of prescribing generic antidepressants than primary care
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providers (OR: 0.48), but higher odds of prescribing generic
estrogens (OR: 1.55) and sympathomimetic agents (OR: 2.53).
Across classes, a provider’s prescription volume or patient
volume had little or no effect on generic prescribing.
Conclusion: In this cross-sectional analysis of electronic health
record data from a mixed-payer health system, we observed
large heterogeneity across providers in outpatient generic
prescribing for select therapeutic classes, even after accounting
for patient characteristics. Health system initiatives may be
warranted to better educate providers on generic prescribing.
Keywords: generic prescribing, provider variation
PS1-07:
Classification and Mapping of Emergency
Department Use in Three San Francisco Bay Area
Hospitals
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Background/Aims: Preventable or nonurgent encounters
to the emergency department (ED) disrupt patient flow and
contribute to the burden of overcrowding. Furthermore,
overcrowding is expected to increase as insurance coverage
expands. We sought to create two categorization schema
for nonurgent and/or preventable encounters to the ED and
to visualize the resulting patient segments geographically in
order to identify gaps in health care delivery services.
Methods: From electronic health records we extracted
demographics, payer type and diagnoses for all encounters from
June 2013 to May 2014 at three Sutter Health EDs in Alameda
County, California. Based on primary diagnosis, we developed
an algorithm to classify each encounter as urgent/nonurgent,
and preventable/nonpreventable, collectively defined as
inappropriate. We geocoded patient addresses and the addresses
of all federally qualified health centers (FQHCs) in the area.
Results: During the study period, 69,595 individuals made
111,535 encounters to the study EDs; 36% (n=25,349) of
individuals had at least one nonurgent encounter, whereas
only 19% (n=13,132) had one or more preventable
encounters. Overall, approximately half of all patients had
at least one type of inappropriate encounter. Demographics
differed between those who used the ED inappropriately and
those who did not. Nonurgent users were younger and those
with preventable encounters were older compared to urgent
and nonpreventable users, respectively. The distribution of
minorities differed with more African-Americans having
inappropriate encounters of both types. The proportion of
uninsured did not vary by type of user (n=57,290 [82%] of all
patients had some type of insurance). We identified that 49%
(23,535 of 48,156) of inappropriate encounters were made by
individuals who lived within one mile of an FQHC.
Conclusion: Using the methods described, we found
that individuals who used the ED for nonurgent and/or
preventable conditions tended to have some type of insurance
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coverage and were disproportionately African-American. By
mapping the encounters and FQHCs, we were able to define
catchment areas for each hospital and estimated that half of all
inappropriate encounters could have been diverted to nearby,
more suitable resources. Further identification and mapping
of alternative health care and community resources will likely
show that even more of these patients have alternative options
available to them.
Keywords:
emergency
department
overcrowding,
inappropriate utilization
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Scaling Lean in Primary Care and Impacts on
Organizational Performance
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Background/Aims: Despite increasing adoption of lean
practices in health care, there are few rigorous studies of its
impacts on delivery system performance over time, particularly
in fee-for-service ambulatory settings. This study examines
the impact of lean implementation on performance metrics,
including workflow efficiencies, physician productivity, cost,
quality and satisfaction in primary care departments of a large
ambulatory care delivery system.
Methods: This was an observational study of phased lean
implementation among 328 physicians in 46 primary care
departments housed within 17 geographically distinct clinic
locations. Performance metrics included: workflow efficiency,
productivity, operating expenses, clinical quality and patient,
physician and staff satisfaction. Interrupted time series analysis
using generalized linear mixed models was used to examine
lean impacts on organizational performance over time.
Results: Systemwide improvements were observed in workflow
efficiencies, physician productivity and clinical quality metrics
(P<0.05). Patient satisfaction with access to care, handling of
personal issues and overall experience of care also increased,
but decreased with respect to interactions with care providers
(P<0.05). Departmental operating costs decreased, though
this was not statistically significant. Finally, annual staff and
physician satisfaction scores increased in key domains, ranging
from employee engagement and connection to purpose to
relationships with staff and physician time spent working.
Conclusion: Lean system redesigns resulted in improvements
on a variety of metrics ranging from provider workflow
efficiencies to satisfaction among patients and staff. This study
contributes to a currently sparse literature on the impact of lean in
primary care. In examining a comprehensive set of performance
metrics, our findings suggest several improvements in areas
targeted by lean redesigns.
Keywords: lean process improvement, delivery systems
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Managing Multiple Conditions During an Acute
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Background/Aims: To obtain publicly subsidized prescription
drug insurance, Medicare beneficiaries must enroll in one of
the 28–39 private plans offered by their state. We sought to
understand the experiences of individuals selecting a Part D
plan, specifically what resources and which factors were of
greatest importance to them.
Methods: Participants were patients of a large multispecialty
group practice in northern California. Potential participants
were recruited through flyers, several events for seniors
and an article in the group practice’s newsletter. Four focus
groups were conducted from June through October 2014
until thematic saturation was reached. The 17 participants
were all in a Medicare Part D plan, with ages ranging from
65 to 91 years (average of 74), primarily wealthy, retired and
Caucasian. Focus groups were transcribed and qualitatively
analyzed for main emergent themes.
Results: Most found the process of selecting a plan to be
a “nightmare” to “extremely difficult” and “confusing”
due to “too many options.” Participants expressed that the
characteristic of most importance to them in choosing a
plan was the lowest cost, mainly through lower copays for
medicines. Another important feature was the reputation
of the company providing the plan to learn if “they make
mistakes often,” “handle claims satisfactorily,” and “can
you reach somebody if you need to.” The main resources
used in the decision-making process were other people
(e.g. spouse, friend, family), books, brokers, AARP, the
Health Insurance Counseling and Advocacy Program
–– a volunteer-supported program run by the California
Department of Aging that provides unbiased information to
help Medicare beneficiaries make the best choices for their
individual health care needs –– and the Internet, specifically
the Medicare.gov website.
Conclusion: While low cost was a top priority for some,
other participants reported that other characteristics like
reputation of the company was so important to them that they
were willing to pay a higher cost. More help from individuals
and clearer information are necessary to assist Medicare
beneficiaries in selecting a Medicare Part D prescription
drug plan. Given that highly educated and affluent Medicare
beneficiaries are finding the Part D plan selection process so
difficult and complex, this poses a greater challenge for those
with fewer resources.
Keywords: qualitative research, Medicare Part D
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Background/Aims: Managing multiple conditions during
an acute visit often requires more comprehensive evaluation
of concurrent conditions and is associated with higher pervisit cost. However, little is known about whether managing
multiple conditions during a single visit affects overall costs
or quality. This study examines this potential impact on the
annual cost per patient and clinical quality.
Methods: Data were from electronic health records and
claims of a large ambulatory group practice with mixed
payment sources. We studied primary care physicians
(PCPs) in 2010–2013 (n=309) who had 1,099 PCP-years,
the unit of analysis. Annual costs were expressed as the
ratio of the observed costs to the expected costs adjusted
for patient age, sex and clinical conditions. Costs included
standardized fees for physicians, laboratory/imaging orders,
specialist services and medications. For the measure of
clinical quality, we combined various indicators pertinent
to primary care practice (e.g. management of chronic
conditions and preventive service) and created a composite
average score (number of patients who met the target/
number of eligible patients for that measure). We analyzed
the ratio of the observed score to the expected score adjusted
for the composition of new (vs. established) patients in the
PCP panel. The management of multiple conditions was
identified through the diagnosis codes for treating “other”
conditions during acute episodes. PCPs were classified
into three tertiles based on the average number of other
conditions addressed per episode across all acute episodes.
We then tested whether costs and quality differed across
the tertiles.
Results: The risk-adjusted costs were not significantly
different across tertiles of “other conditions” (0.997 [±
0.174], 1.005 [± 0.191] and 1.010 [± 0.269] for the low,
middle and high groups, respectively). Managing other
conditions during acute episodes was associated with higher
quality: PCPs in the top tertile of other conditions addressed
had higher quality scores than the middle (1.048 vs. 1.033,
P=0.06) and low groups (1.048 vs. 1.030, P=0.05).
Conclusion: Our preliminary findings suggest that managing
multiple conditions during acute episodes may be associated
with better care (higher quality but not higher costs per year).
More refined analyses will be conducted to confirm the
robustness of findings.
Keywords: cost, clinical quality
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Background/Aims: Our objective is to determine factors
affecting choice of narrow provider network plans, and
whether care covered by a narrow network preferred provider
organization (PPO) plan differs from care provided in a plan
with a broader PPO network. Narrow provider networks,
when built around a single vertically integrated system, hold
the potential for improvements in clinical care due to better
information flow among providers, reduced duplication of
tests and a more holistic knowledge of the patient.
Methods: The study sample includes employees enrolled
through a private health insurance exchange who had
coverage through one of the 93 employers offering network
choice beginning in 2013. We follow enrollees through
2014 to identify the short-term impact of narrow network
choice on patterns of health care delivery. Using claims
data (2010–2014) from a regional health insurer offering a
single-carrier private insurance exchange for employmentbased coverage, we predict enrollment in a narrow network
plan option and use both instrumental variable methods
and difference-in-differences methods to identify the
association between narrow network enrollment and
future patterns in health care delivery. Network options
include a broad PPO network covering 95% of the primary
care physicians in the region, and four narrow provider
networks. Each narrow network is built around a single
vertically integrated delivery system.
Results: Preliminary results indicate a statistically
significant decline in both primary care and specialty care
visits. The probability of accessing any care during the
year was not impacted by narrow network enrollment,
but overall utilization levels declined for those enrolled
in a narrow network. There were no associations between
narrow network enrollment and the risk of hospital-based
care (emergency department visits, avoidable emergency
department visits, inpatient admission) and no associations
with the probability of preventive cancer screening (breast,
cervical, colorectal).
Conclusion: It is encouraging to see reductions in specialty
care visits without increases in emergency department or
inpatient care or decreases in the probability of accessing
any care in the year. While reductions in primary care visits
indicate a need for caution, the pattern of reduced utilization
may be a result of better provider knowledge of the patient
due to care concentrated within a single care system.
Keywords: narrow provider networks, health care utilization
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Background/Aims: Up to 30% of adults have hematuria;
however, 5% or fewer have a significant finding such as
bladder or kidney cancer. Current guidelines recommend
cystoscopy and imaging for all who meet criteria; however,
the guidelines acknowledge evidence gaps resulting in
substantial unnecessary testing with adverse financial
implications for patients and society. Although riskstratified approaches have the potential to reduce testing,
few are available and none have been rigorously evaluated.
The objective of this study is to compare the direct health
care costs of two hematuria evaluation approaches:
American Urological Association (AUA) guidelinebased standard of care versus a theoretical risk-stratified
algorithm.
Methods: We will apply decision-analysis modeling and
simulation to conduct a cost-minimization analysis, a type
of cost-effectiveness analysis that compares interventions
of similar effectiveness, to compare the two hematuria
evaluation approaches. Model inputs including assumptions
and parameter values will be obtained from an established
Geisinger Health System hematuria patient database.
The database includes patient-level clinical information
compiled from extensive chart review of 3,000 patients
for whom hematuria evaluations were conducted from
2004 to 2014. Costs for services are based on Medicare
reimbursement rates. Data from published literature and
inputs from a clinical expert panel will supplement the
model inputs.
Results: The results to be presented are a decisionanalysis model with assumptions, parameters and input
values documented from the Geisinger hematuria database,
literature review and clinical expert inputs. The analysis of
deterministic decision model provides base-case clinical and
economic results for the two approaches.
Conclusion: The finalized results of the cost-minimization
analysis will enable threshold analysis to identify critical
parameter values (e.g. sensitivity, specificity) for the
performance of a theoretical risk-stratified approach to
match the effectiveness of the current AUA guideline-based
standard of care, and compare the direct health care costs
of the two hematuria evaluation approaches from payer
perspective. These results will provide a foundation of
evidence and a model to evaluate risk-stratified approaches.
Keywords: hematuria evaluation, cost-minimization
analysis
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Pent-Up Demand After the Affordable Care Act
Angela R. Fertig,1 Caroline S. Carlin,1 Scott B. Ode,1
Sharon K. Long1
1

Medica Research Institute, Minnetonka, MN

Background/Aims: Many state agencies, insurers and
providers expected newly insured individuals under the
Affordable Care Act (ACA) to inundate the health care market
with high demand for health care. High health care utilization
among newly insured individuals could indicate higher health
risk and/or pent-up demand, defined as initial utilization
caused by foregoing or delaying care while uninsured or
underinsured. This study provides evidence regarding the
relative health risk and pent-up demand for health care among
newly insured adults in Medicaid as health reform rolls out.
Methods: We used claims data from a large health insurer
to examine the first six months of Medicaid coverage for
Minnesota adults 18–64 years old who were newly enrolled
between January and March 2014 (n=4,252). The comparison
group was nonelderly Minnesota adults with Medicaid coverage
with this insurer in 2013 (n=21,556). We compared seven types
of health care utilization over six months for new and ongoing
enrollees: all office visits, new patient office visits, emergency
department visits, inpatient stays, diagnostic procedures, all
prescriptions filled, and new prescriptions filled. We estimated
logit models of the probability of having each type of health care
utilization adjusting for age, gender, race/ethnicity and enrollee
neighborhood characteristics. We used the coefficient estimates
from these models to predict the likelihood of utilizing services
as new enrollees compared to ongoing enrollees.
Results: We found lower average predicted rates of health care
utilization among new Medicaid enrollees compared to similar
ongoing enrollees, with one exception –– new enrollees were
more likely to have a new patient visit. In addition, we found
that utilization among new enrollees declined during the first six
months of coverage in every category except prescriptions filled.
Conclusion: Our analysis of the first six months of Minnesota’s
2014 Medicaid expansion suggests both lower health care needs
relative to similar ongoing enrollees and the presence of pent-up
demand. This preliminary evidence suggests that both the longterm costs of covering the newly insured and the ongoing pressure
on provider supply under the ACA may be lower than expected.
Keywords: health reform, Medicaid
PS1-14:
The Effect of Hard-Stop Medicaid Payment Reform
on Early Elective Deliveries
Heather M. Dahlen,1 Mac McCoullough,2 Angela R.
Fertig,1 Bryan Dowd,3 William Riley2
Medica Research Institute, Minnetonka, MN; 2School
for the Science of Health Care Delivery, Phoenix, AZ;
3
Health Services Research, University of Minnesota,
Minneapolis, MN
1

Supplement

Background/Aims: We assessed the impact of Texas’s
Medicaid payment reform for early elective delivery on
clinical care practices and perinatal outcomes.
Methods: We used National Vital Statistics System data
for the years 2009–2013, which contained birth certificate
records from all U.S. states and the District of Columbia.
Data were merged to the 2014-2015 Area Health Resource
File, which provided information on county-level economic
and primary care provider characteristics for the five years
in our study. Our key outcomes included early elective
deliveries (induced and cesarean sections combined as
well as cesarean section only), gestational age, birth weight
(total, low birth weight, very low birth weight, large for
gestational age) and early nonelective deliveries. We
employed a difference-in-differences strategy to isolate
the effect of the hard-stop policy in Texas from unrelated
underlying trends present in control states. Models were
adjusted for characteristics of the delivery and mother, if a
father was not present on the birth certificate, county-level
economic and provider trends, state-specific time trends,
state fixed effects and linear time trends.
Results: Relative to the control states, there were
significant reductions in early elective inductions of labor
among Medicaid deliveries in Texas, including reduced
rates of cesarean births. Of Texas births paid by Medicaid,
11.2% were the result of early elective induction of labor
prior to hard-stop legislation; after adjusting for changes in
early inductions in comparison states, this share dropped
by 1.1 percentage points (P<0.001). Birth outcomes also
improved for babies covered by Medicaid in Texas, with
relative increases in average gestational age and average
birth weight.
Conclusion: Findings from this study suggest that the
Medicaid hard-stop policy in Texas was effective in reducing
the rate of early elective deliveries among the Medicaid
population. As a result, babies covered by this policy reached
an older gestational age and greater gestational weight.
Since Texas had one of the highest rates of early elective
delivery prior to enacting hard-stop, we would expect that
states with similar baseline rates also would have relatively
large reductions in early elective delivery rates should they
pass hard-stop legislation.
Keywords: Medicaid payment reform, perinatal health
PS1-15:
Contraceptive Choice After the Affordable Care Act
Angela R. Fertig,1 Caroline S. Carlin,1 Bryan Dowd1,2
Medica Research Institute, Minneapolis, MN; 2University
of Minnesota, Minneapolis, MN
1

Background/Aims: The Affordable Care Act (ACA)
mandated that, starting in late 2012, private health insurance
plans that are not exempt or grandfathered were required to
cover all contraceptive methods approved by the U.S. Food
and Drug Administration as prescribed for women without
a patient copayment. This policy has the potential to save
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billions in health care expenditures by reducing the number
of unintended pregnancies, thereby reducing the number of
deliveries and elective abortions. This study investigated
the effect of the ACA-induced change in cost-sharing for
contraceptive care on the rate of contraceptive use, the choice
between long- and short-term contraceptive methods and the
probability of elective abortion.
Methods: We used longitudinal health insurance claims data
on female enrollees 18–45 years old (N=29,990) in insurance
plans obtained through 499 employer groups with at least 50
enrollees. Medical and pharmacy claims from 2008 through
2014 were extracted for the sample. Our control group was
women covered by the employers who had not yet complied
with the ACA-mandated cost sharing as of the end of 2014.
We modeled their contraceptive choice using a multinomial
probit regression with individual random effects to control
for the woman’s time-invariant unobserved characteristics.
In a second regression, we modeled elective abortion using
a binary probit regression with random effects.
Results: We found that when the copay for contraceptives
fell to $0 for those in compliant plans, contraceptive use rose
substantially more than for those in noncompliant plans.
Moreover, the mandate has increased the probability that a
woman chose a long-term contraceptive method above and
beyond the general increasing trend for these methods. We
also observed a marginally significant decline in elective
abortions.
Conclusion: These findings suggest that women are pricesensitive with regard to contraception choice, and thus the
ACA mandate will likely significantly reduce the rate of
unintended pregnancy. Because unwanted pregnancy is
associated with poor birth outcomes, this policy also has
the potential to reduce the fraction of high-cost births and
children in poor health.
Keywords: health reform, maternal and child health
PS1-16:
Patient Loyalty in a Mature IDS Market: Is Population
Health Management Worth It?
Caroline S. Carlin1
1

Medica Research Institute, Minneapolis, MN

Background/Aims: The objective was to understand patient
loyalty to providers over time in order to inform effective
population health management. We studied patient careseeking patterns over a 6-year timeframe in Minnesota, an
environment where care systems are motivated to practice
population health management through shared-saving
contracts with public and private payers.
Methods: A regional health plan provided data from
their administrative files, matched to U.S. Census-based
characteristics of the patient’s neighborhood. Patients
were retrospectively attributed to health care systems by
the health plan based on patterns of primary care. Weibull
duration and probit models were used to examine patterns
of patient attribution to a care system and the continuity of
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patient affiliation with a care system. Clustering of errors
within family unit was used to account for within-family
correlation in unobserved characteristics that affect
patient loyalty.
Results: We found significant patient loyalty, with past
loyalty a very strong predictor of future relationship.
Relationships were shorter when the patient’s health status
was complex and longer when their care system provided
primary and multispecialty care.
Conclusion: Continuity of provider-patient relationships
mean population health management can be beneficial to
the care system that makes this investment, particularly
for patients exhibiting prior continuity in care system
choice. The results suggest that co-located primary and
specialty services are important in maintaining primary
care loyalty.
Keywords: organization and delivery of care, physician
payment
PS1-17:
“Aging Out” of Dependent Coverage and the
Effects on U.S. Labor Market and Health Insurance
Choices
Heather M. Dahlen1
1

Medica Research Institute, Minnetonka, MN

Background/Aims: We examined how labor market and
health insurance outcomes were affected by the loss of
dependent coverage eligibility under the Patient Protection
and Affordable Care Act (ACA).
Methods: We used National Health Interview Survey
data and regression discontinuity models to measure the
percentage-point change in labor market and health insurance
outcomes at age 26. The sample was restricted to unmarried
individuals 24 to 28 years old and to a period of time before
the ACA’s individual mandate (2011–2013). Models were
run separately for men and women to determine if there were
differences based on gender.
Results: Aging out of this provision increased employment
among men, employer-sponsored health insurance offers
for women and reports that health insurance coverage was
worse than it was one year previously (overall and for young
women). Uninsured rates did not increase at age 26, but
there was an increase in the purchase of nongroup health
coverage, indicating interest in remaining insured after
age 26.
Conclusion: Many young adults will turn to state and
federal health insurance marketplaces for information
about health coverage. Because young adults (age 18–29)
regularly use social media sites, these sites could be used
to advertise insurance to individuals reaching their 26th
birthdays.
Keywords: Affordable Care Act, dependent coverage
provision
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ECI Awardee:
Changes in Adolescent HPV Vaccination Following
Incorporation Into California’s Pay-for-Performance
Program
Katharine A. Rendle,1 Caroline A. Thompson,1 Jennifer
Ahern,2 Heidi M. Bauer,2 Sandra R. Wilson1
Palo Alto Medical Foundation Research Institute, Palo
Alto Medical Foundation for Health Care, Research and
Education, Palo Alto, CA; 2Division of Epidemiology,
School of Public Health, University of California,
Berkeley, Berkeley, CA
1

Background/Aims: Pay-for-performance programs (P4P)
are intended to improve care by aligning incentives with
targeted outcomes; however, findings regarding their
impact are mixed. Adolescent female human papillomavirus
(HPV) vaccination was added to the measures reported by
California’s P4P program in 2012. Using electronic health
record data from a mixed-payer, multispecialty health
care organization in northern California, we examined
on-time completion of the three-dose vaccination series
by the recommended age of 13 before and after P4P
implementation among 10,020 adolescent females.
Methods: We included all eligible female patients who
turned 13 years old two years before (2010–2011 cohort)
and two years after P4P implementation (2012–2013 cohort),
excluding those patients with documented history of any
adverse vaccine reaction. We used hierarchical logistic
regression models to account for patient clustering within
primary care providers. We estimated odds ratios (OR)
associated with on-time vaccination completion with 95%
confidence intervals (CI) based on robust estimation of
standard errors, adjusting for patient race, insurance type and
length of patient-provider relationship as well as provider
experience (in years), gender, specialty and location.
Results: We found a positive association between on-time
completion of HPV vaccination and P4P reporting of HPV
vaccination. Patients who turned 13 after P4P implementation
had 27% higher odds of completing vaccination by age 13 than
those who turned 13 before (OR: 1.27, 95% CI: 1.12–1.45),
adjusting for all covariates. Compared with other groups,
African-American and Asian Indian patients had significantly
lower odds of on-time vaccination, and patients with public
or HMO insurance had significantly higher odds of on-time
vaccination. Despite increases, the proportion of patients who
completed the series on time remained remarkably low (12.5%
[538/4,312] in the 2010–2011 cohort and 15.0% [855/5,708] in
the 2012–2013 cohort).
Conclusion: Although further research is needed to establish any
causal effects of P4P implementation on HPV vaccination uptake,
these findings provide support for the continued use of incentive
programs as a means to help improve health care quality and
outcomes. On-time vaccination completion rates, however, remain
suboptimal. Additional efforts, such as quality improvement
initiated by this health care system in early 2014, may be needed to
encourage parents and providers to vaccinate by age 13.
Keywords: cancer prevention, performance incentives
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MENTAL HEALTH, ALCOHOL AND
SUBSTANCE USE/ABUSE
C4-1:
Gender Differences in Alcohol Screening, Brief
Intervention, and Referral to Treatment in Primary
Care
Cynthia Campbell,1 Constance Weisner,1 Felicia W.
Chi,1 Thekla Ross,1 Stacy Sterling,1 Jennifer Mertens2
Division of Research, Kaiser Permanente Northern
California, Oakland, CA; 2Pediatric Developmental
Disabilities Office, Kaiser Permanente Northern
California, Oakland, CA
1

Background/Aims: Alcohol Screening, Brief Intervention,
and Referral to Treatment (SBIRT) in adult primary care is
efficacious in reducing hazardous drinking and is widely
recommended. This study examines whether there are
gender disparities in receipt of alcohol SBIRT among adult
primary care patients by analyzing data from the ADVISe
study, a clustered randomized controlled trial on SBIRT
implementation by primary care physicians (PCP) and
nonphysician providers (NPP) in a large, integrated health
care delivery system.
Methods: This observational prospective cohort study
examined electronic health record data on 639,593 adult
patients who had a primary care visit at an ADVISe study
clinic during Year 1 of the study. We conducted bivariate
analyses to examine differences between males and females
in demographic and clinical characteristics, screening rates
and BI/RT rates among those who screened positive. Within
each intervention arm, multilevel logistic regression models
were fitted to further assess the associations between patient
gender and receipt of alcohol SBIRT while adjusting for
other covariates at patient, physician and system levels and
accounting for clustering within physician and within clinic
correlation of patient outcomes.
Results: Findings from multilevel logistic regression models
suggested that women were less likely to be screened in both
intervention arms (odds ratios [95% confidence intervals]:
0.78 [0.75–0.82] for the PCP arm and 0.82 [0.77–0.87] for
the NPP arm). Among those who screened positive, women
were less likely to receive BI/RT in both intervention arms
(odds ratios [95% confidence intervals]: 0.60 [0.48–0.76]
for the PCP arm and 0.62 [0.51–0.77] for the NPP arm).
The presentation also will include findings of outcomes by
gender and age.
Conclusion: Better understanding of the unique patient-,
provider- and system-level factors that are associated with
receipt of alcohol SBIRT and outcomes for males and
females, and strategies to address such factors, are needed.
Keywords: alcohol screening, gender differences
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C4-2:
Alcohol Screening and Brief Intervention and
Improved Health Outcomes in Hypertensive
Patients: Results From an Implementation Study in
Primary Care Setting

C4-3:
Association of OPRM1 Polymorphisms With DSM5–Defined Prescription Opioid Use Disorder Among
Chronic Pain Patients on Opioid Therapy for
Noncancer Pain

Felicia W. Chi,1 Constance Weisner,1 Stacy Sterling,1
Derek Satre,2 Thekla Ross1

Joseph A. Boscarino,1 Stuart N. Hoffman,1 John J. Han,2
Xin Chu3

Division of Research, Kaiser Permanente Northern
California, Oakland, CA; 2Department of Psychiatry,
University of California, San Francisco, San Francisco, CA

1

1

Background/Aims: Many hypertensive patients drink at
levels above recommended limits, which is associated with
adverse blood pressure changes. Alcohol screening and brief
intervention in adult primary care has been found efficacious
in reducing hazardous drinking, yet little is known about the
impacts on health outcomes. This study aims to evaluate
the effect of alcohol screening and brief intervention on
blood pressure control among adult hypertensive patients by
analyzing data of the ADVISe study, a clustered randomized
controlled trial on Screening, Brief Intervention, and
Referral to Treatment (SBIRT) implementation by primary
care physicians (PCP) and nonphysician providers in a large,
integrated health care delivery system.
Methods: This observational prospective cohort study
examined electronic health record data during 2-year followup on 4,086 hypertensive primary care patients 18+ years old
who screened positive for past-year risky drinking at baseline,
of which 1,478 had a blood pressure measure at both the
index screen and 18-month follow-up (36%). We examined
associations between documented brief intervention and
change in blood pressure by fitting general linear models and
addressed issues of potential selection and attrition bias by
using inverse probability weighting.
Results: Findings suggested a positive association between
receiving brief intervention for positive hazardous drinking
screen and better blood pressure control at 18 months for
those in the PCP arm, for those with less severe drinking
level at index screen and for those with poor blood pressure
control at the index screen. For hypertensive patients with
systolic/diastolic blood pressure at 140+/90+ mmHg who
reported 1–7 hazardous drinking days in the past year, the
adjusted mean decline of systolic blood pressure was 37.9
mmHg for those who received brief intervention compared
to 17.2 mmHg among those who did not receive brief
intervention (P=0.0003). For those in the PCP arm who
had less severe drinking level at index screen, those who
received brief intervention had 10 times higher odds of
having hypertension under control than those who did not.
Conclusion: Preliminary results suggest that alcohol
screening and brief intervention may be beneficial for adult
primary care patients with hypertension.
Keywords: alcohol screening and brief intervention,
hypertension
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Center for Health Research, Geisinger Health System,
Danville, PA; 2Department of Pain Medicine, Geisinger
Health System, Danville, PA; 3Weis Center for Research,
Geisinger Health System, Danville, PA
Background/Aims: The OPRM1 118A>G polymorphism
(rs1799971) has been associated with susceptibility to
drug misuse. Previously we assessed the association
between single nucleotide polymorphisms (SNPs) located
in OPRM1 genetic locus, including rs1799971 and
rs6923231, and susceptibility to substance misuse among
outpatients receiving long-term opioid therapy.
Methods: We identified outpatients receiving opioid therapy
for noncancer pain within a large health care system using
electronic health records. Patients included those 18+ years
old who received opioids for 4+ months in the past 12 months.
We completed diagnostic interviews with 705 subjects to
identify substance use disorders including opioid use disorder
and history of illicit drug use. Genotyping was performed on
an Applied Biosystems™ 7500 real-time polymerase chain
reaction platform, using TaqMan™ kits.
Results: Mean age of patients was 55 years (SD: 13.4),
and 60.9% (95% confidence interval [CI]: 55.9–65.7) were
female. Based on Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (DSM-IV) criteria, the
lifetime prevalence of opioid dependence was 35.6% (95%
CI: 32.1–39.1). Lifetime illicit drug use was 12.8% (95% CI:
10.3–15.2) for cocaine and 14.9% (95% CI: 12.3–17.5) for
amphetamines/methamphetamines. Using ordinal logistic
regression that controlled for age, gender, education and
marital status, lifetime opioid use disorder by DSM-5 criteria
(classified: none, mild, moderate, severe) was associated
with the carriers of the G allele (coded 0, 1 or 2) at SNP
rs6923231 (odds ratio: 1.48, P=0.002), but the OPRM1
118A>G polymorphism (rs1799971) was not associated
(P=0.544). Multivariate linear regressions suggested the
number of days the patient used cocaine (range: 0–100 days)
was significantly associated with SNP marker rs6923231
(β=0.72, P=0.0000565), as was the number of days the patient
used amphetamines/methamphetamines (range: 0–500 days;
β=0.09, P=0.046). When we assessed opioid disorders based
on DSM-IV criteria, neither SNP marker rs6923231 nor
rs1799971 was associated.
Conclusion: We detected genetic liability for addiction
based on the DSM-5 criteria at the OPRM1 genetic locus for
SNP rs6923231, a previously unreported polymorphism for
drug misuse. Since the SNPs for this study were identified
using a tagging algorithm that was correlated with addiction
phenotypes, SNP rs6923231 is likely a valid marker for
addiction liability. To our knowledge, this is the first study to
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report genetic associations for OPRM1 variants based on the
DSM-5 criteria for prescription opioid use disorder.
Keywords: prescription opioid use disorder, chronic pain
patients
C4-4:
Implementing Collaborative Care Management for
Depression, Diabetes, and Cardiovascular Disease
Across Eight Health Care Systems
Arne Beck,1 Jennifer Boggs,1 Angelika Clarke,1 Karen
Coleman,2 Claire Neely,3 Tani Hemmila,3 Kris Ohnsong,4
Leif I. Solberg4
Institute for Health Research, Kaiser Permanente
Colorado, Denver, CO; 2Department of Research and
Evaluation, Kaiser Permanente Southern California,
Pasadena, CA; 3Institute for Clinical Systems
Improvement, Bloomington, MN; 4HealthPartners
Institute for Education and Research, Minneapolis, MN
1

Background/Aims: Collaborative care management is
effective for improving care of patients with depression and
chronic medical conditions. The Care of Mental, Physical, and
Substance use Syndromes (COMPASS) project implemented
evidence-based core collaborative care management
components needed to achieve improvement in patients with
both depression (PHQ-9 > 10) and uncontrolled diabetes
(hemoglobin A1c > 8.0) or cardiovascular disease (systolic
blood pressure > 145 or low-density lipoprotein > 100).
Components included measurement-based care, use of a care
manager and registry, systematic case reviews, treatment
intensification when indicated, relapse/exacerbation prevention
and data evaluation for quality improvement. Supported by an
award from the Centers for Medicare & Medicaid Services,
COMPASS was implemented through a collaborative of eight
health systems and over 190 clinics in eight states. We used
qualitative data to describe variation in the implementation of
core COMPASS components across sites.
Methods: Implementation data across the eight COMPASS
sites were obtained from annual site visit reports prepared by the
Institute for Clinical Systems Improvement and qualitatively
analyzed using Atlas.ti software, yielding emergent themes
related to implementation facilitators and impediments.
The Consolidated Framework for Implementation Research
(CFIR) was used to organize qualitative data from site
visits and as a conceptual framework for understanding
implementation variation across COMPASS sites. CFIR
includes six broad categories of implementation: intervention
characteristics, outer setting, inner setting, implementation
climate, characteristics of individuals, and process. Each
broad category contains three to eight implementation
subcategories.
Results: Four overarching themes were identified from site
visit reports: 1) between-site differences; 2) challenges to
implementation; 3) COMPASS learning and impact on health
system; and 4) staff (characteristics, turnover issues, training,
background). Nine additional subthemes were identified that

Supplement

were mapped to CFIR implementation categories and that
demonstrated considerable cross-site variation: 1) primary
care physician engagement; 2) prior experiences with care
coordination; 3) length of patient enrollment in COMPASS
model; 4) team dynamics; 5) care manager characteristics; 6)
quality improvement reports; 7) registry use; 8) patient social
needs; and 9) organizational environment where COMPASS
was implemented.
Conclusion: Understanding the sources of variation in largescale collaborative care management implementation is critical
to increase the odds for further successful dissemination of
similar models.
Keywords: collaborative care, implementation research
PS1-34:
Antidepressant
Adherence
Across
Populations and Health Care Settings

Diverse

Rebecca C. Rossom,1 Susan Shortreed,2 Karen J.
Coleman,3 Arne Beck,4 Beth Waitzfelder,5 Christine
Stewart,2 Brian K. Ahmedani,6 John Zeber,7 Greg Simon2
HealthPartners Institute for Education and Research,
Minneapolis, MN; 2Group Health Research Institute,
Seattle, WA; 3Department of Research & Evaluation,
Kaiser Permanente Southern California, Los Angeles,
CA; 4Institute for Health Research, Kaiser Permanente
Colorado, Denver, CO; 5Institute for Health Research,
Kaiser Permanente Hawaii, Honolulu, HI; 6Center for
Health Policy and Health Services Research, Henry
Ford Health System, Detroit, MI; 7Center for Applied
Health Research, Baylor Scott & White Health, Temple, TX
1

Background/Aims: Much of the work in antidepressant
adherence relies on self-report and small sample sizes with
limited racial/ethnic representation. Our study aimed to
determine factors associated with poor early adherence to
antidepressants in a large diverse sample of patients using
pharmacy refill data.
Methods: Electronic medical record data for patients 18 and
older with depression who filled a new outpatient antidepressant
prescription between Jan. 1, 2010, and Dec. 31, 2012, in one
of six Mental Health Research Network health care systems
were obtained. Self-reported race/ethnicity and pharmacy fill
data were obtained from electronic medical records. Patients
were considered to have early adherence if they had a second
antidepressant fill within 180 days of the first.
Results: 177,469 adult patients had 184,967 new episodes
of depression associated with a filled antidepressant
prescription. Patients refilled their antidepressants within 180
days of the first dispensing in 71% of treatment episodes.
Race/ethnicity was a strong predictor of early adherence, with
patients who self-identified as Asian, non-Hispanic black,
Hispanic or Native Hawaiian/Pacific Islander significantly
less likely to refill their antidepressant prescriptions than were
non-Hispanic whites or Native Americans/Alaskan Natives.
Other apparent predictors of early adherence, including
neighborhood income and education, gender and prior mental
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health hospitalizations, were no longer significant after
adjusting for race/ethnicity.
Conclusion: Race/ethnicity was a robust predictor of
antidepressant adherence, with racial/ethnic minority groups
other than Native Americans/Alaskan Natives less likely to
be adherent. Patients from these racial and ethnic minority
groups may have the greatest potential benefit from targeted
interventions to improve early antidepressant adherence.
Keywords: depression, adherence
PS1-35:
Early Identification of Autism Spectrum Disorders
Using Patterns of Service Use Prior to Diagnosis
Frances L. Lynch,1 Lisa A. Croen,2 Ashli Owen-Smith,3
Robert L. Davis,4 Ginger C. Hanson,1 Phillip M.
Crawford,1 Kristal C. Ruse,1 Yinge X. Qian2

developing and applying algorithms that can identify children
most at risk in the first few years of life, comprehensive
evaluation could be done at an earlier age, improving the
outcomes for these children.
Keywords: autism spectrum disorders, diagnosis
PS1-36:
Mobile Assessment of Depression Treatment
Response: Recruitment Challenges and Possible
Solutions
Ashli A. Owen-Smith,1 Michelle Panneton,2 Patricia
Arean,3 Joaquin A. Anguera,4 Shelby Reetz,5 Greg N.
Clarke5

Center for Health Research, Kaiser Permanente
Northwest, Portland, OR; 2Division of Research, Kaiser
Permanente Northern California, Oakland, CA; 3Center
for Health Research, Kaiser Permanente Southeast,
Atlanta, GA; 4Health Science Center, University of
Tennessee, Memphis, TN

Department of Health Management and Policy, Georgia
State University, Atlanta, GA; 2Center for Clinical and
Outcomes Research, Kaiser Permanente Southeast,
Atlanta, GA; 3Department of Psychiatry and Behavioral
Sciences, University of Washington, Seattle, WA;
4
Department of Psychiatry, Department of Neurology,
University of California, San Francisco, San Francisco,
CA; 5Center for Health Research, Kaiser Permanente
Northwest, Portland, OR

Background/Aims: Early intervention services in the first
few years of life significantly improve outcomes for children
with autism spectrum disorders (ASD). Yet there are often
delays in the identification and diagnosis of ASD. If health
systems were better able to identify children at high risk for
ASD and bring them in for comprehensive evaluation earlier,
more children could be able benefit from early intervention.
Methods: This study used data from three Kaiser Permanente
sites (Northern California, Georgia, Northwest). All children
born between Jan. 1, 2000, and Dec. 31, 2009, were included in
the study population. All data stored in the electronic medical
records up to June 2012 were collected. Children with an
ASD diagnosis from an ASD specialist or two or more ASD
diagnoses from nonspecialists were considered to have a valid
ASD diagnosis. Controls were matched to cases at a 10:1 ratio
and were matched on age, birth month and membership in the
12 months prior to the case’s first ASD diagnosis. We used
two-part regression models and cluster analysis to examine
whether children diagnosed with ASD have different patterns
of service use prior to their first ASD diagnosis than children
who do not go on to receive an ASD diagnosis.
Results: Standard two-part regression models and cluster
analyses identified differential patterns of service use prior to
diagnosis for children with ASD compared to children without
ASD. Regression models indicated that children with ASD
have much greater use of specialty care (e.g. mental health
services, neurology) prior to first ASD diagnosis. Cluster
analyses provided a more nuanced picture. For example,
early-onset ASD cases had a distinctive pattern separate from
those who received a diagnosis at an older age.
Conclusion: Using data on patterns of service use prior to the
initial ASD diagnosis, it may be possible to identify children
who are likely on a trajectory to get an ASD diagnosis. By

Background/Aims: Effective treatments to depression exist,
but treatment response is variable. Persons likely to respond
to antidepressants often show early change in emotional
processing and attentional bias. Methods to assess these
constructs passively and at low burden/cost are now available
via smartphone apps, with potential for broad dissemination.
Methods: This Mental Health Research Network-supported
study is testing the feasibility, acceptability and utility of
assessing behavior and neuropsychological performance for
prediction of depression treatment response using smartphone
behavioral apps. Kaiser Permanente Northwest (N=75)
and Georgia members (N=75) starting new antidepressant
treatment are recruited via secure online messaging through
their www.kp.org personal health record. Participants
complete assessments at baseline, 4, 8 and 12 weeks. App data
is shared with their provider.
Results: We have experienced several challenges related to
study enrollment. First, read rates of the recruitment message
are at ~60%. Second, of those who read the message, only
12% visit the study website. Third, among those who visit
the study website, only ~3% consent and enroll in the study.
Finally, among enrolled participants, approximately 33%
successfully download and use the apps. We have implemented
several strategies aimed at increasing enrollment: 1) revising
recruitment messaging to highlight the unique features
of the apps and emphasize that results may help improve
their treatment, 2) sending additional recruitment messages
via email/text, 3) initiating recruitment calls using Kaiser
Permanente’s automated telephone system, 4) providing
follow-up phone calls to offer technical assistance for those
experiencing difficulties with downloading/using the apps,
and 5) introducing tiered incentives to motivate completion
of each phase of the study. These efforts appear to be
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improving our recruitment efforts. Additional interviews will
be conducted with participants, and thus additional data about
barriers to/facilitators of recruitment and retention will be
available prior to the conference.
Conclusion: The use of mobile technologies to predict
depression treatment response may have significant
implications for effective and timely depression care.
Understanding the barriers/facilitators of successful
enrollment and retention is critical to the implementation of
this intervention. Lessons learned from the present study may
aid others in similar efforts and in different settings.
Keywords: depression, mobile assessments
PS1-37:
Making Health Changes: Following Preventive
Service Guidelines and Changing Behavior Among
Individuals With Serious Mental Illnesses
Scott P. Stumbo,1 Bobbi Jo Yarborough,1 Micah T.
Yarborough,1 Nancy Perrin,1 Carla A. Green1
Center for Health Research, Kaiser Permanente
Northwest, Portland, OR
1

Background/Aims: People with serious mental illnesses
generally experience greater morbidity and earlier
mortality than individuals without mental health diagnoses.
Understanding factors that influence preventive service use
and assist people in making healthy behavior changes may
reduce health disparities in this population.
Methods: This mixed-methods study, conducted in an
integrated health system, federally qualified health centers and
safety net clinics, derived diagnoses and needed preventive
services from the electronic medical record to identify a sample
(N=142) representing a range of prevention needs. Individuals
from four diagnostic groups (schizophrenia spectrum disorders
[n=41], bipolar disorders/affective psychoses [n=48], major
depressive disorders [n=33], anxiety disorders [n=20])
completed questionnaires and semi-structured interviews.
Survey data were analyzed using SPSS; interviews were
transcribed verbatim and coded using Atlas.ti.
Results: Nearly 50% of participants reported they would
be “extremely likely” to make changes their doctor
recommended on completing lab work, mammogram
screenings, getting a flu shot and completing colon cancer
screening. Only 20% reported they were extremely likely
to improve nutrition or increase exercise, even with doctor
recommendations. Among smokers, 28% reported they were
“not at all likely” to follow doctor recommendations to stop
or cut back. Reported likelihood did not differ by gender,
diagnostic group or study site. While 46% reported they were
“extremely” or “very confident” in following through with
recommended health changes, 78% reported they could use
at least “a little more support” with making recommended
changes. Narrative analyses revealed three themes related
to making changes: 1) making and sustaining health-related
behavioral changes (e.g. losing weight/stopping smoking)
were difficult compared with completing preventive services
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(e.g. doing lab work), 2) additional targeted support was
needed to make and sustain complex changes (e.g. weight
loss), and 3) lack of knowledge about reasons for preventive
care inhibits completion of some services (e.g. colorectal
screening).
Conclusion: Among people with serious mental illnesses,
likelihood of following doctor recommendations is relatively
low for important behavioral changes such as stopping
smoking or increasing exercise. Additional support is needed
to encourage completion of some difficult or invasive
preventive services and for making and sustaining significant
changes in health-related behaviors.
Keywords: behavior change, preventive service use
PS1-38:
Provider Perspectives on Behavioral Health Care
for Adolescents: Barriers and Suggestions for
Improvement
Martina Li,1 Jinnan Li,1 Amy Meehan,1 Judith Chuang,1
Ellis C. Dillon,1 Ming Tai-Seale1
Palo Alto Medical Foundation Research Institute, Palo
Alto Medical Foundation for Health Care, Research and
Education, Mountain View, CA
1

Background/Aims: Onset of behavioral health needs
commonly occurs at adolescence, and best practices call for
early detection and coordinated care. Practices for assessing
and treating these needs are not standardized and may vary
widely. This research explores current provider practices and
perspectives as a first step towards designing better strategies
for adolescent behavioral health care.
Methods: Primary care providers (PCPs) within a
multispecialty delivery system were surveyed and interviewed
about assessment and treatment of adolescent behavioral
health needs, barriers to appropriate care and suggestions for
system improvement.
Results: Of 123 PCPs who completed the survey, 103
(83.7%) felt their teen patients were willing to discuss
behavioral health, 94 (76.4%) felt their teen patients would
want them to treat their behavioral health problems and 95
(76.9%) were confident in their ability to identify behavioral
health needs. However, 61 (49.6%) PCPs were unaware of
available resources, 63 (51.2%) lacked confidence in making
effective referrals, 65 (52.8%) reported limited time was a
barrier, and 72 (58.5%) found behavioral health evaluations
overburdening. Analyses of interviews with 21 PCPs revealed
a lack of confidence among PCPs in assessing and treating
less commonly seen adolescent behavioral health needs
such as bipolar disorder, schizophrenia, substance abuse
and suicidality. Other barriers to adolescent behavioral
health care included: lack of time during appointments,
lack of standardized referral process, and difficulties in
accessing specialty behavioral health providers. PCPs desired
improved care coordination, accessible behavioral health
specialists within the delivery system for better continuity
and coordination of care in contrast to outside specialists,
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and additional resources to help teen patients and families
navigate the system.
Conclusion: While confident about identifying behavioral
health needs among their teen patients, many PCPs report
multiple challenges to providing necessary and appropriate
care to treat their patients. Further research and quality
improvement efforts are needed to improve existing
resources and provide adequate support for providers to
ensure adolescent behavioral health needs are expertly
addressed.
Keywords: adolescent behavioral health, barriers to care

emergency health care visits over three years. Findings
highlight the need to consider the complex interplay between
psychological health and chronic illness management during
adolescence.
Keywords: adolescent mental health, asthma

PS1-39:
Adolescent Psychiatric Comorbidities Prospectively
Predict Greater Asthma-Related Emergency Health
Care Visits

1

Megan Flynn,1 Scott B. Ode1
1

Medica Research Institute, Minneapolis, MN

Background/Aims: Mismanagement of asthma, a prevalent
chronic illness in which breathing airways are narrowed,
can be life-threatening. Although psychiatric diagnoses are
known to hinder self-care, less is known about the individual
and combined impact of three relatively common psychiatric
diagnoses (i.e. depression, anxiety, attention deficit disorder)
on the management of asthma during adolescence, a
developmental stage at which risk for psychiatric diagnoses
is heightened and enduring health habits are established. The
goal of this study was to examine whether the co-occurrence
of adolescent psychiatric diagnoses (i.e. comorbidities)
interferes with the management of asthma, specifically by
contributing to more asthma-related emergency health care
visits across three years.
Methods: Health insurance claims records were extracted for
a sample of 1,158 adolescents (age 10–19 years; 47% female)
diagnosed with asthma who had continuous enrollment across
three years in a regional health plan. Diagnostic grouping
software identified diagnoses of depression, anxiety and
attention deficit disorder as well as their comorbidities.
Place of service codes captured asthma-related emergency
department and urgent care visits. General linear modeling
was used to examine whether psychiatric comorbidities
predicted the average number of asthma-related emergency
health care visits across three years. Specifically, for the focal
independent variable, adolescents were categorized according
to the number of psychiatric diagnoses present; for the focal
dependent variable, the number of emergency department and
urgent care visits were averaged for each month of enrollment
across the three study years.
Results: In the comprehensive model, which controlled
for potential covariates (i.e. gender, age, SES, months
of enrollment), the number of psychiatric comorbidities
significantly positively predicted the average number of
emergency visits across three years (χ2=8.41, P<0.01).
Conclusion: Adolescents with greater psychiatric
comorbidities experienced significantly more asthma-related
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PS1-40:
Adolescent Psychiatric Comorbidities Contribute to
Diabetes-Related Emergency Health Care Visits
Megan Flynn,1 Scott B. Ode1
Medica Research Institute, Minneapolis, MN

Background/Aims: Type 1 diabetes (T1D) is a chronic
illness involving failure to produce insulin, and requires
a demanding management regime to protect against
serious ailments including stroke and cardiovascular
disease. Although psychiatric diagnoses hinder selfcare, less is known about the impact of three relatively
common psychiatric diagnoses (i.e. depression, anxiety,
attention deficit disorder) on the management of T1D
during adolescence, a developmental stage at which risk
for psychiatric diagnoses is heightened, metabolic control
declines and enduring health habits are established. The goal
of this study was to examine whether the co-occurrence (i.e.
comorbidity) of psychiatric diagnoses interferes with the
management of T1D, specifically by contributing to a higher
number of T1D-related emergency health care visits across
three years in adolescence.
Methods: Health insurance claims records were extracted
for a sample of 145 adolescents (age 10–19 years;
52% female) diagnosed with T1D who had continuous
enrollment in a regional health plan across the three study
years. Diagnostic grouping software identified diagnoses of
depression, anxiety and attention deficit disorder, and their
comorbidities. Place of service codes captured T1D-related
emergency department and urgent care visits.
Results: A random effect logistic regression was used to
examine whether psychiatric comorbidities increased the
probability of T1D-related emergency health care visits
within a study year. Potential covariates (i.e. gender,
age, insurance policy type, months of enrollment) were
included; the no psychiatric diagnosis group was used for
comparison. Although single psychiatric diagnoses did not
increase the probability of an emergency health care visit
(P>0.50), psychiatric comorbidities significantly positively
predicted emergency health care visits (P<0.001). Followup analysis revealed a marginal effect of +22%, indicating
that the presence of psychiatric comorbidities substantially
increased the likelihood of an emergency health care visit.
Conclusion: Results supported the hypothesis that psychiatric
diagnoses have a synergistic effect on adolescents’ ability to
successfully manage T1D. These findings highlight the need
to consider the complex interplay between psychological
health and chronic illness management across adolescence.
Keywords: adolescent mental health, diabetes
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PATIENT, PROVIDER AND HEALTH SYSTEM
ENGAGEMENT

C5-2:
An Examination of Mentoring and Training in the
Health Care Systems Research Network

C5-1:
Pathway to Measuring Patient and Family
Engagement: Prioritizing Engagement Behaviors in
the Hospital Setting

Sharon L. Larson,1 Marc Williams,1 Ella Thompson,2
Amber Eruchalu,3 Lela McFarland4

Emily A. Elstad, Mangrum Rikki, Pam K. Dardess, Eric
Johnson2
1

1
2

1

1

American Institutes for Research, Chapel Hill, NC;
American Institutes for Research, Washington, DC

Background/Aims: Growing evidence suggests that patient
and family engagement (PFE) can help achieve the “Triple
Aim” of improving population health and patient experiences
of care while reducing costs. One critical gap as we work
toward these goals is the lack of a clear approach to PFE
measurement to assess associated outcomes and gauge health
care performance. In this project, we draw on an existing
framework to define behaviors that constitute PFE in the
hospital setting and identify a subset of these behaviors that are
of high priority for measure development and implementation.
Methods: We identified engagement behaviors for hospital
leadership, clinicians and patients/families through: a literature
scan of publications and existing measures; key informant
interviews; and input from an eight-member advisory group that
included patients and families, clinicians, measurement experts
and hospitals. To prioritize engagement behaviors, we categorized
these behaviors into thematic domains, surveyed our advisory
group and other experts in PFE and synthesized feedback to
select a set of high-priority behaviors for PFE measurement
that address multiple domains, are feasible to measure and are
important for driving change or increasing accountability.
Results: Eight domains of engagement in the hospital
setting were prioritized: access to medical record, creating
opportunities for engagement, communication, discharge
planning, family presence, goal-setting, shared care planning,
and transparency. These domains include specific highpriority engagement behaviors at the hospital, clinician and
patient levels. For example, priority behaviors in the “access
to medical record domain” include: hospitals make medical
records easily accessible and involve patients and families in
designing medical record access mechanisms and policies;
clinicians record patient medical information in plain language
(free of jargon and abbreviations); and patients access and use
their medical record.
Conclusion: PFE measurement is at a nascent stage. To our
knowledge, this is the first work to systematically identify
behaviors that constitute PFE in the hospital setting and
prioritize those that are feasible and important to measure.
The resulting matrix of high-priority measurement behaviors
mapped against domains and levels of PFE provides a
comprehensive approach for measuring PFE in the hospital
setting, including the selection and development of measures.
Keywords: patient and family engagement, hospital quality
improvement
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Center for Health Research, Geisinger Health System,
Danville, PA; 2Group Health Research Institute, Seattle,
WA; 3Catholic Health Initiatives, Englewood, CO;
4
Catholic Health Initiatives, Baltimore, MD
1

Background/Aims: The Health Care Systems Research
Network (HCSRN) commissioned a survey to characterize
mentoring and training within member organizations and
to identify gaps in mentoring and training at the member
organization and network levels. In an era of increasing focus
on team science and multidisciplinary teams, it is important
for organizations such as HCSRN to understand the capacity
of its member organizations to train and develop a new
generation of researchers. The goals of this study were to:
describe mentoring within organizations, identify gaps as well
as strong programs of mentoring, and identify other meetings
that our researchers attend to understand the education and
training of interest.
Methods: A 14-item electronic survey was distributed to
HCSRN board members for distribution to all researchers in
each organization. This represents a descriptive analysis of
responses.
Results: A total of 157 researcher/scientists and executives
from 19 organizations responded to the survey. Responses
by career level included 12 institutional leaders, 35
junior faculty, 33 midlevel faculty and 60 senior faculty.
About half of all respondents indicated that there is a
formal mentoring program in their organization. The most
frequently reported characteristics of mentoring programs
included: 1) development of joint applications by junior and
senior researchers (49%), 2) advocacy by mentor (40%), 3)
methods training (39%), and 4) formal mentoring meetings
(39%). Further analysis of characteristics of mentoring will
be presented.
Conclusion: There are a number of opportunities to shape
a network approach to mentorship by capitalizing on
existing approaches taken by individual organizations
within the network. There were several suggestions for the
development of mentoring networks and mentorship training
and to provide senior researchers with tools and resources to
mentor their protégés. Additionally, the network may offer
didactic training in grantsmanship, project management
and portfolio development for investigators at the junior,
midcareer and senior levels of research within the purview
of training that HCSRN can provide to its membership.
Finally, many respondents requested training in specific
methodologies that may warrant the development of a
webinar series for all career levels.
Keywords: mentor, scientific education
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C5-3:
A Clinical Decision Support System Promotes
Shared Decision-Making and Cardiovascular Risk
Factor Management

C5-4:
Connecting Primary Care Patients to Community
Resources: Lessons Learned From the Development
of a New Lay Primary Care Team Role

JoAnn M. Sperl-Hillen,1 A.L. Crain,1 Heidi L. Ekstrom,1
Karen L. Margolis,1 Patrick J. O’Connor1

Clarissa W. Hsu,1 Erin Hertel,1 June BlueSpruce,1 Tyler
R. Ross,1 Allen Cheadle,1 Eric Johnson,1 Juno Matthys,1
Kelly Ehrlich,1 Katie Coleman,1 Janice Tufte,1 Michelle
Robbins,1 Paul Fishman1

HealthPartners Institute for Education and Research,
Minneapolis, MN
1

Background/Aims: Cardiovascular (CV) Wizard is a
web-based electronic health record-integrated point-ofcare clinical decision support (CDS) system that presents
personalized CV risk information to providers and patients
in both a low-numeracy visual format and a high-numeracy
quantitative format. We report primary care provider
perspectives on how this CDS system affected shared
decision-making and CV risk factor management.
Methods: Twenty clinics were randomized to either usual
care or use of the CDS system with diabetes, heart disease
or high-reversible CV risk adults. The CDS system targeted
20% of office visits and was used at 70–80% of targeted visits
over a 2-year period. Consented providers (N=102) were
surveyed at baseline and 18 months after implementation.
Corrected survey response rates were 90% at baseline and
82% at follow-up. Generalized linear mixed models were
used to compare usual care and CDS responses to common
questions at baseline and follow-up, and CDS users were
queried on their perceptions of the CDS system at followup only.
Results: Compared to usual care providers, those in the
CDS group reported increased follow-up rates of CV risk
calculations while seeing patients (73% vs. 28%, P=0.006),
being better prepared to discuss CV risk reduction priorities
with patients (98% vs. 78%, P=0.03), providing accurate
advice on aspirin for primary prevention (75% vs. 48%,
P=0.02) and more often discussing CV risk reduction
(60% vs. 30%, P=0.06). CDS users reported that the CDS
system improved CV risk factor control (98%), saved time
when talking to patients about CV risk reduction (93%),
efficiently elicited patient treatment preferences (90%),
was useful for shared decision-making (95%), influenced
treatment recommendations (89%) and helped initiate CV
risk discussions (94%); 85% of providers reported that their
patients liked CV Wizard.
Conclusion: The CV Wizard CDS system was successfully
integrated into the workflow of primary care visits with high
sustained use rates, high primary care provider satisfaction,
high patient satisfaction and positive impacts on providerreported clinical processes related to CV risk factor
management.
Keywords: clinical decision support, patient engagement
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1

Group Health Research Institute, Seattle, WA

Background/Aims: Social determinants of health play
a critical role in both the prevalence and outcomes of a
wide range of chronic illnesses. The growing recognition
of both the role that social determinants play in population
health outcomes and the need to address these requires
stronger partnerships between primary care teams and
community organizations. In support of this goal, the
Learning to Integrate Neighborhoods and Clinical
Care (LINCC) project, funded by the Patient-Centered
Outcomes Research Institute and implemented at Group
Health, convened patients and staff to co-design a new role
on the primary care team aimed at helping patients better
connect with community resources through one-on-one
coaching and follow-up. We implemented this program in
three pilot clinics to assess the challenge of incorporating
this new team member into primary care practices and the
potential impact this program would have if scaled to the
entire delivery system.
Methods: We used a mixed-methods approach to document
and evaluate the design and implementation of this new role.
Data collection included patient surveys, review of electronic
health record documentation, site visits, staff interviews and
patient focus groups.
Results: We will present a case study on the implementation
and evaluation of this role (analysis in progress) with a focus
on findings and lessons learned that will enable others to
learn from or replicate this pilot. Our findings will include
documentation of the patient-centered design and specific
scope of work for the role, its integration into the primary
care team, and specific tools and approaches developed. We
also will report process measures including patient volume,
descriptions of the patients served, percentage of patients
who completed an action plan, progress made toward
accomplishing goals, resources referred and used, and patient
satisfaction with the services received.
Conclusion: The LINCC project helped patients connect to
community resources by providing deep knowledge of local
resources, personalized coaching, goal setting and followup, and an ongoing connection to the primary care team.
Preliminary findings highlight the challenges and successes
associated with implementing this role and show promising
results in terms of patient receptivity and satisfaction with the
service.
Keywords: implementation science, primary care teams
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PS2-60:
Integration of Clinical Research Into Health Care
Operations: A Comparison of Two Systems
Steven Ziemba,1 Brent Ibata2
Marshfield Clinic Research Foundation, Marshfield
Clinic, Marshfield, WI; 2Cardiac Research Foundation,
Sentara Heart Hospital, Norfolk, VA
1

Background/Aims: Clinical research has become a common
component of many health care systems, whether or not they
embrace research on a strategic level. However, the nuances
of clinical research differ from those of health care, opening
the door for inefficiency, poor study outcomes and increased
participant risk. We present here a comparative case study on
two unaffiliated health care systems that successfully engage
in clinical research via different models.
Methods: We examine the clinical research operations of
two health care systems, Marshfield Clinic in Marshfield, WI,
and Sentara Healthcare in Norfolk, VA. Each system brings
unique attributes to the administration of clinical research,
including patient population, support infrastructure, physician
engagement, regulatory compliance, financial performance,
and overall study selection and conduct. Each of these factors
are assessed and presented in a comparison of the models each
health care system utilizes.
Results: The clinical research operations of the two health
care systems described present successful models for the
integration of research into health care. Similarities exist, but
an analysis of their different approaches will provide valuable
information to other sites faced with comparable challenges.
Conclusion: Clinical research is engaged in an environment of
contrasts. It shares some common elements such as regulatory
requirements and compliance. Drastic differences also can
exist between organizations, such as the types of patients
served and the engagement of physicians and organization
leadership. Understanding how to identify and address these
differences can facilitate more successful research overall,
providing benefit to all health care systems.
Keywords: clinical research, system model
PS2-61:
WIC Nutritionist Perspectives on Opportunities and
Challenges Regarding Care Coordination With Primary
Care Providers for Early Childhood Obesity Prevention
Lisa Bailey-Davis,1 Lindsey B. Hess,2 Michele Marini,2
Jacob Mowery,3 Shawnee Lutcher,1 Jennifer S. Savage2
Obesity Institute, Geisinger Health System, Danville, PA;
Center for Childhood Obesity Research, Pennsylvania
State University, University Park, PA; 3Center for Health
Research, Geisinger Health System, Danville, PA
1
2

Background/Aims: Economically disadvantaged children
experience disparities in obesity rates despite having
numerous points of contact with the broader health care
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community, namely primary care and the Woman, Infants, and
Children (WIC) federal assistance program. Our purpose was
to evaluate the perspectives of WIC regarding the potential to
coordinate community-based care with the primary care.
Methods: We used a semi-structured interview guide to
gather perspectives of WIC nutritionists (N=35), including
state program leaders, through seven focus groups in a MidAtlantic state. Investigators used a grounded-theory approach
to independently open-code transcripts. Next, categories were
identified and emerging themes reported.
Results: Key themes include: a) WIC is challenged by a
clutter of feeding messages from health care, media, family
and friends; b) Coordinating care across sectors could enhance
patient-centeredness and outcomes; and c) Health information
technology strategies are but one piece of a coordinated care
system. WIC nutritionists, experts in feeding education,
described their role in care but perceive limited power and
influence to resolve conflicts in messaging that function as
barriers to learning. Bidirectional data sharing (e.g. measured
weight and length, immunizations) would be a first step forward
toward coordination of care between sectors. Core educational
messages, parent written consent, time-sensitivity, defining
the scope of practice, relationship building and training are
additional issues to be addressed to coordinate care.
Conclusion: WIC perceives opportunity for exponential
benefits in reducing message conflict by coordinating care for
mother and child-centered needs. Health care provider and
patient perceptions should be explored.
Keywords: health system engagement, community providers
PS2-62:
Weight-Related Messages in Well-Child Visits: What
Do Teens Desire?
Andrew S. Bossick,1 Gwen Alexander,1 Tanya Troy,1 Heather
Olden,1 Charles Barone,2 Andrea E. Cassidy-Bushrow1
Department of Public Health Sciences, Henry Ford
Health System, Detroit, MI; 2Department of Pediatrics,
Henry Ford Health System, Detroit, MI
1

Background/Aims: With the United States’ prevalence of
childhood obesity at approximately 17%, well-child visits
are a critical time to discuss well-being, physical activity
and other concerns. Discussion of healthy weight is a key
component of these pediatric visits. Appropriate delivery of
weight-related messages to adolescents and their families is
critical. Accusatory messages may distance adolescents from
health care, whereas nondirect approaches could suggest
unhealthy weight is nonproblematic. Feedback on weightrelated messages during the well-child visit may improve
health care delivery in this setting.
Methods: Opinions on weight, weight-related messaging,
blood pressure and lipid testing knowledge were collected
through focus groups with adolescents 14–18 years old.
Eligible adolescents had a body mass index > 85th percentile
and/or a diagnosis of high blood pressure or high cholesterol.
A framework matrix method was used for data analysis.
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Results: Four focus groups, stratified by gender, were held
(16 participants [9 male]; mean age 15.7 ± 1.05 years). Teens
expressed that a relationship based on provider trust, built over
time, with personal and parental responsibility, are important
aspects of the well-child “team.” Adolescents voiced strong
desire for parental inclusion in health-related discussions.
Ideal parental involvement was described as supportive and
encouraging to provider recommendations. Teens expressed a
lack of knowledge and awareness, along with misconceptions,
about health consequences due to unhealthy weight, blood
pressure and cholesterol. Providers were described as a resource
to discuss weight-related topics; teens expected and welcomed
weight-related conversations. Adolescents appreciated casual
conversations based on activities and interests, although a serious
approach was considered helpful to encourage meaningful
changes. Discussions about blood pressure, cholesterol and
diabetes were categorized as “scary” and “overwhelming.”
Conclusion: Our data suggest a provider-adolescent relationship
built on trust, team work, support and encouragement creates
a positive atmosphere for weight-related messages for teens
during a well-child visit. Adolescents described long-standing
patient-provider histories, suggesting a pediatric medical home
concept may be critical in positive discussions of weight. Next
steps include analyzing similar parent and provider focus group
data and incorporating focus group concepts into a patientcentered, brief, educational intervention for providers focusing
on weight-related messages during the well-child visit.
Keywords: well-child visit, qualitative data

framework recruits and trains a representative group of PFAs and
embeds them in projects where their perspective is incorporated
into patient care, work processes and current/future research.
Through collaboration with PFAs, researchers, community
leaders, system senior leadership, and clinical, operational and
corporate support services, we are continuously evaluating our
processes, learning and making improvements.
Results: A key success story example is our process
improvement project for head and neck cancer patients begun
as a PFA council to develop a patient resource guide, which
evolved using our engagement model into a Patient-Centered
Outcomes Research Institute-funded award to study qualityof-life outcomes. Total PFAs = 110, total system improvement
teams = 8, and total research project teams = 5.
Conclusion: Developing a PFA resource has provided three
key benefits. Researchers benefit by executing patientcentered research through engagement of advisors in all
phases of projects, including the development of new grant
ideas. PFAs benefit by sharing their stories with providers
to create evidence-based improvements and results. Finally,
learning how we can improve our health system through the
eyes of patients can improve outcomes through safe, effective
and patient-centered care processes.
Keywords: patient advisor, engagement

PS2-63:
Leveraging Core Competencies of Collaboration
and Innovation to Create a Health System Patient
Advisor Resource

Janet L. Williams,1 Alanna Kulchak Rahm,1 F. Daniel
Davis2

Karen E. Kippen,1 Heather Olden1
Department of Public Health Sciences, Henry Ford
Health System, Detroit, MI
1

Background/Aims: The Institute of Medicine’s Six Aims for
Improvement include health care that is patient-centered. With
this foundation, Henry Ford has established a unique network
rooted in patient, community and health system priorities
to create a patient advisor group housed in its public health
sciences department. This sustainable health system resource
recruits, trains and engages four types of patient/family
advisors (PFA): health system advisors, research advisors,
e-advisors, and focus group advisors. These advisors are
integrated into patient-centered outcomes research, quality
improvement projects and service excellence teams, with an
increasing demand for more advisors throughout the system.
Methods: Located in a vertically integrated health system,
our innovation is making patient-centered approaches central
to our research and to the health care the system provides.
By leveraging our core competencies of collaboration and
innovation, this group was built on the foundation of shared
patient, community and health system interests with an overall
goal to create advisory councils at all system locations. This
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PS2-64:
Formalizing and Optimizing Patient Engagement in
a Large Health Care System

Genomic Medicine Institute, Geisinger Health System,
Danville, PA; 2Bioethics, Geisinger Health System,
Danville, PA
1

Background/Aims: Patient engagement and patientcenteredness have become catchphrases used as core principles
in reference to the Affordable Care Act, the Learning Healthcare
System workshop, value-driven care and the Patient-Centered
Outcomes Research Institute. Patient engagement is not a new
concept; in 2001, the Institute of Medicine defined patientand family-centered care as care based on continuous healing
relationships, customized according to patient needs and
values, patient control, information equipoise, transparency
and anticipation of patient needs. Increased attention is also
being paid to include patient-defined outcomes, demonstrated
shared decision-making and patient assessed value in their
care as benchmarks for reimbursement.
Methods: At Geisinger Health System, we have developed a
framework to guide patient engagement across the continuum
of care and in research and discovery to meet the strategic aim
of enhancing the experience and quality of care for patients and
their families. We have launched several initiatives and working
groups to improve engagement of patients, families and clinical
stakeholders to continue evolving as a learning health care
system. Initiatives include assessment of existing expertise to
assist in engagement across the research continuum, multiple
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advisory boards and development of purposeful community
engagement activities. Workgroups developed include projectspecific patient advisory committees, a patient engagement
workgroup comprised of stakeholders across research and health
care operations, and workgroups to design specific engagement
tasks such as symposia and knowledge assessments regarding
the learning health care system environment.
Results: We will present the overarching framework and
strategies developed by the patient engagement workgroup
and share materials and strategies employed to encourage
meaningful patient engagement in study design, measures,
analysis and conclusions. Strategies include pre-engagement
activities, identifying patient research partners, supporting
patient partners and defining the role of patient partners in
dissemination and implementation.
Conclusion: Effective patient and family engagement in research
depends on adequate technical, programmatic and human
resources that collectively constitute an integral infrastructure.
Keywords: patient engagement, learning health care system
PS2-65:
Building a Patient Stakeholder Council and Patient
Partner Registry: Resources for Patients and
Researchers
Sarah Madrid,1 Leslie Wright,1 Heather Tabano1
Institute for Health Research, Kaiser Permanente
Colorado, Denver, CO
1

Background/Aims: Patient input is critical to ensuring that
research studies and their outcomes are relevant to patient
priorities and needs. Research teams need a way to quickly identify
appropriate patient partners for engaged research, and patients
anxious for a voice in research need a way to access research
teams and organizations. The Patient Stakeholder Council (PSC)
and Colorado Patient Partners in Research (CoPPiR) network
address these needs. The PSC broadly informs research agendas
while the CoPPiR network connects patients with research teams,
giving teams a way to rapidly identify, contact and recruit patient
partners with specific characteristics.
Methods: Kaiser Permanente Colorado’s Institute for Health
Research, Denver Health’s Center for Health Systems Research
(CHSR), and the CHSR’s Community Advisory Panel are
partnering equally to create these resources, and methods will
be the focus of this presentation. All three partners defined the
purpose and goals of the PSC and are collaborating to recruit
and train all members of the PSC. Simultaneously, the three
partners are building the CoPPiR network infrastructure. The
CoPPiR website provides a centralized means of providing
information about the network, facilitating recruitment of
members and responding to requests from individual research
teams. Both resources explicitly prioritize recruitment of
members reflecting the demographic, socioeconomic and racial/
ethnic characteristics of these two health system memberships.
Results: The outcomes of the successful creation of both the
PSC and the CoPPiR network include improving research
teams’ abilities to write patient-centered research proposals
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and conduct studies whose outcomes are more relevant to
patient populations. Equally important is the empowerment of
patient research partners to influence overall research agendas
and, in individual research studies, to voice concerns, insights
and preferences of patients.
Conclusion: Tackling the needs of both patients and researchers
in the development of engagement resources provides a winwin in the effort to increase the quality and meaningfulness
of patient-centered outcomes research. Further, establishing
both a broadly focused panel and a mechanism for matching
patient partners with specific research teams to provide deeper
insights on a particular disease burden or health condition
effectively addresses distinct needs of research organizations
and provides a model for replication elsewhere.
Keywords: patient engagement, patient-centered outcomes
research
PS2-66:
Evidence-Based Practice Integration Designed to
Optimize Patient Care and Outcomes to Achieve the
Triple Aim
Jeffrey Hansen,1 Camille Haycock,1 Elizabeth M. Evans2
CHI Evidence-Based Practice/Care Continuum, CHI
Institute for Research and Innovation, Englewood,
CO; 2CHI Foundation, CHI Institute for Research and
Innovation, Englewood, CO
1

Background/Aims: Evidence-based practice (EBP) integration
at Catholic Health Initiatives (CHI) is a multidisciplinary
collaborative approach to optimize patient care and outcomes.
The process and structure for EBP integration at CHI involves
translating research-based, evidence-supported knowledge
into clinical practice and process flows. In 2011, CHI founded
the National EBP Advisory Council (NEBPAC) to facilitate
multidisciplinary collaborative identification of and support
for organizational EBP initiatives. The first organizational
EBP initiative addressed by the NEBPAC was to review
published EBP models for facilitated development of a
custom organizational EBP model and algorithm that would
align with CHI’s core values. In 2012, a five-phase custom
EBP Model© and Algorithm© was deployed by the NEBPAC
to guide EBP integration across the organization.
Methods: In 2013, the NEBPAC facilitated multidisciplinary
development of 13 new organizational EBP toolkits with
inclusion of referential hyperlinks to resources that provide
data-driven decision-making and directional guidance for
addressing identified organizational clinical quality improvement
opportunities. Potential considerations for accurately identifying
organizational clinical quality improvement opportunities
include the following: a) appraisal of organizational culture
and readiness for EBP integration, b) provider/clinician/staff
awareness of foundational clinical practice guidelines published
by national organizations and/or regulatory agencies, c) accuracy
of clinical documentation with ease of electronic abstraction for
analysis and regulatory reporting purposes, and d) evaluation of
clinician resourcing based on patient acuity designed to improve
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clinical quality outcomes.
Results: Potential results associated with EBP integration
include the following: a) improved patient outcomes with
reduced cost of care involving complications, length of
stay or mortality; b) increase in government-sponsored
incentives with avoidance of penalties; and c) achievements
in accreditations and designations for excellence.
Conclusion: CHI’s approach to EBP integration allows for
data-driven decision-making that promotes clinical quality
improvement. This approach contributes to achievement of
the Triple Aim.
Keywords: evidence-based practice, Triple Aim

VDW METHODS AND PROCESSES
B2-1:
Transition to ICD-10 Diagnoses and Procedures in
the HCSRN Virtual Data Warehouse
Don Bachman,1 Michael J. Allison,1 Alan E. Bauck,1
Catherine Cleveland,1 Phil Crawford,1 Suzanne
Gillespie,1 Mary Ann McBurnie,1 Mark C. Hornbrook,1
Alexandra M. Varga,1 Xiahai Yang,1 Roy Pardee2
Center for Health Research, Kaiser Permanente
Northwest, Portland, OR; 2Group Health Research
Institute, Seattle, WA
1

Background/Aims: Federal regulations require that all U.S.
health care providers transition from ICD-9 to ICD-10 for
diagnosis and hospital procedure coding on Oct. 1, 2015.
The changes between the two versions are dramatic; the new
version expands the number of diagnosis codes from about
13,000 to 68,000 and increases the number of procedure
codes from approximately 4,000 to 90,000. These changes
require programmers to modify their file-building software
when creating the diagnosis and procedure tables in the
Health Care Systems Research Network (HCSRN) Virtual
Data Warehouse (VDW). We will describe the transition to
ICD-10 diagnostic and procedure data in the VDW as well as
development of data quality reports to check on completeness
of ICD-10 conversion at the participating HCSRN sites.
Methods: The ICD-10 transition team from Kaiser Permanente
Northwest’s Center for Health Research worked with subject
matter experts and research project staff to develop categories
of ICD-9 and ICD-10 diagnosis and procedure codes that all
signify the same general condition (e.g. diabetes, congestive
heart failure). The team then developed a program that plots
daily counts of patients with one or more of the codes in
each category. These plots show the consistency of counts of
patients within each category before and after the transition
date for the two ICD coding systems. This program will be
distributed to the HCSRN sites to use as an early warning
system for issues in the transition and to validate the VDW
tables. Sites shared their results with the HCSRN Utilization
Work Group.
Results: We expect to find that the counts of patients with
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specific ICD diagnosis and procedure categories are consistent
before and after the transition to ICD-10 for most HCSRN
sites. We also believe the monitoring reports will be useful
for identifying issues early, which should prompt corrections
to the VDW before research teams begin using ICD-10 data.
Conclusion: We expect that HCSRN sites will use these
reports to validate ICD-10 diagnostic and procedure data
and demonstrate these data are ready to be used in the VDW.
Research teams will need to create crosswalks between ICD-9
and ICD-10 data if their projects span Oct. 1, 2015.
Keywords: ICD-10 diagnoses, ICD-10 procedures
B2-2:
Application of Propensity Score Models
Observational Studies Using VDW Data

in

Nikki M. Carroll1
Institute for Health Research, Kaiser Permanente
Colorado, Denver, CO
1

Background/Aims: Treatment effects from observational
studies may be biased since the patients were not randomly
allocated to a treated or untreated group. Propensity
score methods are increasingly being used to address this
bias. The propensity score is the probability of treatment
assignment conditional on observed baseline characteristics.
After appropriately adjusting for the propensity score, the
distribution of observed baseline covariates will be similar
between treated and untreated patients.
Methods: The estimation of propensity scores and how they
can help in adjusting the treatment effect for differences in
baseline imbalances are reviewed. Variable selection for the
propensity score model, balancing the propensity score, and
suggestions on what to do when the propensity score does not
balance also are reviewed. The strengths and limitations of each
of the different methods of propensity score adjustment are
presented (e.g. matching, covariate adjustment, stratification,
inverse probability of treatment weighted [IPTW], stabilized
IPTW) as well as recommendations for different sensitivity
analyses to look at the magnitude of hidden biases. Finally,
suggestions are provided on what to present in the report of
the final analysis.
Results: Propensity score methods are illustrated by
estimating the effect of angiotensin-converting enzyme
inhibitor (ACEI) and angiotensin receptor blocker (ARB) use
in stage IIIb/IV non-small cell lung cancer (a project funded
by Kaiser Permanente’s Center for Effectiveness & Safety
Research). All steps of the propensity score methods used
to analyze the effect of ACEI and/or ARB antihypertension
treatment on survival in advanced stage non-small cell lung
cancer patients are described.
Conclusion: Although propensity scores cannot control for
unobserved or unmeasured confounding, propensity score
analyses can address residual confounding by simulating
randomized control trials and are a tool one can use when
comparing two treatment groups.
Keywords: propensity score, observational study methods
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B2-3:
Mapping Medication Orders to RxNorm Concepts
Jenny Staab,1 Andy Karnopp1
Center for Health Research, Kaiser Permanente
Northwest, Portland, OR
1

Background/Aims: There is a multitude of coding or
classification systems for medications. While dispensed
medications have traditionally been identified using National
Drug Codes (NDCs), there has been no equally universal
vocabulary for ordered medications. However, RxNorm, a
nonproprietary drug terminology system developed by the
National Library of Medicine, has become increasingly
popular. Both PCORnet and the Observational Medical
Outcomes Partnership’s Common Data Models have adopted
RxNorm as a standard vocabulary for medications. RxNorm
concepts range in specificity from branded packaged drugs
to simple ingredients and can be linked to many proprietary
and nonproprietary vocabularies such as NDCs or Medi-Span
Generic Product Identifier (GPIs). We developed a method
to map drugs from drug names and other drug terminologies
to RxNorm concept unique identifiers (CUIs).
Methods: Data on ordered medications were extracted from
Kaiser Permanente Northwest’s Clarity database. These
data contained text strings identifying drugs and generic
ingredient names as well as codes from different drug
vocabularies including RxNorm, GCN Sequence Numbers,
GPIs and NDCs. These vocabularies were available for
overlapping subsets of the medications list. We used directly
available CUIs and crosswalks linking other vocabularies to
RxNorm. For drugs that could not be mapped satisfactorily,
we also employed approximate string matching using
RxMix. Potential concept matches were ranked using a
scoring algorithm and the best match chosen. CUIs deemed
highly reliable, such as those provided directly from Clarity
or deemed a perfect match by RxMix, scored higher. CUIs
scored lower if they were derived from obsolete NDCs or
scored poorly on RxMix.
Results: We found CUIs for over 95% of orders; 75% of
matches were fully specified drugs, the remaining were
mostly ingredients. About 10% of CUIs were found only via
string match, with an average confidence score of 75%.
Conclusion: There are multiple ways to map medications
to RxNorm concepts. Using direct crosswalks based on
standardized terminology is preferable, as it affords higher
certainty. However, approximate string matching can provide
mappings for medications without available standardized
terminology. It also can improve data quality by mapping to
more specific RxNorm concepts and supporting validation
of the direct mapping results. The adopted level of certainty
for inclusion in the dataset should be well documented.
Keywords: RxNorm, pharmacy
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B2-4:
The CHI Institute for Research and Innovation
Virtual Data Warehouse –– A Case Study of Health
Operations Partnership in Development of Data
Assets
Lela McFarland,1 Deborah O’Dell,2 Matthew Taylor,3
Laurie Jenson4
Clinical Data Research Management, CHI Institute for
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CO; 4National Oncology Service Line, CHI Institute for
Research and Innovation, Englewood, CO
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Background/Aims: The Virtual Data Warehouse (VDW)
was created as a mechanism for producing comparable data
across different health care organization sites for purposes of
proposing and conducting research. At the core of the VDW
are a series of standardized file definitions. The content areas
and data elements included in the VDW data specification are
commonly required for research studies.
Methods: The VDW specifications were used as a
foundational guide for the development of an organizationally
shared Catholic Health Initiatives (CHI) enterprise data
store. This shared organizational data capability became the
upstream source from which the CHI Institute for Research
and Innovation was able to establish a VDW, along with other
research industry standard models such as Observational
Medical Outcomes Partnership or Informatics for Integrating
Biology and the Bedside databases.
Results: In order to collaboratively build a repository with our
parent health care organization, several key elements needed
to be established. First, effective governance structures
needed to be employed including cooperative buy-in into
shared timelines and priorities. Second, VDW specifications
had to be translated to be more easily consumable by a
nonresearch audience. Third, organizational reporting
needs were compared against VDW model capabilities to
understand their relevancy beyond research analytics and
identify enhancements that were needed to make base VDW
model capabilities to broaden the applicable audience of the
model. Fourth, cooperative approaches to understanding
data quality had to be developed. Finally, the process of
ongoing governance and prioritization of improvements and
expansions were established.
Conclusion: The approach of research analytics sharing in
the development of organizational health operations data
assets has brought a number of benefits in establishing a
VDW. However, the shared approach also highlighted areas
where additional work is needed to establish synergy between
research analytics and health operations analytics efforts.
Keywords: Virtual Data Warehouse, analytics
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PS2-67:
Estimating Generic Drug Utilization With Electronic
Health Records From a Mixed-Payer Ambulatory
Health Care Delivery System
Robert J. Romanelli, Vani Nimbal, Trang Le, Jodi B.
Segal3
1

1

2

Palo Alto Medical Foundation Research Institute, Palo
Alto Medical Foundation for Health Care, Research
and Education, Palo Alto, CA; 2Department of Clinical
Pharmacy, University of California, San Francisco, San
Francisco, CA; 3Department of Medicine, Johns Hopkins
School of Medicine, Baltimore, MD
1

Background/Aims: Generic drug utilization in an outpatient
setting is typically measured through reconciled pharmacy
claims data; however, not all health care systems have access
to these data for their populations. We sought to develop and
validate an automated algorithm to estimate generic drug
utilization with electronic health records (EHR) data.
Methods: We chose 25 therapeutic classes to study due
to their potential for poor generic uptake. We developed a
generic utilization algorithm using EHR prescribing data (i.e.
medication name and indicator of a dispense-as-written request)
from a mixed-payer health care system in northern California in
2013. These data were combined with information on generic
product availability from Drugs@FDA and Redbook™ at the
time prescriptions were written. The algorithm was validated in
a cohort of ambulatory managed-care beneficiaries for whom
prescribing data and pharmacy claims data (i.e. gold standard)
are both available. An estimated generic utilization rate (GUR)
across therapeutic classes was calculated by applying the
algorithm, and its performance was assessed. We next applied
the algorithm to electronic prescribing data from a cohort of
non-managed-care beneficiaries for whom pharmacy claims
data are not available.
Results: We identified 20,750 managed-care beneficiaries
with an electronic prescription for a drug product in the
therapeutic classes of interest in 2013 and a corresponding
pharmacy claim. We also identified 119,153 non-managedcare beneficiaries with electronic prescriptions for products
in the same therapeutic classes. Managed-care and nonmanaged-care beneficiaries were similar with respect to age,
sex and race/ethnicity. Applying the algorithm, we estimated a
GUR of 58.7% among managed-care beneficiaries; the actual
GUR based on pharmacy claims was 57.2%. Sensitivity (96%)
and specificity (94%) of the algorithm were high, and total
percent agreement was 96%. In the cohort of non-managedcare beneficiaries, a similar GUR was estimated (56.1%).
Conclusion: A generic utilization algorithm that combined
EHR data with information on generic product availability
was validated and performed well in estimating the GUR
for outpatient prescriptions in a cohort of managed-care
beneficiaries, independent of pharmacy claims data. Health
care delivery systems may apply the methods described herein
to quantify generic utilization in their ambulatory populations
for quality improvement and research initiatives.
Keywords: generic drugs, electronic health records
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PS2-68:
Using SmartTools to Capture Structured Data From
Text: The LINCC Case Study
Tyler R. Ross,1 June BlueSpruce,1 Erin Hertel,1 Woody
Favinger,1 Clarissa Hu1
1

Group Health Research Institute, Seattle, WA

Background/Aims: The widespread adoption of modern
electronic heath records (EHR) has digitized medical
information previously captured on paper. However,
research and analysis requires use of narrative text and
involves resource intensive chart review and/or natural
language processing. An emerging alternative solution is to
use SmartTools in Epic’s EHR. We present a case study of
a research project using linked SmartTools in Epic to create
structured data from text and describe the strengths and
challenges of these tools.
Methods: The Learning to Integrate Neighborhoods and
Clinical Care (LINCC) study collaborated with clinic staff
to develop SmartPhrases with embedded SmartLists to be
used by community resources specialists (CRS). The CRS
were trained to use these SmartPhrases to document their
patient interactions and capture critical information for
process improvement and evaluation. The LINCC study
worked with information technology (IT) to preserve
SmartList selections in discrete fields in the EHR
reporting database. The study team retrieved both the CRS
notes and the linked SmartList selections and created an
abstraction system in which values for relevant variables
could be coded.
Results: The CRS began documenting patient encounters
using SmartPhrases before their embedded SmartLists were
linked to the reporting database. As a result, only free-text
data were available from the early part of the study period. As
the CRS position evolved, the SmartPhrases were modified
and new SmartLists required linkage. This iterative process
created inconsistency in measurement over the study period
and occasional loss of information due to linkage timing.
Inconsistency in how SmartPhrases were used within and
across the CRS led to further measurement error. Ultimately,
the team abstracted variable values from free-text notes for
the final set of measures for analysis.
Conclusion: In this case study, despite clinic leadership and
IT support and the opportunity to use SmartTools, abstraction
from each CRS note was necessary to obtain some analytic
measures. Although SmartTools did not eliminate the need
for note review, they helped structure documentation,
reduced the number of abstracted measures and provided
supplemental information that aided the abstraction process.
Extensive planning, coordination and training are critical
for SmartTools to be used effectively for gathering research
quality metrics.
Keywords: informatics, electronic health records
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PS2-69:
Design, Implementation, and Response Rates From
an Online Patient Survey to Assess Genitourinary
Symptoms and Related Health Care Experiences of
Postmenopausal Women
Joanna Bulkley,1 Ashley Stoneburner,1 Michael Leo,1
Amanda Clark,2 Kate Beadle,2 Kimberly K. Vesco1
Center for Health Research, Kaiser Permanente
Northwest, Portland, OR; 2Obstetrics and Gynecology,
Kaiser Permanente Northwest, Portland, OR
1

Background/Aims: Nearly 50% of postmenopausal women
experience symptoms related to genitourinary syndrome
of menopause (GSM), including vulvovaginal dryness and
irritation, painful intercourse and urinary incontinence. As
part of a clinician-focused intervention to improve diagnosis
and management of GSM at Kaiser Permanente Northwest,
we conducted an online survey of women with a wellwoman visit to primary care and obstetrics/gynecology (OB/
GYN) to assess patient vulvovaginal, urinary and sexual
symptoms and related health care experiences. Our goal was
to maximize patient participation while minimizing staffing
requirements.
Methods: Electronic communication was used for all contact
with patients, including recruitment, consent, eligibility
screening, survey and thank you gift cards. REDCap was used
for everything except e-gift card ($5) delivery, which required
a separate system. We sent an email invitation to all women
≥ 55 years old with a well-woman visit to primary care or
OB/GYN during the previous week and an email address
on file. Eligible patients were identified from the electronic
medical record and uploaded to REDCap weekly. An initial
recruitment email, which included a link to the survey, was
sent each Tuesday morning. Patients who did not respond were
re-sent the email the next Monday afternoon. Patients who
clicked the survey link were taken to the REDCap site, which
explained the study and contained the IRB-required consent
language. Participants who actively agreed to participate
then completed an eligibility screening page and, finally, the
survey. For security, only one-time access was allowed to the
survey. E-gift cards were sent weekly to all new respondents.
REDCap and SAS software reports were run weekly to track
recruitment patterns and watch for data anomalies.
Results: Email addresses were found for 80% of eligible
women (5,961/7,483). The overall response rate was 25%
(1,483/5,961) and varied across the 18 randomized clinics from
19% to 34%. The response rate was lower for women ≥ 75 years
old (18% vs. 26% for < 75). The active refusal rate was 2%.
Conclusion: Electronic surveys can successfully be used at
relatively low cost, even for topics that are sensitive in nature.
Lessons learned and copies of recruitment, consent, screening
and survey materials as well as recruitment reports will be
presented.
Keywords: patient survey methodology, genitourinary
syndrome of menopause
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PS2-70:
A Novel Method for Estimating Transgender Status
Using EMR Data
Douglas W. Roblin,1 Michael Goodman,2 Lee Cromwell,1
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Emory University, Atlanta, GA
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Background/Aims: “Transgender” broadly describes
individuals who either do not identify with their biological sex or
do not conform to binary gender categories. Studies of transgender
persons are impeded by lack of consistent terminology or coding
to identify the population. Thus, transgender prevalence, direction
of change (male-to-female [MTF] or female-to-male [FTM])
and health outcomes are not well known. We describe a novel
algorithm for identifying a cohort of transgender persons from
diverse electronic medical record (EMR) system data sources.
Methods: Provider visits for Kaiser Permanente Georgia
members enrolled between 2006 and 2014 were collected
from EMR databases. The method to build a cohort involved
an SAS software algorithm, which scanned these databases
for relevant ICD-9 codes and presence of specific keywords
in digitized provider notes. The first step was to identify
transgender status (e.g. keywords “transgender” or “gender
identity”) and the second step to determine natal sex
(e.g. keywords of “ovaries” or “testes”) given confirmed
transgender status. Trained reviewers confirmed transgender
status and, if confirmed, determined natal sex from a limited,
focused review of keyword-containing text strings (± 50–100
characters around the keyword, stripped of protected health
information). Accuracy of identification and proportions of
MTF and FTM subjects were computed, along with 95%
confidence intervals (CI).
Results: Of 823,104 members, 271 were identified as possibly
transgender by the SAS algorithm: 137 through keywords
only, 25 through ICD-9 codes only, and 109 through both ICD9 and keywords. Of these 271, 185 (68%, 95% CI: 62–74)
were confirmed as transgender: 62 (45%, 95% CI: 37–54), 14
(56%, 95% CI: 35–75), and 109 (100%; 95% CI: 96–100) for
keywords only, ICD codes only, and both, respectively. Of the
185 confirmed transgender persons, 95 (51%, 95% CI: 44–59)
were MTF and 76 (41%, 95% CI: 34–49) were FTM; natal sex
remained unknown for the remaining 14 (8%, 95% CI: 4–13).
Conclusion: This method for support of research on
transgender persons is low cost, rapid and valid –– saving
substantial time and cost that would have been required of
review of nearly 1 million medical records. The overall
approach, and the SAS algorithm, can be easily transferred to
other health care systems.
Keywords: disparities, transgender
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PS2-71:
VDW Data Sources: CHI Institute for Research and
Innovation
Lela L. McFarland,1 John Weeks,1,2 Penne Perry,3
Rebecca Towne3
Clinical Data Research Management, CHI Institute for
Research and Innovation, Englewood, CO; 2Perficient
Inc., Englewood, CO; 3National Oncology Service Line,
CHI Institute for Research and Innovation, Englewood, CO
1

Background/Aims: The Virtual Data Warehouse (VDW) was
created as a mechanism for producing comparable data across
sites for purposes of proposing and conducting research. It
is “virtual” in the sense that the data remain at the local sites
rather than at a centralized data coordinating center.
Methods: At the core of the VDW are a series of standardized
file definitions. Content areas and data elements that are
commonly required for research studies are identified, and
data dictionaries are created for each of the content areas,
specifying a common format for each of the elements —
variable name, label, description, code values and value labels.
Local site programmers have mapped the data elements from
their HMO’s data systems into this standardized set of variable
definitions, names and codes as well as onto standardized SAS
software file formats. This common structure of the VDW
files enables a SAS analyst at one site to write one program to
extract and/or analyze data at all participating sites.
Results: The CHI Institute for Research and Innovation
(CIRI) local implementation of the VDW contains detailed
medical information on Catholic Health Initiatives patients.
The initial establishment of the VDW data files focused on the
development of patient demographics, provider demographics,
code mapping capabilities, utilization data, chem laboratory
data, vital signs, social history and tumor data sets. Phase
I also included the development of a non-VDW dataset for
pathology labs. Phase II development focused on pharmacy,
census, decedent and enrollment data as well as the non-VDW
dataset for clinical notes.
Conclusion: This poster demonstrates the range of data
sources used at CIRI to feed information into our local
implementation of the VDW datasets.
Keywords: Virtual Data Warehouse, standardization
PS2-72:
Identifying Race/Ethnicity Data via Natural Language
Processing Among Women in a Uterine Fibroid
Cohort Study
Jane R. Grafton,1 Onchee Yu,1 David Carrell,1 Susan Reed,1
Renate Shulze-Rath,2 Kelly Hansen,1 Delia Scholes1
Group Health Research Institute, Seattle, WA; 2Bater
Health Care, Leverkusen, Germany
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Background/Aims: Uterine fibroids are associated with
morbidity including abnormal bleeding, anemia, pelvic/bladder
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symptoms and adverse reproductive outcomes. Symptomatic
fibroids may affect 25% of women in their late 40s. Race is
among the most consistent risk factors known. The Uterine
Fibroid Study aims to use automated data to estimate fibroid
incidence rates/trends during 2005–2014 in a retrospective
cohort of women at Group Health. Race/ethnicity captured
from automated structured data has improved yet remains
incomplete, particularly with use of retrospective data.
Methods: The study included women 18–65 years old
without hysterectomy, continuously enrolled with evidence of
encounter in 3 years before study entry. Incidence estimates
required absence of fibroid history. We collected fibroid
diagnoses, demographics and other data from the Virtual Date
Warehouse (VDW). VDW demographic race/ethnicity data is
sourced from data collected from Group Practice patients, at
time of encounter, via entry in the electronic health record.
Additionally, Group Health collects race/ethnicity data from
breast cancer screening program and tumor registry data. To
complement traditional structured race/ethnicity data from
VDW, we augmented with race/ethnicity extracted from freetext clinical notes via natural language processing (NLP). Our
NLP system used a rule-based dictionary look-up approach to
identify common terms used to describe patient race/ethnicity
and custom rules to disambiguate race/ethnicity terms that
also have other clinical meanings (e.g. the term “white” in
“54-year-old white female” as opposed to “Her white blood
cell count improved”). We conducted a partial validation of
the NLP system in a sample of patients with known structured
race/ethnicity data.
Results: Prior to amending race/ethnicity data with NLP,
in the cohort of 277,821 women, 37.4% had race/ethnicity
unknown. Fibroid incidence rates (per 10,000 person-years)
were 156 for Hispanics, 133 for whites, 265 for AfricanAmericans, 152 for Asian/Pacific Islanders and 108 for
unknown race. NLP work on identifying race/ethnicity in the
unknown race group is ongoing and results are pending.
Conclusion: Race/ethnicity is an important risk factor for a
number of conditions, including uterine fibroids. Improving
capture of race/ethnicity from available automated data sources
potentially could improve accuracy of research findings and
enhance patient care by providing a better understanding of
the burden of disease in subgroups of affected patients.
Keywords: race, natural language processing
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The Learning Healthcare (Data) System: Virtual Data
Warehouse Data Capture Revisited
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Education and Research, Bloomington, MN; 6Institute for
Health Research, Kaiser Permanente Colorado, Denver,
CO; 7Mid-Atlantic Research Institute, Kaiser Permanente
Mid-Atlantic States, Rockville, MD; 8Essentia Institute of
Rural Health, Essentia Health, Duluth, MN; 9Center for
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Background/Aims: At the 2014 HCSRN annual
meeting, Bachman and colleagues presented an excellent
investigation into rates of encounters and drug fills at Virtual
Data Warehouse (VDW) sites in order to evaluate (among
other things) the VDW enrollment file’s “OUTSIDE_
UTILIZATION” field, which purported to flag periods
during which complete data capture of either pharmacy or
encounter data was suspect. That investigation revealed
serious problems with the flag, calling its usefulness
into question. Taking this to heart, the VDW enrollment
workgroup proposed removing this field and adding a
suite of six new flags intended to express confidence in
the capture of pharmacy, laboratory, outpatient encounter,
inpatient encounter, tumor and electronic medical record
data individually. These flags are assigned by local
VDW analysts on the basis of their knowledge of data
capture limitations at their respective sites for identifiable
subgroups of patients. VDW programs were written and
tested for creating these new data incompleteness variables.
All HCSRN sites were invited to run these programs and
share their results.
Methods: Modeled after Bachman et al.’s work, we
calculated rates of pharmacy fills, lab results, encounters,
tumor records and vital signs by the appropriate new flag.
We then plotted these rates over time to see whether in fact
the people/periods flagged as having suspect data capture
did in fact have lower rates compared to those who/that
were not.
Results: At the sites that implemented the flags, data
capture rates generally varied in line with expectations
— suspected incomplete groups had markedly lower
rates. Of the six flags, “incomplete_rx” saw the best
implementations, with all seven implementing sites showing
clear distinctions between people whose data capture was
suspect and those for whom it was not. “Incomplete_
tumor” had the most variable implementations, with
clear distinctions at some sites but not others.
Conclusion: On balance, the new flags stand to improve
the quality of data-based research in the HCSRN. Projects
needing to define populations at risk of exposure to
particular pharmacy fills, tumors or lab result values, for
example, would do well to use the new flags to screen out
people for whom exposure risk may not be completely
captured.
Keywords: data capture, population-based research
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Validation of the Automated Diagnosis, Intractability,
Risk, Efficacy (DIRE) Opioid Risk Assessment Tool
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Background/Aims: Despite the drastic increases in
prescription opioid misuse and abuse, risk assessment for
aberrant drug-related behaviors prior to initiating opioid
therapy for chronic noncancer pain management continues
to be underutilized in clinical practice. The purpose of the
study was to investigate availability of data elements in
the electronic health record that could be used to assess
risk for aberrant drug-related behaviors with the automated
Diagnosis, Intractability, Risk, Efficacy (DIRE) opioid risk
assessment tool.
Methods: DIRE is a 7-item tool usually administered by a
clinician and used to predict efficacy of analgesia and patient
compliance with long-term opioid therapy. Each factor is
rated from 1 (least favorable case) to 3 (more favorable
case for opioid prescribing). The total score is used for risk
stratification with scores < 14 being an unsuitable candidate
and scores ≥ 14 being possible candidate for opioid therapy.
The validation of the automated process versus clinicianadministered rating was conducted using kappa analysis
and test characteristics (sensitivity, specificity, positive and
negative predictive values).
Results: We developed structured data queries, natural
language processing (NLP) algorithms for unstructured data,
and data mapping strategies to populate the DIRE for a cohort
of chronic noncancer pain patients who were on long-term
opioid therapy and who had a clinician-administered DIRE
documented in the electronic health record prior to signing
the most recent opioid agreement. We used ICD-9 diagnosis
codes and NLP to populate diagnosis, psychological and
chemical risk items. Encounter data and NLP were used for
the reliability item. Intractability and social support items
were populated using NLP only. Information on oral morphine
equivalents, length of treatment, changes in pain scores and
NLP were used to populate the efficacy item. If no information
was found, most items were scored as 3 and efficacy as 2. The
results of the NLP versus clinician-administered validation
kappa analysis and test characteristics are pending.
Conclusion: Among major barriers to appropriate
management of chronic noncancer pain with opioids are
inadequate time and resources available to clinicians at a
point of care for risk assessment. Novel approaches, such as
NLP, may support clinical decision-making by automating the
process of data extraction.
Keywords: natural language processing, risk assessment
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PS2-75:
Automating Research Data Using MetadataDriven Processes to Dynamically Create Loader
Programs
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Background/Aims: The growing complexity and
heterogeneity of source data systems makes maintaining
a research data warehouse challenging, especially with
the increasing need for current data with shorter refresh
cycles and consistent results. A stable extract-transformload (ETL) environment is essential to maintain consistent
results. To address inconsistency, high maintenance costs
and the need to rapidly adapt to data changes, Kaiser
Permanente Northwest’s Center for Health Research
(CHR-NW) undertook an effort to automate the ETL
loading process.
Methods: CHR-NW developed a dynamic loader program
to generate, validate and execute on-demand programs that
load data into the production version of the Virtual Data
Warehouse. It was developed in SQL Server Integration
Services, and SQL Server Agent is used for scheduling and
execution. Transform programs add entries to a task table
upon completion, which the dynamic loader uses to identify
staging tables with new data and then generate a loader
program. Programs are generated using metadata about the
staging tables, allowing adaptation to changes in the data
structures and rapid deployment of new content.
Results: The dynamic loader approach enables CHR-NW
to generate loader code without manual intervention. Its
use of metadata in the staging environment provides the
mechanism to adapt to changes in the data structures. It has
reduced the effort needed to maintain the load step of the
ETL process by reducing the number of programs from 55
to 1. As a reference, in the first half of 2015, those 55 loader
programs were updated an average of four times each and
each program change took approximately 2 hours to change,
review and test. That effort has largely been eliminated.
The load process also runs more consistently, reducing the
error rate from 0.1 to 0.005. Business logic and new and
developing best practices can be applied in one place and are
automatically implemented. In one recent example, CHRNW was able to reduce load times for large tables by 50%
(34 minutes to 15).
Conclusion: Developing the dynamic loader has increased
programmer productivity and the consistency of data load
results, allowing CHR-NW to rapidly apply techniques to
improve computing processing efficiency.
Keywords: Virtual Data Warehouse, dynamic programming
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Background/Aims: Due to the progressive nature of type 2
diabetes mellitus (T2DM), deterioration in a patient’s general
health is inevitable. Hence, the overall health of a T2DM
patient is poor. Markers of worsening overall health such as
metabolic abnormalities are predominant in the progression
to any of the T2DM complications, which mask patterns of
progression to individual complications, thereby making it
difficult to predict which particular complication a patient will
progress to (i.e. direction of progression). We aim to unmask
the patterns and develop the most distinctive and predictive
markers of progression to each individual complication.
Methods: We take a two-step modeling approach using
94,536 T2DM patients’ 10-year, de-identified data from the
OptumLabs™ Data Warehouse, a database that includes
retrospective administrative claims data on commercially
insured and Medicare Advantage enrollees, as well as electronic
medical record data from a nationwide network of provider
groups. First, we build a “general progression” model that
predicts development of any new complication and captures
markers of general health deterioration. Next, we develop
“differential progression” models that predict progression to
individual complications. We use least absolute shrinkage and
selection operator (LASSO)-penalized Cox regressions to select
variables and penalize the “differential progression” models
against the “general progression” model such that “differential
progression” patterns become unmasked. Significance of
markers is determined via permutation test and predictive
performance is evaluated through bootstrap estimation.
Results: For a 6-year follow-up period, 31,968 (34%) of all
patients progressed to at least one complication: chronic kidney
disease (12%), ischemic heart disease (11%), cerebrovascular
disease (8%), congestive heart failure (5%), peripheral vascular
disease (5%), and renal failure (1%). In this ongoing research,
we anticipate our predictive model to demonstrate improved
interpretation of progression to each individual complication
without causing reduced predictive performance.
Conclusion: We study the progression of T2DM to multiple
complications systematically and comprehensively by
applying data mining techniques on the large amount
of claims and clinical data from the OptumLabs Data
Warehouse. By unmasking previously masked patterns and
developing markers that suggest progression to a specific
target complication, our study findings will assist clinicians in
the management and treatment of T2DM.
Keywords: data mining, predictive model, progression of
type 2 diabetes mellitus
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